Mitesco (MITI) 10-Q 13 Feb 24 2023 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2023	Feb. 12, 2024
Document Information Line Items
Entity Registrant Name	MITESCO, INC.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		5,609,014
Amendment Flag	false
Entity Central Index Key	0000802257
Entity Current Reporting Status	No
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-53601
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	87-0496850
Entity Address, Address Line One	505 Beachland Blvd., Suite 1377
Entity Address, City or Town	Vero Beach
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32963
City Area Code	844
Local Phone Number	844-383-8689
Title of 12(b) Security	N/A
No Trading Symbol Flag	true
Security Exchange Name	NONE
Entity Interactive Data Current	Yes

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 24,642	$ 6,191
Accounts Receivable	0	0
Prepaid expenses	0	51,632
Current assets of discontinued operations	1,665	122,465
Total current assets	26,307	180,288
Right to use operating leases, net	0	83,810
Fixed assets, net of accumulated depreciation of $1.1 million and $.06 million	0	44,655
Non-current assets of discontinued operations	0	2,293,228
Total Assets	26,307	2,601,981
Current liabilities
Accounts payable and accrued liabilities	1,903,600	1,945,848
Derivative liabilities	152,937	568,912
Lease liability - operating leases, current	93,758	93,758
SBA Loan Payable	428,507	460,406
Other current liabilities	96,136	96,136
Current liabilities of discontinued operations	9,955,164	5,932,838
Total current liabilities	17,508,089	17,802,473
Lease Liability- operating leases, non-current	0	0
Long term liabilities of discontinued operations	0	3,936,858
Total Liabilities	17,508,089	21,739,331
Commitments and contingencies
Stockholders' equity (deficit)
Common stock subscribed	0	36,575
Common stock, $0.01 par value, 500,000,000 shares authorized, 5,544,519 and 4,630,372 shares issued and outstanding as of September 30, 2023 and December 31, respectively	55,448	46,305
Additional paid-in capital	45,879,763	29,452,514
Accumulated deficit	(63,424,929)	(48,714,462)
Total stockholders' deficit	(17,481,782)	(19,137,350)
Total liabilities and stockholders' equity (deficit)	26,307	2,601,981
Series A Preferred Stock [Member]
Stockholders' equity (deficit)
Preferred stock, Value	0	0
Series C Preferred Stock [Member]
Stockholders' equity (deficit)
Preferred stock, Value	0	10,476
Series D Preferred Stock [Member]
Stockholders' equity (deficit)
Preferred stock, Value	7,500	31,000
Series F Preferred Stock [Member]
Stockholders' equity (deficit)
Preferred stock, Value	194	0
Series X Preferred Stock [Member]
Stockholders' equity (deficit)
Preferred stock, Value	242	242
Nonrelated Party [Member]
Current liabilities
Accrued interest	164,722	185,732
Notes payable, net of discounts	1,143,265	5,112,702
Preferred stock dividends payable	973,872	395,407
Related Party [Member]
Current liabilities
Accrued interest	416,815	198,753
Notes payable, net of discounts	2,100,956	2,776,962
Preferred stock dividends payable	$ 78,357	$ 35,019

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Fixed assets, accumulated depreciation (in Dollars)	$ 1,100,000	$ 60,000
Common stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	5,544,519	4,630,372
Common stock, shares outstanding	5,544,519	4,630,372
Series A Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series C Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares issued	0	1,047,619
Preferred stock, shares outstanding	0	1,047,619
Series D Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares issued	750,000	3,100,000
Preferred stock, shares outstanding	750,000	3,100,000
Series F Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares issued	16,353	0
Preferred stock, shares outstanding	16,353	0
Series X Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares issued	24,227	24,227
Preferred stock, shares outstanding	24,227	24,227
Nonrelated Party [Member]
Notes payable, discounts (in Dollars)	$ 0	$ 400,000
Related Party [Member]
Notes payable, discounts (in Dollars)	$ 0	$ 22,670

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue	$ 0	$ 0	$ 0	$ 0
Cost of goods sold	0	0	0	0
Gross (loss) profit	0	0	0	0
Operating expenses:
General and administrative	321,752	851,528	2,218,835	3,055,703
Impairment of fixed assets	0	0	132,000	0
Total operating expenses	321,752	851,528	2,350,835	3,055,703
Net Operating Loss	(321,752)	(851,528)	(2,350,835)	(3,055,703)
Other income (expense):
Equity investment incentives	(1,214,970)	0	(7,644,077)	0
Financing cost	0	0	(18,617)	0
Gain on forgiveness of debt	0	0	25,000	0
Loss on settlement of true-up obligation	0	0	(119,370)	0
(Loss) Gain on waiver and commitment fee shares	0	(14,081)	0	172,573
Gain (Loss) on issuance of shares to service provider	0	0	33,092	0
Gain on sale of assets	0	0	8,876	0
Gain – other	40,622	0	40,622	0
Loss on legal settlement	0	0	(18,759)	0
Gain on settlement of accrued salary	0	0	0	15,032
Gain (Loss) on conversion of notes and accounts payable to common stock - related party	139,837	0	139,837	0
Gain (Loss) on conversion of notes and accounts payable to common stock	19,687	(10,000)	19,687	(88,235)
(Loss) Gain on revaluation of derivative liabilities	(14,725)	(37,977)	(85,765)	(111,564)
Total other expense	(1,215,382)	(1,774,935)	(9,535,029)	(3,415,607)
Loss before provision for income taxes	(1,537,134)	(2,626,463)	(11,885,864)	(6,471,310)
Provision for income taxes	0	0	0	0
Net loss from continuing operations	(1,537,134)	(2,626,463)	(11,885,864)	(6,471,310)
Net loss from discontinued operations	(15,239)	(1,457,288)	(2,824,604)	(5,062,920)
Consolidated net loss	(1,552,373)	(4,083,751)	(14,710,468)	(11,534,230)
Preferred stock dividends	(531,738)	(81,112)	(1,080,102)	(241,196)
Net loss available to common shareholders - continuing operations	(2,068,872)	(2,707,575)	(12,965,966)	(6,712,506)
Net loss available to common shareholders - discontinued operations	$ (15,239)	$ (1,457,288)	$ (2,824,604)	$ (5,062,920)
Net loss per share from continuing operations - basic and diluted (in Dollars per share)	$ (0.39)	$ (0.59)	$ (2.57)	$ (1.52)
Net loss per share from discontinued operations - basic and diluted (in Dollars per share)	$ 0	$ (0.32)	$ (0.56)	$ (1.15)
Weighted average shares outstanding - basic and diluted (in Shares)	5,329,816	4,569,115	5,048,070	4,408,891
Service [Member]
Revenue	$ 0	$ 0	$ 0	$ 0
Cost of goods sold	0	0	0	0
Product [Member]
Revenue	0	0	0	0
Cost of goods sold	0	0	0	0
Nonrelated Party [Member]
Other income (expense):
Interest expense	(69,775)	(1,712,877)	(1,556,661)	(3,403,413)
Preferred stock dividends	(530,502)	(52,723)	(1,001,745)	(186,219)
Related Party [Member]
Other income (expense):
Interest expense	(116,058)	0	(358,894)	0
Preferred stock dividends	$ (1,236)	$ (28,389)	$ (78,357)	$ (54,977)

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)	Commitments [Member] Common Stock [Member]	Commitments [Member] Additional Paid-in Capital [Member]	Commitments [Member]	Waiver Fee [Member] Common Stock [Member]	Waiver Fee [Member] Additional Paid-in Capital [Member]	Waiver Fee [Member]	Other Waiver Fees [Member] Common Stock [Member]	Other Waiver Fees [Member] Additional Paid-in Capital [Member]	Other Waiver Fees [Member]	Shares Previously Subscribed [Member] Common Stock [Member]	Shares Previously Subscribed [Member] Additional Paid-in Capital [Member]	Shares Previously Subscribed [Member] Stock Subscribed [Member]	Transaction Costs [Member] Additional Paid-in Capital [Member]	Transaction Costs [Member]	True-up Agreement [Member] Common Stock [Member]	True-up Agreement [Member] Additional Paid-in Capital [Member]	True-up Agreement [Member]	Series C Preferred Stock [Member] Series C Preferred Stock [Member] Preferred Stock [Member]	Series C Preferred Stock [Member] Series F Preferred Stock [Member] Preferred Stock [Member]	Series C Preferred Stock [Member] Additional Paid-in Capital [Member]	Series C Preferred Stock [Member]	Series D Preferred Stock [Member] Series D Preferred Stock [Member] Preferred Stock [Member]	Series D Preferred Stock [Member] Series F Preferred Stock [Member] Preferred Stock [Member]	Series D Preferred Stock [Member] Additional Paid-in Capital [Member]	Series D Preferred Stock [Member]	Pinnacle [Member] Common Stock [Member]	Pinnacle [Member] Additional Paid-in Capital [Member]	Pinnacle [Member]	Howe [Member] Common Stock [Member]	Howe [Member] Additional Paid-in Capital [Member]	Howe [Member]	Accounts Payable [Member] Series F Preferred Stock [Member] Preferred Stock [Member]	Accounts Payable [Member] Series F Preferred Stock [Member] Additional Paid-in Capital [Member]	Accounts Payable [Member] Series F Preferred Stock [Member]	Accounts Payable [Member] Common Stock [Member]	Accounts Payable [Member] Additional Paid-in Capital [Member]	Accounts Payable [Member]	Related Party Debt [Member] Common Stock [Member]	Related Party Debt [Member] Additional Paid-in Capital [Member]	Related Party Debt [Member]	Debt and Accrued Salaries [Member] Series F Preferred Stock [Member] Preferred Stock [Member]	Debt and Accrued Salaries [Member] Series F Preferred Stock [Member] Additional Paid-in Capital [Member]	Debt and Accrued Salaries [Member] Series F Preferred Stock [Member]	Debt and Accrued Salaries [Member] Additional Paid-in Capital [Member]	Debt and Accrued Salaries [Member]	Convertible Debt [Member] Series F Preferred Stock [Member] Preferred Stock [Member]	Convertible Debt [Member] Series F Preferred Stock [Member] Additional Paid-in Capital [Member]	Convertible Debt [Member] Series F Preferred Stock [Member]	Convertible Debt [Member] Common Stock [Member]	Convertible Debt [Member] Additional Paid-in Capital [Member]	Convertible Debt [Member]	Accounts Payable and Debt [Member] Common Stock [Member]	Accounts Payable and Debt [Member] Additional Paid-in Capital [Member]	Accounts Payable and Debt [Member]	Series C Preferred Stock [Member] Preferred Stock [Member]	Series C Preferred Stock [Member]	Series D Preferred Stock [Member] Preferred Stock [Member]	Series D Preferred Stock [Member]	Series X Preferred Stock [Member] Preferred Stock [Member]	Series X Preferred Stock [Member] Common Stock [Member]	Series X Preferred Stock [Member] Additional Paid-in Capital [Member]	Series X Preferred Stock [Member]	Series F Preferred Stock [Member] Preferred Stock [Member]	Series F Preferred Stock [Member] Additional Paid-in Capital [Member]	Series F Preferred Stock [Member]	Series A Preferred Stock [Member] Additional Paid-in Capital [Member]	Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Stock Subscribed [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2021																																																							$ 9,406		$ 31,000		$ 242									$ 42,667	$ 26,385,728	$ 132,163	$ (25,478,332)	$ 1,122,874
Balance (in Shares) at Dec. 31, 2021																																																							940,644		3,100,000		24,227									4,266,669
Vesting of common stock issued to employees																																																																					3,685			3,685
Vesting of stock options issued to employees																																																																					331,690			331,690
Series A dividends previously satisfied																																																								$ 981
Shares issued for services																																																																				$ 6,182	174,391			180,573
Shares issued for services (in Shares)																																																																				618,177
Legal settlement	$ 716	$ 884,636	$ 885,352	$ 344	$ 242,962	$ 243,306	$ 452	$ 366,706	$ 367,158
Legal settlement (in Shares)	71,555			34,400			45,235
Stock issued for conversion of debt										$ 76	$ 95,512	$ (95,588)																							$ 7,422	$ 661,817	$ 669,239
Stock issued for conversion of debt (in Shares)										7,648																									742,190
Conversion to Series F Preferred Stock										$ 76	95,512	(95,588)																							$ 7,422	661,817	669,239
Conversion to Series F Preferred Stock (in Shares)										7,648																									742,190
Shares issued (in Shares)	71,555			34,400			45,235
Fee shares	$ 716	884,636	885,352	$ 344	$ 242,962	$ 243,306	$ 452	$ 366,706	$ 367,158
Fee shares (in Shares)	71,555			34,400			45,235
Warrants issued																																																																					94,672			94,672
Shares issued for Series X dividends																																																												$ 82	$ 86,971	$ 87,053
Shares issued for Series X dividends (in Shares)																																																												8,103
Gain on settlement of accrued payroll																																																																				$ (80)	80			(78,235)
Gain on settlement of accrued payroll (in Shares)																																																																				(8,000)
Preferred stock dividends																																																								(49,700)		$ (96,847)				(45,423)							(241,196)			(241,196)
Transaction costs of sales of Series F Preferred Stock for cash																																																								981
Loss for the period																																																																							(11,534,230)	(11,534,230)
Balance at Sep. 30, 2022																																																							$ 9,406		$ 31,000		$ 242									$ 57,861	29,087,654	36,575	(37,012,562)	(7,789,824)
Balance (in Shares) at Sep. 30, 2022																																																							940,644		3,100,000		24,227									5,785,977
Balance at Dec. 31, 2021																																																							$ 9,406		$ 31,000		$ 242									$ 42,667	26,385,728	132,163	(25,478,332)	1,122,874
Balance (in Shares) at Dec. 31, 2021																																																							940,644		3,100,000		24,227									4,266,669
Balance at Dec. 31, 2022																																																							$ 10,476		$ 31,000		$ 242									$ 46,305	29,452,514	36,575	(48,714,461)	(19,137,350)
Balance (in Shares) at Dec. 31, 2022																																																							1,047,619		3,100,000		24,227									4,630,372
Balance at Jun. 30, 2022																																																							$ 9,406		$ 31,000		$ 242									$ 45,043	28,956,513	36,575	(32,928,811)	(3,850,032)
Balance (in Shares) at Jun. 30, 2022																																																							940,644		3,100,000		24,227									4,504,203
Vesting of common stock issued to employees																																																																					699			699
Vesting of stock options issued to employees																																																																					29,380			29,380
Shares issued for services																																																																				$ 6,032	71,416			77,448
Shares issued for services (in Shares)																																																																				603,177
Legal settlement	$ 6,786	84,218	91,004
Legal settlement (in Shares)	678,597
Shares issued (in Shares)	678,597
Fee shares	$ 6,786	84,218	91,004
Fee shares (in Shares)	678,597
Warrants issued																																																																					26,540			26,540
Preferred stock dividends																																																																					(81,112)			(81,112)
Loss for the period																																																																							(4,083,751)	(4,083,751)
Balance at Sep. 30, 2022																																																							$ 9,406		$ 31,000		$ 242									$ 57,861	29,087,654	36,575	(37,012,562)	(7,789,824)
Balance (in Shares) at Sep. 30, 2022																																																							940,644		3,100,000		24,227									5,785,977
Balance at Dec. 31, 2022																																																							$ 10,476		$ 31,000		$ 242									$ 46,305	29,452,514	$ 36,575	(48,714,461)	(19,137,350)
Balance (in Shares) at Dec. 31, 2022																																																							1,047,619		3,100,000		24,227									4,630,372
Vesting of stock options issued to employees																																																																					2,799			2,799
Series A dividends previously satisfied																																																																		$ 10,967	$ 10,967
Shares issued for services																																																																				$ 3,000	894,000			897,000
Shares issued for services (in Shares)																																																																				300,000
Legal settlement																										$ 26	$ 2,133	$ 2,159	$ 196	$ 16,404	$ 16,600
Legal settlement (in Shares)	2,952									2,926					94,738											2,552			19,622
Stock issued for conversion of debt																		$ (10,476)	$ 22	$ 1,198,450	$ 1,187,996	$ (23,500)	$ 41	$ 1,610,965	$ 1,587,506							$ 2	$ 146,212	$ 146,214	$ 2,244	76,275	78,519				$ 22	$ 2,137,033	$ 2,137,055			$ 90	$ 9,523,088	$ 9,523,178	$ 571	$ 82,885	$ 83,456	$ 1,816	$ 3,632	$ 5,448						$ 283	60,281	60,564
Stock issued for conversion of debt (in Shares)																		(1,047,619)	2,289			(2,350,000)	4,055									147			224,338						2,138					9,027			57,138			181,606								28,275
Shares sold for cash																																																															$ 17						1,583,483			1,583,500
Shares sold for cash (in Shares)																																																															1,746
Conversion to Series F Preferred Stock																		$ (10,476)	$ 22	$ 1,198,450	$ 1,187,996	$ (23,500)	$ 41	$ 1,610,965	$ 1,587,506							$ 2	$ 146,212	$ 146,214	$ 2,244	76,275	78,519				$ 22	$ 2,137,033	$ 2,137,055			$ 90	$ 9,523,088	$ 9,523,178	$ 571	$ 82,885	$ 83,456	$ 1,816	$ 3,632	$ 5,448						$ 283	$ 60,281	$ 60,564
Conversion to Series F Preferred Stock (in Shares)																		(1,047,619)	2,289			(2,350,000)	4,055									147			224,338						2,138					9,027			57,138			181,606								28,275
Shares issued	$ 30	$ 3,778	$ 3,808							$ 30	$ 36,545	$ (36,575)			$ 947	$ 118,423	$ 119,370
Shares issued (in Shares)	2,952									2,926					94,738											2,552			19,622
Fee shares																										$ 26	$ 2,133	$ 2,159	$ 196	$ 16,404	$ 16,600
Fee shares (in Shares)	2,952									2,926					94,738											2,552			19,622
Shares issued for Series X dividends (in Shares)																																																														28,275
Gain on settlement of accrued payroll																																																																								0
Preferred stock dividends																																																								$ (17,603)		$ (76,307)				$ (45,423)			$ (940,769)				(1,080,102)			(1,080,102)
Transaction costs of sales of Series F Preferred Stock for cash																																																																		$ 10,967	$ 10,967
Loss for the period																																																																							(14,710,468)	(14,710,468)
Balance at Sep. 30, 2023																																																									$ 7,500		$ 242				$ 194					$ 55,448	45,879,765		(63,424,929)	(17,481,782)
Balance (in Shares) at Sep. 30, 2023																																																									750,000		24,227				19,402					5,544,519
Balance at Jun. 30, 2023																																																									$ 7,500		$ 242				$ 163					$ 51,388	43,355,536		(61,872,556)	(18,457,727)
Balance (in Shares) at Jun. 30, 2023																																																									750,000		24,227				16,353					5,138,575
Vesting of stock options issued to employees																																																																					933			933
Series A dividends previously satisfied													$ (72,000)	$ (72,000)
Stock issued for conversion of debt																																			$ 2,244	76,275	78,519	$ 1,816	$ 3,632	$ 5,448	$ 22			$ 2,137,032	$ 2,137,054																		$ 9	$ 910,093	910,102
Stock issued for conversion of debt (in Shares)																																			224,338			181,606			2,138																						911
Conversion to Series F Preferred Stock																																			$ 2,244	$ 76,275	$ 78,519	$ 1,816	$ 3,632	$ 5,448	$ 22			$ 2,137,032	$ 2,137,054																		$ 9	$ 910,093	$ 910,102
Conversion to Series F Preferred Stock (in Shares)																																			224,338			181,606			2,138																						911
Preferred stock dividends																																																																					(531,738)			(531,738)
Transaction costs of sales of Series F Preferred Stock for cash													$ (72,000)	$ (72,000)
Loss for the period																																																																							(1,552,373)	(1,552,373)
Balance at Sep. 30, 2023																																																									$ 7,500		$ 242				$ 194					$ 55,448	$ 45,879,765		$ (63,424,929)	$ (17,481,782)
Balance (in Shares) at Sep. 30, 2023																																																									750,000		24,227				19,402					5,544,519

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,552,373)	$ (4,083,751)	$ (14,710,468)	$ (11,534,230)
Adjustments to reconcile net loss to net cash used in operating activities:
Impairment of assets			2,343,462	0
Depreciation			78,230	639,455
Penalties on notes payable			1,027,778	0
Amortization of right-to-use asset			0	370,064
Share-based compensation			899,799	335,375
Shares issued as compensation for fundraising			36,900	0
Shares issued for true-up liability			119,370	0
Conversion fees on notes payable			75,000	0
Equity investment incentive on notes payable			3,565,759	0
Gain on forgiveness of note payable	0	0	(25,000)	0
Gain – other	(40,622)	0	(40,622)	0
Gain on conversion of notes payable and accrued liabilities to common stock - related party	(139,837)	0	(139,837)	0
Gain on conversion of accounts payable to common stock			(100,950)	0
Financing cost - waiver fee shares			0	565,431
Gain on waiver fee shares			0	(198,273)
Loss on commitment shares			0	25,700
Gain on conversion of accrued salary	0	0	0	(15,032)
Gain on lease terminations			(287,897)	0
Loss on revaluation of derivative liabilities	14,725	37,977	85,765	111,564
Gain on shares issued to service provider			(33,092)	0
Gain on sale of assets			(111,843)	0
Loss on legal settlement	0	0	18,759	0
Loss on settlement of accounts payable			0	78,235
Investment incentive on cash sales of Series F Preferred Stock			845,000	0
Changes in assets and liabilities:
Accounts receivables			30,943	(79,041)
Prepaid expenses			113,722	114,836
Inventory			0	(30,662)
Accounts payable and accrued liabilities			1,408,182	1,501,904
Operating lease liability, net			0	(26,567)
Other current liabilities			0	(73,286)
Net cash used in operating activities			(845,947)	(5,463,305)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash received for the sale of assets			102,967	0
Cash paid for acquisition of assets and construction in progress			0	(190,248)
Net cash used in investing activities			102,967	(190,248)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from sale of Series F Preferred Stock, net of fees			738,500	0
Principal payments on PPP Loan			(4,836)	0
Principal payments on notes payable related parties			0	(235,294)
Net cash provided by financing activities			733,664	4,495,306
Net increase (decrease) in cash and cash equivalents			(9,316)	(1,158,247)
Cash and cash equivalents change – discontinued operations			27,767	99,395
Cash and cash equivalents at beginning of period			6,191	1,160,465	$ 1,160,465
Cash and cash equivalents at end of period	24,642	1,613	24,642	1,613	6,191
Cash and cash equivalents at end of period - discontinued operations	1,665	4,623	1,665	4,623	$ 29,432
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid			0	2,680
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Preferred stock dividend	531,738	81,112	1,080,102	241,196
Change in capital expenditures included in accounts payable			110,511	4,403,346
Shares issued for Series X dividends			60,564	83,002
Series C Preferred Stock [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Incentive on conversion of Stock			1,016,887	0
Series D Preferred Stock [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Incentive on conversion of Stock			1,371,846	0
Stock Subscribed [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock issued for common stock subscribed			36,575	0
Series F Preferred Stock [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Incentive on conversion of debt			843,227	0
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Preferred stock dividend			940,769
Common Stock [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Incentive on conversion of debt			1,357	0
Series C Preferred Stock [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Preferred stock dividend			17,603	49,700
Adjustment of Series C Preferred Stock to common stock			0	981
Conversion to Series F Preferred Stock			181,563	0
Series D Preferred Stock [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Preferred stock dividend			76,307	96,847
Series A accrued dividends reclassified to APIC from prior transaction			10,967	0
Conversion to Series F Preferred Stock			239,118	0
Accounts Payable [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of payable to stock			78,519	500,000
Accounts Payable [Member] | Series F Preferred Stock [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of payable to stock			146,214	0
Convertible Notes Payable [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of payable to stock			83,456	0
Convertible Notes Payable [Member] | Series F Preferred Stock [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of payable to stock			11,158,379	0
Nonrelated Party [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of discount on notes payable			32,011	2,588,963
Changes in assets and liabilities:
Accrued interest			621,566	162,259
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable, net of discounts			0	1,812,500
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Preferred stock dividend	530,502	52,723	1,001,745	186,219
Related Party [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of discount on notes payable			22,670	0
Changes in assets and liabilities:
Accrued interest			45,529	0
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable, net of discounts			0	2,918,100
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Preferred stock dividend	$ 1,236	$ 28,389	$ 78,357	$ 54,977

Description of Business

Description of Business	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1: Description of Business Company Overview Mitesco, Inc. (the “Company,” “we,” “us,” or “our”) was formed in the state of Delaware on January 18, 2012. On December 9, 2015, we restructured our operations and acquired Newco4pharmacy, LLC, a development stage company which sought to acquire compounding pharmacy businesses. As a part of the restructuring, we completed a “spin out” of our former business line. On April 24, 2020, we changed our name to Mitesco, Inc. On October 13, 2023, the Company effected a Redomestication to Nevada. We are a holding company seeking to provide products, services and technology to make accessible higher quality, and more affordable healthcare solutions. We have recently discontinued the business activities within “The Good Clinic, LLC” healthcare subsidiary due to lack of profitability and limited funding. We have a number of near-term opportunities that we hope to pursue, assuming the capital markets make sufficient funding available at reasonable rates. Our operations are subject to comprehensive federal, state, and local laws and regulations in the jurisdictions in which it does business. There also continues to be a heightened level of review and/or audit by federal and state regulators of the health and related benefits industry’s business and reporting practices. As of the date of this filing, we are not subject to any actual or anticipated regulatory reviews or audits relating to our operations. The laws and rules governing our businesses and interpretations of those laws and rules continue to evolve each year and are subject to frequent change. The application of these complex legal and regulatory requirements to the detailed operation of our businesses creates areas of uncertainty. Further, there are numerous proposed health care, financial services and other laws and regulations at the federal and state level some of which could adversely affect our businesses if they are enacted. We cannot predict whether pending or future federal or state legislation will have an adverse effect on our business. We can give no assurance that the businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that we will not be required to materially change its business practices, based on: (i) future enactment of new health care or other laws or regulations; (ii) the interpretation or application of existing laws or regulations, including the laws and regulations described in this Government Regulation section, as they may relate to one or more of our businesses, one or more of the industries in which we compete and/or the health care industry generally; (iii) our pending or future federal or state governmental investigations. Discontinued Operations We have recently discontinued business activities within “The Good Clinic, LLC” healthcare subsidiary due to lack of profitability and limited funding. See note 4. On December 8, 2023, the Company sold the remaining assets of The Good Clinic, LLC to Leading Primary Care LLC, a company organized by Michael C. Howe, the former CEO of The Good Clinic, LLC for total consideration of approximately $2.5 million. See note 16. As a result, the accounts of The Good Clinic, LLC have been included in “Net (loss) from discontinued operations” in our consolidated statements of operations. Additionally, these assets and liabilities have been presented as discontinued operations in our consolidated balance sheet as of September 30, 2023 and December 31, 2022. See Note 4 - Discontinued Operations for additional information. Reverse Stock Split On December 12, 2022, our board of directors approved the filing of a certificate of amendment to our amended and restated certificate of incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to affect the one-for-fifty. The Amendment became effective at 5:00 p.m. Eastern Time on December 12, 2022. Pursuant to the Amendment, at the effective time of the Amendment, every fifty (50) shares of our issued and outstanding common stock was automatically combined into one (1) issued and outstanding share of common stock. The Reverse Stock Split affected all shares of our common stock outstanding immediately prior to the effective time of the Amendment. No fractional shares were issued as a result of the Reverse Stock Split. Stockholders of record who would otherwise be entitled to receive a fractional share received a full share thereof. As a result of the Reverse Stock Split, proportionate adjustments were made to the per share exercise price and/or the number of shares issuable upon the exercise or vesting of all stock options and warrants issued by us and outstanding immediately prior to the effective time of the Amendment, which resulted in a proportionate decrease in the number of shares of our common stock reserved for issuance upon exercise or vesting of such stock options and warrants and a proportionate increase in the exercise price of all such stock options and warrants. In addition, the number of shares reserved for issuance under our equity compensation plans immediately prior to the effective time of the Amendment were reduced proportionately. All share and per share amounts of common stock presented in this Quarterly Report on Form 10-Q have been retroactively adjusted to reflect the Reverse Stock Split.

Financial Condition, Going Conc

Financial Condition, Going Concern and Management Plans	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern [Text Block]	N ote 2: Financial Condition, Going Concern and Management Plans As of September 30, 2023, the Company had cash and cash equivalents of approximately $25,000, current liabilities of $17.5 million, and has incurred significant losses from the previous clinic operations. As previously noted, we made a strategic decision to reduce our capital needs by closing our clinic operations in the fourth quarter of 2022 and releasing a significant portion of our staff. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to execute its business plan. Effective December 8, 2022, we closed all of our clinic locations due to a lack of profitability and limited funding. Subsequent to that date we have given up possession of all clinic locations, and are in the process of negotiating settlements with leaseholders and other suppliers and contractors. As a result of these factors, there is substantial doubt about the ability of the Company to continue as a going concern for one year from the date the financial statements are issued. The Company’s continuance is dependent on raising capital and generating revenues sufficient to sustain operations. However, as of the date of these consolidated financial statements, no formal agreement exists. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts classified as liabilities that might be necessary should the Company be forced to take any such actions. The COVID-19 pandemic, decades-high inflation and concerns about an economic recession in the United States or other major markets has resulted in, among other things, volatility in the capital markets that may have the effect of reducing the Company’s ability to access capital, which could in the future negatively affect the Company’s liquidity. In addition, a recession or market correction due to these factors could materially affect the Company’s business and the value of its common stock.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 3: Summary of Significant Accounting Policies Principles of Consolidation Use of Estimates - Significant Accounting Policies Discontinued Operations: Presentation of Financial Statements Property, Plant and Equipment New Accounting Standards From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies that the Company adopts as of the specified effective date. Unless otherwise discussed, the Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on its financial position or results of operations upon adoption.

Discontinued Operations

Discontinued Operations	9 Months Ended
	Sep. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	Note 4: Discontinued Operations On December 8, 2023, the Company sold the remaining assets of The Good Clinic, LLC to Leading Primary Care LLC, a company organized by Michael C. Howe, the former CEO of The Good Clinic, LLC for total consideration of approximately $2.5 million. ASC 360-10-45-9 requires that a long-lived asset (disposal group) to be sold shall be classified as held for sale in the period in which a set of criteria have been met, including criteria that the sale of the asset (disposal group) is probable and actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. This criteria was achieved on December 8, 2023. Additionally, the discontinued operations are comprised of the entirety of The Good Clinic, LLC. For comparability purposes certain prior period line items relating to the assets held for sale have been reclassified and presented as discontinued operations for all periods presented in the accompanying condensed consolidated statements of net loss and comprehensive loss and the condensed consolidated balance sheets. The following information presents the major classes of line item of assets and liabilities included as part of discontinued operations in the consolidated balance sheets: September 30, December 31, 2023 2022 Current assets - discontinued operations: Cash $ 1,665 $ 29,432 Accounts receivable - 30,943 Prepaid expenses and deposits - 62,090 Total current assets - discontinued operations $ 1,665 $ 122,465 Noncurrent assets - discontinued operations: Property and equipment $ - $ 1,832,974 Right-of-use assets - 460,254 Total noncurrent assets - discontinued operations $ - $ 2,293,228 Current liabilities - discontinued operations: Accounts payable $ 5,555,218 $ 5,114,559 Accrued payroll and related liabilities 225,515 292,808 Other current liabilities 25,000 - Accrued interest 176,362 176,362 Operating lease liabilities 3,973,069 349,109 Total current liabilities - discontinued operations $ 9,955,164 $ 5,932,838 Long term liabilities - discontinued operations: Operating lease liabilities $ - $ 3,936,858 Total long term liabilities - discontinued operations $ - $ 3,936,858 The following information presents the major classes of line items constituting the after-tax loss from discontinued operations in the consolidated statements of operations: Three Months Ended September 30, September 30, 2023 2022 Revenue $ - $ 198,049 Cost of goods sold - 2,262 Gross margin - 195,787 Selling, general, and administrative expenses (188,248 ) (1,653,075 ) Other (income) expense: Gain on sale of assets 91,746 - Gain on settlement of accounts payable 81,263 - Loss from discontinued operations, net of tax $ (15,239 ) $ (1,457,288 ) Nine Months Ended September 30, September 30, 2023 2022 Revenue $ - $ 487,510 Cost of goods sold - 13,510 Gross margin - 474,000 Selling, general, and administrative expenses (1,085,269 ) (5,536,920 ) Other (income) expense: Impairment of assets (2,211,462 ) - Gain on sale of assets 102,967 - Gain on settlement of accounts payable 81,263 - Gain on settlement of operating lease 287,897 - Loss from discontinued operations, net of tax $ (2,824,604 ) $ (5,062,920 ) The following information presents the major classes of line items constituting significant operating and investing cash flow activities in the consolidated statements of cash flows relating to discontinued operations: Nine months Ended September 30, September 30, 2023 2022 Depreciation expense $ 78,230 $ 587,222 Cash used for construction in progress $ - $ (1,030,397 ) Cash used for the purchase of fixed assets $ - $ (29,771 ) Impairment of RTU assets $ 544,063 $ - Impairment of property and equipment $ 1,799,399 -

Net Loss Per Share Applicable t

Net Loss Per Share Applicable to Common Shareholders	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	Note 5: Net Loss Per Share Applicable to Common Shareholders Net Loss per Share Applicable to Common Stockholders Basic loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the reporting period. Diluted loss per common share is computed similarly to basic loss per common share except that it reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. The following table sets forth the computation of loss per share for the three and nine months ended September 30, 2023 and 2022, respectively: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Numerator: Net loss applicable to common shareholders – continuing operations $ (2,068,872 ) $ (2,707,575 ) $ (12,965,966 ) $ (6,712,506 ) Net loss applicable to common shareholders – discontinued operations $ (15,239 ) $ (1,457,288 ) $ (2,824,604 ) $ (5,062,920 ) Net loss per share: Basic and diluted – continuing operations $ (0.39 ) $ (0.59 ) $ (2.57 ) $ (1.52 ) Basic and diluted – discontinued operations $ (0.00 ) $ (0.32 ) $ (0.56 ) $ (1.15 ) Denominator: Weighted average common shares outstanding 5,329,816 4,569,115 5,048,070 4,408,891 The Company excluded all common equivalent shares outstanding for warrants, options, and convertible instruments to purchase common stock from the calculation of diluted net loss per share because all such securities are antidilutive for the periods presented. As of September 30, 2023 and 2022, the following shares were issuable and excluded from the calculation of diluted loss: For the Nine Months Ended September 30, 2023 2022 Common stock options 100,934 327,099 Common stock purchase warrants 673,208 672,325 Convertible Preferred Stock 63,000 847,652 Accrued interest on Preferred Stock 33,105 30,451 Potentially dilutive securities 870,247 1,377,527

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 6: Related Party Transactions For the Nine Months Ended September 30, 2023: The Company accrued dividends on its Series X Preferred Stock in the total amount of $45,423. Of this amount, a total of $5,905 was payable to officers and directors, $23,620 was payable to a related party shareholder, and $15,898 was payable to non-related parties. The Company issued a total of 28,275 shares of common stock for accrued dividends on its Series X Preferred Stock. Of this amount, a total of 3,739 shares were issued to officers and directors, 14,586 were issued to a related party shareholder, and 9,950 were issued to non-related parties. The Company issued 1,610 shares of its Series F Preferred Stock to Larry Diamond, it’s CEO, for the conversion of notes payable in the principal amount of $534,927, premium on notes payable of $75,146, accrued interest of $115,381, accrued salary of $250,106, and equity investment incentive in the amount of $634,114 for a total amount of $1,609,674. See notes 11 and 13. The Company issued 210 shares of its Series F Preferred Stock to Juan Carlos Iturregui, a board member, for the conversion of notes payable in the principal amount of $48,162, premium on notes payable of $2,941, accrued interest of $7,295, accrued board fees of $67,500, and equity investment incentive in the amount of $84,073 for a total amount of $209,971. See notes 11 and 13. The Company issued 318 shares of its Series F Preferred Stock to Tom Brodmerkel, it’s CFO and a board member, for the conversion of notes payable in the principal amount of $18,750, accrued interest of $2,101, accrued board fees of $45,000, accrued salary of $126,519, and equity investment incentive in the amount of $125,041 for a total amount of $317,411. See notes 11 and 13. The Company issued 181,606 shares of its restricted common stock to Sheila Schweitzer, it’s COO and a board member, for the conversion of notes payable in the principal amount of $18,750, accrued interest of $2,101, and accrued salary of $64,434 for a total amount of $145,285. Ms. Schweitzer did not receive any equity investment incentive for this, or any other, transactions. The Company recorded a gain in the amount of $139,837 on this transaction. See notes 11 and 13. For the Nine Months Ended September 30, 2022: Mitesco, Inc. (the “Company”) issued a 10% Promissory Note due, as extended, November 30, 2022, dated December 30, 2021, to the Michael C. Howe Living Trust (“Howe Note 1”) (the “Lender”). Michael C. Howe is the Chief Executive Officer of the Good Clinic LLC, one of our subsidiaries. The principal amount of the Howe Note 1 is $1,000,000, carries a 10% interest rate per annum, payable in monthly installments, and had a maturity date, as extended, that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Howe Note 1 payable to the Company for the Howe Note 1 was $850,000 and was funded on December 30, 2021. An original issue discount in the amount of $150,000 was recorded. In addition, the Lender was issued (i) 2,100,000 5-year warrants at a price of $0.50 with a fair value of $261,568 that may be exercised on substantially the same terms as the Series A warrant issued in connection with our Series D Convertible Preferred Stock and (ii) 96,471 shares of Common Stock as commitment shares. The amount payable at maturity will be $1,000,000 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default, as defined in the note, the principal amount shall bear interest for each day until paid, at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Howe Note 1 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security, which the Lender reasonably believes contains a term that is more favorable than those in the note, the Company shall notify the Lender of such term, and such term, at the option of the Lender, shall become a part of the note. At September 30, 2022, the principal balance of this note was $1,000,000; $150,000 of the original issue discount was amortized to interest expense during the nine months ended September 30, 2022, and the remaining original issue discount at September 30, 2022 was $0. The Company issued a 10% Promissory Note due, as amended, June 18, 2022 (the “Diamond Note 2”), dated March 18, 2022, to Lawrence Diamond (the “Lender”). Lawrence Diamond is the Chief Executive Officer of the Company. The principal amount of the Diamond Note 2 is $235,294, carries a 10% interest rate per annum, payable in monthly installments, and has a maturity date, as amended, that is the earlier of (i) November 30, 2022, (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE, or (iii) the date of receipt of the Company of the next round of debt or equity financing in an amount of at least $1,000,000. The purchase price of the Diamond Note 2 payable to the Company for the Diamond Note 2 was $200,000 and was funded on March 18, 2022. The amount payable at maturity will be $235,294 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default, as defined in the Diamond Note 2, the principal amount shall bear interest for each day until paid, at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Diamond Note 2 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security, which the Lender reasonably believes contains a term that is more favorable than those in the Diamond Note 2, the Company shall notify the Lender of such term, and such term, at the option of the Lender, shall become a part of the note. In addition, the Lender will be issued 200,000 5-year warrants that may be exercised on substantially the same terms as the Series A warrant issued in connection with the Company’s Series D Convertible Preferred Stock. The warrants have an aggregate commitment date fair value of $2,213. All amounts due for The Diamond Note 2, with the exception of $23,529, was paid on April 8, 2022. $23,529 remained outstanding as of September 30, 2022. On March 22, 2022, the Company issued 168,221 shares of common stock with a contract price of $0.25 per share or $42,055 and a grant date market value of $0.127 per share or $21,364 were issued to Larry Diamond, it’s Chief Executive Officer, as compensation for the waiver of certain covenants as set forth and defined in Diamond Note 1. On April 27, 2022, the Company issued 96,471 shares of common stock with a contract price of $0.25 per share or $24,118 and a grant date market value of $0.16 or $15,434 to Larry Diamond, it’s Chief Executive Officer, as compensation for the waiver of certain covenants as set forth and defined in Diamond Note 2. The Company also issued five-year warrants to purchase 92,942 shares of common stock at a price of $0.50 to Mr. Diamond pursuant to a promissory note. On April 27, 2022, the Company issued a 10% Promissory Note due, as extended, November 30, 2022 (the “Diamond Note 3”) to Lawrence Diamond (the “Lender”). Lawrence Diamond is the Chief Executive Officer of the Company. The principal amount of the Diamond Note 3 is $235,294, carries a 10% interest rate per annum, payable in monthly installments, and has a maturity date, as extended, that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Diamond Note 3 payable to the Company for the Diamond Note was $200,000 and was funded on April 27, 2022. The amount payable at maturity will be $235,294 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default, as defined in the Diamond Note 3, the principal amount shall bear interest for each day until paid, at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Diamond Note 3 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security, which the Lender reasonably believes contains a term that is more favorable than those in the Diamond Note 3, the Company shall notify the Lender of such term, and such term, at the option of the Lender, shall become a part of the note. At September 30, 2022, the principal balance of this note was $235,294; $35,294 of the original issue discount was amortized to interest expense during the nine months ended September 30, 2022, and the remaining original issue discount at September 30, 2022 was $0. The Company issued a 10% Promissory Note due as described below (the “Diamond Note 4”), dated May 18, 2022, to Lawrence Diamond. The principal amount of the Diamond Note 4 is $47,059.00, carries a 10% interest rate per annum, payable in monthly installments, and has a maturity date, as extended, that is the earlier of (i) November 30, 2022 or (ii) five days after the date on which we successfully list our shares of common stock on any of the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, or the Nasdaq Capital Market. The purchase price of the Diamond Note 4 payable to us for the Diamond Note 4 was $40,000 and was funded on May 18, 2022. The amount payable at maturity will be $47,059 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default, as defined in the Diamond Note 4, the principal amount shall bear interest for each day until paid, at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Diamond Note 4 contains a “most favored nations” clause that provides that, so long as the Diamond Note 4 is outstanding, if we issue any new security, which the Lender reasonably believes contains a term that is more favorable than those in the Diamond Note 4, we shall notify Mr. Diamond of such term, and such term, at the option of Mr. Diamond, shall become a part of the note. In addition, Mr. Diamond will be issued (1) 19,294 five-year warrants (the “May 18 Diamond Warrants”) that may be exercised on substantially the same terms as the Series A warrant issued in connection with our Series D Convertible Preferred Stock and (2) 19,294 shares of Common Stock as commitment shares. At September 30, 2022, the principal balance of this note was $47,059; discounts in the amount of $14,778 were amortized to interest expense during the nine months ended September 30, 2022, and total discounts in the amount of $6,478 remained outstanding at September 30, 2022. On May 23, 2022, the Company issued a 10% Promissory Note due as described below (the “Finnegan Note 1”) to Jessica Finnegan. Jessica Finnegan is VP of Human Resources of the Company. The principal amount of the Finnegan Note 1 is $47,059, carries a 10% interest rate per annum, payable in monthly installments, and has a maturity date that is November 20, 2022. The purchase price of the Finnegan Note 1 was $40,000 resulting in an original issue discount of $7,059 and was funded on May 18, 2022. The amount payable at maturity will be $47,059 plus 10% of that amount plus any accrued and unpaid interest, resulting in a premium and related discount in the amount of $4,706. Following an event of default, as defined in the Finnegan Note 1, the principal amount shall bear interest for each day until paid, at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Finnegan Note 1 contains a “most favored nations” clause that provides that, so long as the Finnegan Note 1 is outstanding, if we issue any new security, which the Lender reasonably believes contains a term that is more favorable than those in the Finnegan Note 1, we shall notify Ms. Finnegan of such term, and such term, at the option of Ms. Finnegan, shall become a part of the note. In addition, Ms. Finnegan will be issued (1) 19,295 five-year warrants with a fair value of $2,000 (the “May 18 Finnegan Warrants”) that may be exercised on substantially the same terms as the Series A warrant issued in connection with our Series D Convertible Preferred Stock and (2) 19,295 shares of Common Stock with a value of $3,240 as commitment shares; these amounts were charged to discount on the note, resulting in a total discount on this note in the amount of $17,005. Discounts in the amount of $12,478 were amortized to interest expense during the nine months ended September 30, 2022, and total discounts in the amount of $4,518 remained outstanding at September 30, 2022. The Company issued five 10% Promissory Notes due as described below (collectively, the “May 26 Notes”), dated May 26, 2022, to Larry Diamond, Jenny Lindstrom, and other related parties (the “May 26 Lenders”), in respect of which we received proceeds of $175,000. Jenny Lindstrom was the Chief Legal Officer of the Company. The May 26 Notes carry a 10% interest rate per annum, payable in monthly installments, and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) the date on which we successfully lists our shares of common stock on Nasdaq or NYSE. The aggregate amount payable at maturity will be $205,883 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default, as defined in the May 26 Notes, the principal amount shall bear interest for each day until paid, at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The May 26 Notes contain a “most favored nations” clause that provides that, so long as the May 26 Notes are outstanding, if we issue any new security, which the May 26 Lenders reasonably believe contains a term that is more favorable than those in the May 26 Notes, we shall notify the May 26 Lenders of such term, and such term, at the option of the May 26 Lenders, shall become a part of the May 26 Notes. In addition, the May 26 Lenders will be issued in the aggregate (1) 84,412 five The Company issued a 10% Promissory Note due as described below (the “Howe Note 2”), dated June 9, 2022, to Michael C. Howe Living Trust and in respect of which we received proceeds of $255,000. Michael C. Howe was the Chief Executive Officer of the Good Clinic LLC, one of the Company’s subsidiaries. The Howe Note 2 carries a 10% interest rate per annum, payable in monthly installments. The Howe Note 2 has a maturity date, as extended, that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which we successfully list our shares of common stock on Nasdaq or NYSE. The amount payable at maturity will be $300,000 plus 10% of that amount plus any accrued and unpaid interest. In addition, the Company issued (1) 123,000 five-year warrants with a fair value of $21,500 and (2) 123,000 shares of Common Stock with a market value of $44,000 as commitment shares. The warrants have an initial exercise price of $0.50 per share and are not exercisable for nine months following their issuance. At September 30, 2022, the principal balance of this note was $300,000. Discounts in the amount of $71,012 were amortized to interest expense during the nine months ended September 30, 2022, and total discounts in the amount of $37,393 remained outstanding at September 30, 2022. On June 13, 2022, the Company issued 4,000 ten-year stock options with an exercise price of $12.50 and a fair value of $23,316 to Tom Brodmerkel, its Chairman, for taking on the position of Chief Financial Officer. On July 21, 2022, the Company issued a 10% Promissory Notes due to Michael C Howe Living Trust (the “Howe Note 3”) and in respect of which the Company received proceeds of $255,000. The Howe Note 3 carries a 10% interest rate per annum, accrued monthly and payable at maturity. The Howe Note 3 has a maturity date, as extended, that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The amount payable at maturity will be $300,000 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default, as defined in the Howe Note 3, the principal amount shall bear interest for each day until paid, at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Howe Note 3 contains a “most favored nations” clause that provides that, so long as the Howe Note 3 is outstanding, if the Company issues any new security, which Mr. Howe reasonably believes contains a term that is more favorable than those in the Note, the Company shall notify Mr. Howe of such term, and such term, at the option of Mr. Howe, shall become a part of the Howe Note 3. In addition, Mr. Howe will be issued (1) 2,460 five-year warrants and (2) 2,460 shares of Common Stock as commitment shares. The Commitment Shares are priced at $12.50. The Warrants have an initial exercise price of $25.00 per share. The Warrants are not exercisable for six months following their issuance. Mr. Howe may exercise the Warrants on a cashless basis if after the six-month anniversary of date of issuance, the shares of Common Stock underlying the Warrants are not then registered pursuant to an effective registration statement. Discounts in the amount of $97,440 were amortized to interest expense during the nine months ended September 30, 2022, and total discounts in the amount of $0 remained outstanding at September 30, 2022. On July 21, 2022, the Company issued a 10% Promissory Note due to Juan Carlos Iturregui (the “Iturregui Note”) and in respect of which the Company received proceeds of $25,000. Mr. Iturregui is a member of the Company’s Board of Directors. The Iturregui Note carries a 10% interest rate per annum, accrued monthly and payable at maturity. The Iturregui Note has a maturity date that is the earlier of (i) January 21, 2023, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The amount payable at maturity will be $29,412 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default, as defined in The Iturregui Note, the principal amount shall bear interest for each day until paid, at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Iturregui Note contains a “most favored nations” clause that provides that, so long as The Iturregui Note is outstanding, if the Company issues any new security, which Mr. Iturregui reasonably believes contains a term that is more favorable than those in The Iturregui Note, the Company shall notify Mr. Iturregui of such term, and such term, at the option of Mr. Iturregui, shall become a part of The Iturregui Note. In addition, Mr. Iturregui will be issued (1) 241 five-year warrants (the “Warrants”) and (2) 242 shares of Common Stock as commitment shares (“Commitment Shares”). The Commitment Shares are priced at $12.50. The Warrants have an initial exercise price of $25.00 per share. The Warrants are not exercisable for six months following their issuance. Mr. Iturregui may exercise the Warrants on a cashless basis if after the six-month anniversary of date of issuance, the shares of Common Stock underlying the Warrants are not then registered pursuant to an effective registration statement. Discounts in the amount of $3,686 were amortized to interest expense during the nine months ended September 30, 2022, and total discounts in the amount of $5,867 remained outstanding at September 30, 2022. On August 4, 2022, the Company issued a 10% Promissory Note due to Jessica, Kevin C., Brody, Isabella and Jack Finnegan (the “Finnegan Note 3”) and in respect of which the Company received proceeds of $25,000. The Finnegan Note 3 carries a 10% interest rate per annum, accrued monthly and payable at maturity. The Finnegan Note 3 has a maturity of February 3, 2023. The amount payable at maturity will be $29,412 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default, as defined in the Finnegan Note 3, the principal amount shall bear interest for each day until paid, at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Finnegan Note 3 contains a “most favored nations” clause that provides that, so long as the Finnegan Note 3 is outstanding, if the Company issues any new security, which the Finnegans reasonably believes contains a term that is more favorable than those in the Finnegan Note 3, the Company shall notify the Finnegans of such term, and such term, at the option of the Finnegans, shall become a part of the Finnegan Note 3. In addition, the Finnegans will be issued in aggregate (1) 241 five-year warrants and (2) 241 shares of Common Stock as Commitment Shares. The Commitment Shares are priced at $12.50. The Warrants have an initial exercise price of $25.00 per share. The Warrants are not exercisable for six months following their issuance. The Finnegans may exercise the Warrants on a cashless basis if after the six-month anniversary of date of issuance, the shares of Common Stock underlying the Warrants are not then registered pursuant to an effective registration statement. Discounts in the amount of $2,898 were amortized to interest expense during the nine months ended September 30, 2022, and total discounts in the amount of $6,405 remained outstanding at September 30, 2022. On August 18, 2022, the Company issued a 10% Promissory Note due to Michael C Howe Living Trust (the “Howe Note 4”) and in respect of which the Company received proceeds of $170,000. The Howe Note 4 carries a 10% interest rate per annum, accrued monthly and payable at maturity. The Howe Note 4 has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The aggregate amount payable at maturity will be $200,000 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default, as defined in the Howe Note 4, the principal amount shall bear interest for each day until paid, at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Howe Note 4 contains a “most favored nations” clause that provides that, so long as the Howe Note 4 is outstanding, if the Company issues any new security, which Mr. Howe reasonably believes contains a term that is more favorable than those in the Howe Note 4, the Company shall notify Mr. Howe of such term, and such term, at the option of Mr. Howe, shall become a part of the Howe Note 4. In addition, Mr. Howe will be issued 1,640 shares of Common Stock as commitment shares (the “Howe Note 4 Commitment Shares”). The Howe Note 4 Commitment Shares are priced at $12.50. Discounts in the amount of $25,128 were amortized to interest expense during the nine months ended September 30, 2022, and total discounts in the amount of $35,647 remained outstanding at September 30, 2022.

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	9 Months Ended
	Sep. 30, 2023
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	Note 7: Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities consisted of the following at September 30, 2023 and December 31, 2022: September 30, December 31, 2023 2022 Trade accounts payable $ 1,466,337 $ 1,647,233 Accrued payroll and payroll taxes 437,263 298,108 Other - 507 Total accounts payable and accrued liabilities $ 1,903,600 $ 1,945,848

Right to Use Assets and Lease L

Right to Use Assets and Lease Liabilities - Operating Leases	9 Months Ended
	Sep. 30, 2023
Disclosure Text Block [Abstract]
Lessee, Operating Leases [Text Block]	Note 8: Right to Use Assets and Lease Liabilities Operating Leases During the year ended December 31, 2022, the Company recognized an impairment of Right-to-Use (RTU) assets in the amount of $3.2 million in connection with the closing of its clinics during the period. During the nine months ended September 30, 2023, the Company recognized an additional impairment in the amount of $0.5 million in connection with its remaining leased properties. This amount is included in Net Loss from Discontinued Operations on the Company’s statement of operations for the three and nine months ended September 30, 2023. As of September 30, 2023, the Company had total operating lease liabilities of approximately $94,000 and right-of-use assets of $0, which were included in the condensed consolidated balance sheet. Right to use assets – operating leases are summarized below: September 30, 2023 December 31, 2022 Right to use assets, net $ - $ 83,810 Operating lease liabilities are summarized below: September 30, 2023 December 31, 2022 Lease liability $ 93,758 $ 93,758 Less: current portion (93,758 ) (93,758 ) Lease liability, non-current $ - $ - Maturity analysis under these lease agreements are as follows: For the twelve months ended September 30, 2024 $ 99,477 For the twelve months ended September 30, 2025 - For the twelve months ended September 30, 2026 - For the twelve months ended September 30, 2027 - For the twelve months ended September 30, 2028 - Thereafter - Total $ 99,477 Less: Present value discount (5,719 ) Lease liability $ 93,758

SBA Loan Payable

SBA Loan Payable	9 Months Ended
	Sep. 30, 2023
Small Business Administration Loan Payable Abstract
Small Business Administration Loan Payable [Text Block]	Note 9: SBA Loan Payable PPP Loan Conversion to SBA Loan During March 2020, in response to the COVID-19 crisis, the federal government announced plans to offer loans to small businesses in various forms, including the Payroll Protection Program, or “PPP”, established as part of the Corona Virus Aid, Relief and Economic Security Act (“CARES Act”) and administered by the U.S. Small Business Administration (the “SBA”). On April 25, 2020, the Company entered an unsecured Promissory Note with Bank of America for a loan in the original principal amount of $460,400, and the Company received the full amount of the loan proceeds on May 4, 2020 (the “PPP Loan”). The PPP Loan bears interest at the rate of 1% per year. During the year ended December 31, 2022, the Company accrued interest in the amount of $4,632. On July 12, 2023, the Company received confirmation of a payment plan arrangement from the SBA. Pursuant to this payment plan, the Company agreed to pay a minimum of $2,595 each month until the loan is paid in full in July 2028. The SBA confirmed the balance due on the loan, including principal and interest, was $467,117. The Company will amortize the balance due on the loan including interest at the original PPP loan rate of 1% per annum; a gain on restructure of debt in the amount of $40,622 was recorded on this transaction during the three months ended September 30, 2023, and the balance of the loan was recorded at the amount of $433,343 representing the net cash flows discounted at 1%. During the three and nine months ended September 30, 2023, the Company made principal payments of $4,836 on this loan; during the three and nine months ended September 30, 2023, the Company recorded interest in the amount of $1,081 and $3,351, respectively, on this loan.

Notes Payable

Notes Payable	9 Months Ended
	Sep. 30, 2023
Notes Payable [Line Items]
Debt Disclosure [Text Block]	Note 10: Notes Payable AJB Note On March 18, 2022, the Company entered into a Securities Purchase Agreement (the “AJB Agreement”) with AJB Capital Investments, LLC (“AJB”) with respect to the sale and issuance to AJB of: (i) an initial commitment fee in the amount of $430,000 in the form of 34,400 shares (the “AJB Commitment Fee Shares”) of the Company’s Common Stock, (ii) a promissory note in the aggregate principal amount of $750,000 (the “AJB Note”), and (iii) Common Stock Purchase Warrants to purchase 15,000 shares of the Company’s Common Stock (the “AJB Warrants”). The AJB Note and AJB Warrants were issued on March 17, 2022 and were held in escrow pending effectiveness of the AJB Agreement. Should AJB receive net proceeds of less than $430,000 from the sale of the AJB Commitment Fee Shares, the Company will issue additional shares to AJB or pay the shortfall amount to AJB in cash (the “AJB True-up Obligation”. The terms of the AJB Agreement resulted in the Company recording a derivative liability in the initial amount of $106,608. On November 18, 2022, the Company issued 91,328 shares of common stock to AJB and recorded a loss in the amount of $9,007 in connection with the settlement of the AJB True-up Obligation. See notes 12 and 14. The AJB Note was issued in the principal amount of $750,000 for a purchase price of $675,000, resulting in an original issue discount of $75,000, and has a due date, as extended, of March 17, 2023. The AJB Note bears interest at the rate of 10% per year for the first six months and 12% thereafter. In the event of default as defined in the AJB Note this rate will increase to 18% and the AJB Note will become convertible at a price per share equal to the lowest trading price during the previous twenty trading days prior to the conversion date. The AJB Note entered default status on October 6, 2022. The AJB Commitment Fee Shares and AJB Warrants resulted in a discount to the AJB Note in the amount of $349,914. The Company charged the amount of $62,000 to interest on the AJB Note during the year ended December 31, 2022. Discounts in the amount of $424,914 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $750,000 and $22,833, respectively, were due on the AJB Note at December 31, 2022. During the nine months ended September 30, 2023, a default penalty in the amount of $375,000 and an additional fee in the amount of $15,000 were added to the principal amount of the AJB note. During the three and nine months ended September 30, 2023, interest in the amounts of $6,270 and $62,897, respectively, was accrued on the AJB Note. On April 11, 2023, an equity investment incentive in the amount of $800,800 representing 65% of the total amount due under the AJB Note, along with original principal of $750,000, the default penalty of $375,000, the fee of $15,000, and accrued interest of $92,000 (a total of $2,032,800) was converted to 2,033 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $800,800, there was no additional gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At September 30, 2023, there were no amounts due under the AJB Note. Anson Investments Note On April 6, 2022, the Company entered into a Securities Purchase Agreement (the “Anson Investments Agreement”) with Anson Investments Master Fund LP (“Anson Investments”) with respect to the sale and issuance to Anson Investments of: (i) an initial commitment fee in the amount of $322,500 in the form of 25,800 shares (the “Anson Investments Commitment Fee Shares”) of the Company’s Common Stock, (ii) a promissory note in the aggregate principal amount of $562,500 (the “Anson Investments Note”), and (iii) Common Stock Purchase Warrants to purchase 11,250 shares of the Common Stock (the “Anson Investments Warrants”). Should Anson Investments receive net proceeds of less than $322,500 from the sale of the Anson Investments Commitment Fee Shares, the Company will issue additional shares to Anson Investments or pay the shortfall amount to Anson Investments in cash. The terms of the Anson Investments Agreement resulted in the Company recording a derivative liability in the initial amount of $27,040. The Anson Investments Note was issued in the principal amount of $562,500 for a purchase price of $506,250 resulting in an original issue discount of $56,250. The Anson Investments Note has a due date of October 6, 2022 and bears interest at the rate of 10% per year for the first six months and 12% thereafter. In the event of default as defined in the Anson Investments Note this rate will increase to 18% and the Anson Investment Note will become convertible at a price per share equal to the lowest trading price during the previous twenty trading days prior to the conversion date. The Anson Investments Note entered default status on October 6, 2022. The Anson Investments Commitment Fee Shares and Anson Investments Warrants resulted in a discount to the Anson Investments Note in the amount of $416,375. The Company charged the amount of $68,844 to interest on the Anson Investments note during the year ended December 31, 2022. Discounts in the amount of $472,625 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $562,500 and $41,500, respectively, were due on the AJB Note at December 31, 2022. During the nine months ended September 30, 2023, a default penalty in the amount of $281,250 and an additional fee in the amount of $15,000 were added to the principal amount of the Anson Investments Note. During the three and nine months ended September 30, 2023, interest in the amounts of $4,724 and $27,157, respectively, was accrued on the Anson Investments Note. On April 11, 2023, an equity investment incentive in the amount of $602,815 representing 65% of the total amount due under the Anson Investments Note, along with original principal of $562,500, the default penalty of $281,250, the fee of $15,000, and accrued interest of $68,657 (a total of $1,530,222) was converted to 1,531 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $602,815, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At September 30, 2023, there were no amounts due under the Anson Investments Note. Anson East Note On April 6, 2022, the Company entered into a Securities Purchase Agreement (the “Anson East Agreement”) with Anson East Master Fund LP (“Anson East”) with respect to the sale and issuance to Anson East of: (i) an initial commitment fee in the amount of $107,500 in the form of 8,600 shares (the “Anson East Commitment Fee Shares”) of the Company’s Common Stock, (ii) a promissory note in the aggregate principal amount of $187,500 (the “Anson East Note”), and (iii) Common Stock Purchase Warrants to purchase 3,750 shares of the Company’s common stock (the “Anson East Warrants”). Should Anson East receive net proceeds of less than $107,500 from the sale of the Anson East Commitment Fee Shares, the Company will issue additional shares to Anson East or pay the shortfall amount to Anson East in cash. The terms of the Anson East Agreement resulted in the Company recording a derivative liability in the initial amount of $9,014. The Anson East Note was issued in the principal amount of $187,500 for a purchase price of $168,750 resulting in an original issue discount of $18,750. The Anson East Note has a due date of October 6, 2022 and bears interest at the rate of 10% per year for the first six months and 12% thereafter. In the event of default as defined in the Anson East Note this rate will increase to 18%, and the Anson East Note will become convertible at a price per share equal to the lowest trading price during the previous twenty trading days prior to the conversion date. The Anson East Note entered default status on October 6, 2022. The Anson East Commitment Fee Shares and Anson East Warrants resulted in a discount to the Anson East Note in the amount of $147,290. The Company charged the amount of $22,948 to interest on the Anson Investments note during the year ended December 31, 2022. Discounts in the amount of $166,040 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $187,500 and $13,833, respectively, were due on the Anson East Note at December 31, 2022. During the nine months ended September 30, 2023, a default penalty in the amount of $93,750 and an additional fee in the amount of $15,000 were added to the principal amount of the Anson East Note. During the three and nine months ended September 30, 2023, the amounts of $9,552 and $23,385, respectively, was accrued on the Anson East Note. On April 11, 2023, an equity investment incentive in the amount of $207,763 representing 65% of the total amount due under the Anson East Note, along with original principal of $187,500, the default penalty of $93,750, the fee of $15,000, and accrued interest of $23,385 (a total of $527,398) was converted to 528 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $207,763, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At September 30, 2023, there were no amounts due under the Anson East Note. GS Capital Note On April 18, 2022, the Company entered into a Securities Purchase Agreement (the “GS Capital Agreement”) with GS Capital Investments, LLC (“GS Capital”) with respect to the sale and issuance to GS Capital of: (i) an initial commitment fee in the amount of $159,259 in the form of 12,741 shares (the “GS Capital Commitment Fee Shares”) of the Company’s Common Stock, (ii) a promissory note in the aggregate principal amount of $277,777 (the “GS Capital Note”), and (iii) Common Stock Purchase Warrants to purchase 5,556 shares of the Company’s common stock (the “GS Capital Warrants”). Should GS Capital receive net proceeds of less than $159,259 from the sale of the GS Capital Commitment Fee Shares, the Company will issue additional shares to GS Capital or pay the shortfall amount to GS Capital in cash. The terms of the GS Capital Agreement resulted in the Company recording a derivative liability in the initial amount of $21,920. The GS Capital Note was issued in the principal amount of $277,777 for a purchase price of $250,000 resulting in an original issue discount of $27,777. The GS Capital Note has a due date of November 10, 2022 and bears interest at the rate of 10% per year for the first six months and 12% thereafter. In the event of default as defined in the GS Capital Note this rate will increase to 18%, and the GS Capital Note will become convertible at a price per share equal to the lowest trading price during the previous twenty trading days prior to the conversion date. The GS Capital Note entered default status on October 19, 2022. The GS Capital Commitment Fee Shares and GS Capital Warrants resulted in a discount to the GS Capital Note in the amount of $162,158. The Company charged the amount of $32,155 to interest on the GS Capital Note during the year ended December 31, 2022. Discounts in the amount of $212,435 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $277,777 and $19,578, respectively, were due on the GS Capital Note at December 31, 2022. During the nine months ended September 30, 2023, GS Capital converted an aggregate amount of $72,777 of principal and $8,679 of accrued interest in the GS Capital Note into an aggregate of 57,140 shares of the Company’s common stock at an average price of $1.46 per share. These conversions were made pursuant to the terms of the GS Capital Note, and no gain or loss was recorded on these transactions. During the nine months ended September 30, 2023, a default penalty in the amount of $138,889 and an additional fee in the amount of $15,000 were added to the principal amount of the GS Capital Note. During the three and nine months ended September 30, 2023, interest in the amount of $2,374 and $13,965, respectively, was accrued on the GS Capital Note. On April 11, 2023, an equity investment incentive in the amount of $249,439 representing 65% of the total amount due under the GS Capital Note, along with original principal of $205,000, the default penalty of $138,889, the fee of $15,000, and accrued interest of $24,864 (a total of $633,192) was converted to 634 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $249,439, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At September 30, 2023, there were no amounts due under the GS Capital Note. Kishon Note On May 10, 2022, the Company entered into a Securities Purchase Agreement (the “Kishon Agreement”) with Kishon Investments, LLC (“Kishon”) with respect to the sale and issuance to Kishon of: (i) an initial commitment fee in the amount of $159,259 in the form of 12,741 shares (the “Kishon Commitment Fee Shares”) of the Company’s Common Stock, (ii) a promissory note in the aggregate principal amount of $277,777 (the “Kishon Note”), and (iii) Common Stock Purchase Warrants to purchase 5,556 shares of the Company’s common stock (the “Kishon Warrants”). Should Kishon receive net proceeds of less than $159,259 from the sale of the Kishon Commitment Fee Shares, the Company will issue additional shares to Kishon or pay the shortfall amount to Kishon in cash. The terms of the Kishon Agreement resulted in the Company recording a derivative liability in the initial amount of $27,793. The Kishon Note was issued in the principal amount of $277,777 for a purchase price of $250,000 resulting in an original issue discount of $27,777. The Kishon Note has a due date of November 10, 2022 and bears interest at the rate of 10% per year for the first six months and 12% thereafter. In the event of default as defined in the Kishon Note this rate will increase to 18%, and the Kishon Note will become convertible at a price per share equal to the lowest trading price during the previous twenty trading days prior to the conversion date. The Kishon Note entered default status on November 11, 2022. The Kishon Commitment Fee Shares and Kishon Warrants resulted in a discount to the Kishon Note in the amount of $138,492. The Company charged the amount of $28,624 to interest on the Kishon Note during the year ended December 31, 2022. Discounts in the amount of $181,269 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $277,777 and $17,822, respectively, were due on the Kishon Note at December 31, 2022. During the nine months ended September 30, 2023, a default penalty in the amount of $138,889 and an additional fee in the amount of $15,000 were added to the principal amount of the Kishon Note. During the three and nine months ended September 30, 2023, interest in the amounts of $19,641 and $51,502, respectively, was accrued on the Kishon Note. At September 30, 2023, principal and interest in the amount of $431,666 and $69,324, respectively, were due on the Kishon Note. This note was in default at December 31, 2022 and September 30, 2023. Finnegan Note 1 On May 23, 2022, the Company issued a 10% Promissory Note in the principal amount of $47,059 to Jessica Finnegan (the “Finnegan Note 1”). The Finnegan Note 1 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 20, 2022, as extended, or (ii) five (5) business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Finnegan Note 1 was $40,000; the amount payable at maturity will be $47,059 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Finnegan Note 1, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Finnegan Note 1 entered default status on November 21, 2022, and the interest rate increased to 18%. The Finnegan Note 1 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Ms. Finnegan reasonably believes contains a term that is more favorable than those in the Finnegan Note 1, the Company shall notify Ms. Finnegan of such term, and such term, at the option of Ms. Finnegan, shall become a part of the Finnegan Note 1. In addition, Ms. Finnegan received five-year warrants to purchase 386 shares of common stock at a price of $25.00 per share with a fair value of $2,000 at the date of issuance, and 1,930 shares of common stock with a value of $3,240; these amounts were recorded as discounts to the Finnegan Note 1. Interest in the amount of $3,285 was accrued on the Finnegan Note 1 during the year ended December 31, 2022. Discounts in the amount of $17,005 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $51,765 and $3,285, respectively, were due on the Finnegan Note 1 at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $2,164 and $6,469, respectively, was accrued on the Finnegan Note 1; principal and accrued interest in the amount of $51,765 and $9,754, respectively, were due on this note at September 30, 2023. This note was in default at September 30, 2023. M Diamond Note On May 26, 2022, the Company issued a 10% Promissory Note in the principal amount of $58,823 to Melissa Diamond (the “M Diamond Note”). The M Diamond Note bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the M Diamond Note was $50,000; the amount payable at maturity will be $58,823 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the M Diamond Note, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The M Diamond Note entered default status on December 1, 2022, and the interest rate increased to 18%. The M Diamond Note contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Ms. Diamond reasonably believes contains a term that is more favorable than those in the M Diamond Note, the Company shall notify Ms. Diamond of such term, and such term, at the option of Ms. Diamond, shall become a part of the M Diamond Note. In addition, Ms. Diamond received five-year warrants to purchase 483 shares of common stock at a price of $25.00 per share with a fair value of $2,500 at the date of issuance, and 483 shares of common stock with a value of $4,050; these amounts were recorded as discounts to the M Diamond Note. Interest in the amount of $3,929 was accrued on the M Diamond Note during the year ended December 31, 2022. Discounts in the amount of $21,256 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $64,705 and $3,929, respectively, were due on the M Diamond Note at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $2,706 and $8,084, respectively, was accrued on the M Diamond Note; principal and accrued interest in the amount of $64,705 and $12,013, respectively, were due on this note at September 30, 2023. This note was in default at September 30, 2023. Finnegan Note 2 On May 26, 2022, the Company issued a 10% Promissory Note in the principal amount of $29,412 to Jessica Finnegan (the “Finnegan Note 2”). The Finnegan Note 2 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Finnegan Note 2 was $25,000; the amount payable at maturity will be $29,412 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Finnegan Note 2, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Finnegan Note 2 entered default status on December 1, 2022, and the interest rate increased to 18%. The Finnegan Note 2 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Ms. Finnegan reasonably believes contains a term that is more favorable than those in the Finnegan Note 2, the Company shall notify Ms. Finnegan of such term, and such term, at the option of Ms. Finnegan, shall become a part of the Finnegan Note 2. In addition, Ms. Finnegan received five-year warrants to purchase 242 shares of common stock at a price of $25.00 per share with a fair value of $1,250 at the date of issuance, and 242 shares of common stock with a value of $2,025; these amounts were recorded as discounts to the Finnegan Note 2. Interest in the amount of $1,965 was accrued on the Finnegan Note 2 during the year ended December 31, 2022. Discounts in the amount of $10,625 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $32,353 and $1,965, respectively, were due on the Finnegan Note 2 at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $1,353 and $4,042, respectively, was accrued on the Finnegan Note 2; principal and accrued interest in the amount of $32,353 and $6,007, respectively, were due on this note at September 30, 2023. This note was in default at September 30, 2023. Dragon Note On June 9, 2022, the Company issued a 10% Promissory Note in the principal amount of $588,235 (the “Dragon Note”) to Dragon Dynamic Funds Platform Ltd (“Dragon Dynamic”). The Dragon Note bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) December 9, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Dragon Note was $500,000; the amount payable at maturity will be $588,235 plus 10% of that amount plus any accrued and unpaid interest. Costs in the amount of $47,500 were charged to discount on the Dragon Note. Following an event of default as defined in the Dragon Note, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Dragon Note entered default status on December 10, 2022, and the interest rate increased to 18%. The Dragon Note contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Dragon Dynamic reasonably believes contains a term that is more favorable than those in the Dragon Note, the Company shall notify Dragon Dynamic of such term, and such term, at the option of Dragon Dynamic, shall become a part of the Dragon Note. In addition, Dragon Dynamic received five-year warrants to purchase 4,824 shares of common stock at a price of $25.00 per share with a fair value of $21,500 at the date of issuance, and 4,824 shares of common stock with a value of $44,000; these amounts were recorded as discounts to the Dragon Note. Interest in the amount of $35,874 was accrued on the Dragon Note during the year ended December 31, 2022. Discounts in the amount of $260,059 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $647,059 and $35,874, respectively, were due on the Dragon Note at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $3,235 and $29,706, respectively, was accrued on the Dragon Note. On April 11, 2023, an equity investment incentive in the amount of $463,539 representing 65% of the total amount due under the Dragon Note, along with original principal of $647,059 and accrued interest of $66,078 (a total of $1,176,676) was converted to 1,177 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $463,539, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At September 30, 2023, there were no amounts due under the Dragon Note. Mackay Note On July 7, 2022, the Company issued a 10% Promissory Note in the principal amount of $294,118 to Mackay Investments, LLC (the “Mackay Note”). The Mackay Note bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) August 10, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Mackay Note was $250,000; the amount payable at maturity will be $294,118 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Mackay Note, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Mackay Note entered default status on August 11, 2022, and the interest rate increased to 18%. The Mackay Note contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mackay Investments, LLC reasonably believes contains a term that is more favorable than those in the Mackay Note, the Company shall notify Mackay Investments, LLC of such term, and such term, at the option of Mackay Investments, LLC , shall become a part of the Mackay Note. In addition, Mackay Investments, LLC received five-year warrants to purchase 2,412 shares of common stock at a price of $25.00 per share with a fair value of $10,250 at the date of issuance, and 2,412 shares of common stock with a value of $44,118; these amounts were recorded as discounts to the Mackay Note. Interest in the amount of $20,193 was accrued on the Mackay Note during the year ended December 31, 2022. Discounts in the amount of $96,280 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $323,530 and $20,193, respectively, were due on the Mackay Note at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $13,382 and $43,614, respectively was accrued on the Mackay Note On September 29, 2023, an equity investment incentive in the amount of $258,269 representing 65% of the total amount due under the Mackay Note, along with original principal of $294,118, premium of $29,412, accrued interest of $63,807, and fee of $10,000 (a total of $655,606) was converted to 656 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $258,269, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At September 30, 2023, there were no amounts due under the Mackay Note. Schrier Note On July 7, 2022, the Company issued a 10% Promissory Note in the principal amount of $23,259 to Charles Schrier (the “Schrier Note”). The Schrier Note bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) January 8, 2023, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Schrier Note was $20,000; the amount payable at maturity will be $23,529 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Schrier Note, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Schrier Note contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Schrier reasonably believes contains a term that is more favorable than those in the Schrier Note, the Company shall notify Mr. Schrier of such term, and such term, at the option of Mr. Schrier, shall become a part of the Schrier Note. In addition, Mr. Schrier received five-year warrants to purchase 193 shares of common stock at a price of $25.00 per share with a fair value of $820 at the date of issuance, and 193 shares of common stock with a value of $1,000; these amounts were recorded as discounts to the Schrier Note. Interest in the amount of $1,141 was accrued on the Schrier Note during the year ended December 31, 2022. Discounts in the amount of $7,367 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $335 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $25,882 and $1,141, respectively, were due on the Schrier Note at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $1,071 and $3,174, respectively, was accrued on the Schrier Note; principal and accrued interest in the amount of $25,882 and $4,315, respectively, were due on this note at September 30, 2023. This note was in default at September 30, 2023. Nommsen Note On July 26, 2022, the Company issued a 10% Promissory Note in the principal amount of $58,823 to Eric S. Nommsen (the “Nommsen Note”). The Nommsen Note bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Nommsen Note was $50,000; the amount payable at maturity will be $58,823 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Nommsen Note, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Nommsen Note entered default status on December 1, 2022, and the interest rate increased to 18%. The Nommsen Note contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Nommsen reasonably believes contains a term that is more favorable than those in the Nommsen Note, the Company shall notify Mr. Nommsen of such term, and such term, at the option of Mr. Nommsen, shall become a part of the Nommsen Note. In addition, Mr. Nommsen received five-year warrants to purchase 483 shares of common stock at a price of $25.00 per share with a fair value of $1,850 at the date of issuance, and 483 shares of common stock with
Related Party [Member]
Notes Payable [Line Items]
Debt Disclosure [Text Block]	Note 11: Notes Payable Related Parties Howe Note 1 On December 30, 2021, we issued a 10% Promissory Note in the principal amount of $1,000,000 in a related party transaction to the Michael C. Howe Living Trust (the “Howe Note 1”). Michael C. Howe was the Chief Executive Officer of the Good Clinic LLC, one of our subsidiaries. The Howe Note 1 bears interest at the rate of 10% interest rate per annum and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five (5) business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Howe Note 1 was $850,000; the amount payable at maturity will be $1,000,000 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default, as defined in the Howe Note 1, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Howe Note 1 entered delinquent status on December 1, 2022, and the interest rate increased to 18%. The Howe Note 1 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security, which Mr. Howe reasonably believes contains a term that is more favorable than those in the Howe Note 1, we shall notify Mr. Howe of such term, and such term, at the option of Mr. Howe, shall become a part of the Howe Note 1. In addition, Mr. Howe five-year warrants to purchase 42,000 shares of common stock at a price of $25.00 per share, and five-year warrants to purchase 42,000 shares of common stock at $37.50 per share with an aggregate fair value of $261,568 at the date of issuance, which was recorded as a discount to this note. Interest in the amount of $106,795 was accrued on the Howe Note 1 during the year ended December 31, 2022. Discounts in the amount of $511,568 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $1,100,000 and $106,795, respectively, were due on the Howe Note 1 at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $46,000 and $138,261, respectively, was accrued on the Howe Note 1; principal and accrued interest in the amount of $1,100,000 and $245,056, respectively, were due on this note at September 30, 2023. This note was in default at September 30, 2023. See note 16. Diamond Note 1 On February 24, 2022, the Company issued a 10% Promissory Note in the principal amount of $175,000 in a related party transaction to Lawrence Diamond, who was Chief Executive Officer and a member of our Board of Directors (the “Diamond Note 1”). The Diamond Note 1 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Diamond Note 1 was $148,750; the amount payable at maturity will be $175,000 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Diamond Note 1, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Diamond Note 1 entered default status on December 1, 2022, and the interest rate increased to 18%. The Diamond Note 1 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Diamond reasonably believes contains a term that is more favorable than those in the Diamond Note 1, the Company shall notify Mr. Diamond of such term, and such term, at the option of Mr. Diamond, shall become a part of the Diamond Note 2. In addition, Mr. Diamond received five-year warrants to purchase 7,350 shares of common stock at a price of $25.00 per share, and five-year warrants to purchase 7,350 shares of common stock at $37.50 per share with an aggregate fair value of $2,914 at the date of issuance, which was recorded as a discount to this note. Interest in the amount of $16,052 was accrued on the Diamond Note 1 during the year ended December 31, 2022. Discounts in the amount of $46,664 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $192,500 and $16,052, respectively, were due on the Diamond Note 1 at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $7,963 and $24,024, respectively, was accrued on the Diamond Note 1 On September 29, 2023, an equity investment incentive in the amount of $151,174 representing 65% of the total amount due under the Diamond Note 1, along with original principal of $175,000, premium of $17,500, and accrued interest of $40,076 (a total of $383,750) was converted to 384 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $151,174, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At September 30, 2023, there were no amounts due under the Diamond Note 1. Diamond Note 2 On March 18, 2022, the Company issued a 10% Promissory Note in the principal amount of $235,294 in a related party transaction to Lawrence Diamond, who was Chief Executive Officer and a member of our Board of Directors (the “Diamond Note 2). The Diamond Note 2 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Diamond Note 2 was $200,000; the amount payable at maturity will be $235,294 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Diamond Note 2, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Diamond Note 2 entered default status on December 1, 2022, and the interest rate increased to 18%. The Diamond Note 2 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Diamond reasonably believes contains a term that is more favorable than those in the Diamond Note 2, the Company shall notify Mr. Diamond of such term, and such term, at the option of Mr. Diamond, shall become a part of the Diamond Note 2. In addition, Mr. Diamond received five-year warrants to purchase 1,930 shares of common stock at a price of $25.00 per share a fair value of $2,213 at the date of issuance, which was recorded as a discount to this note. Interest in the amount of $1,676 was accrued on the Diamond Note 2 during the year ended December 31, 2022. Principal in the amount of $235,294 was paid on the Diamond Note 2 during the year ended December 31, 2022. Discounts in the amount of $61,036 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $23,529 and $1,676, respectively, were due on the Diamond Note 2 at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $0 was accrued on the Diamond Note 2 On September 29, 2023, an equity investment incentive in the amount of $16,398 representing 65% of the total amount due under the Diamond Note 2, along with the premium of $23,529 and accrued interest of $1,699 (a total of $41,626) was converted to 42 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $16,398, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At September 30, 2023, there were no amounts due under the Diamond Note 2. Diamond Note 3 On April 27, 2022, the Company issued a 10% Promissory Note in the principal amount of $235,294 in a related party transaction to Lawrence Diamond, who was Chief Executive Officer and a member of our Board of Directors (the “Diamond Note 3”). The Diamond Note 3 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Diamond Note 3 was $200,000; the amount payable at maturity will be $235,294 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Diamond Note 3, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Diamond Note 3 entered default status on December 1, 2022, and the interest rate increased to 18%. The Diamond Note 3 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Diamond reasonably believes contains a term that is more favorable than those in the Diamond Note 3, the Company shall notify Mr. Diamond of such term, and such term, at the option of Mr. Diamond, shall become a part of the Diamond Note 3. In addition, Mr. Diamond received five-year warrants to purchase 1,930 shares of common stock at a price of $25.00 per share with a fair value of $8,800 at the date of issuance, and 1,930 shares of common stock with a value of $16,200; these amounts were recorded as discounts on the Diamond Note 3. Interest in the amount of $17,586 was accrued on the Diamond Note 3 during the year ended December 31, 2022. Discounts in the amount of $83,823 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $258,823 and $17,586, respectively, were due on the Diamond Note 3 at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $10,706 and $32,244, respectively, was accrued on the Diamond Note 3. On September 29, 2023, an equity investment incentive in the amount of $200,624 representing 65% of the total amount due under the Diamond Note 3, along with original principal of $235,294, premium of $23,529, and accrued interest of $49,830 (a total of $509,277) was converted to 509 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $200,624, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At September 30, 2023, there were no amounts due under the Diamond Note 3. Diamond Note 4 On May 18, 2022, the Company issued a 10% Promissory Note in the principal amount of $47,059 in a related party transaction to Lawrence Diamond, who was Chief Executive Officer and a member of our Board of Directors (the “Diamond Note 4”). The Diamond Note 4 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Diamond Note 4 was $40,000; the amount payable at maturity will be $47,059 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Diamond Note 4, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Diamond Note 4 entered default status on December 1, 2022, and the interest rate increased to 18%. The Diamond Note 4 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Diamond reasonably believes contains a term that is more favorable than those in the Diamond Note 4, the Company shall notify Mr. Diamond of such term, and such term, at the option of Mr. Diamond, shall become a part of the Diamond Note 4. In addition, Mr. Diamond received five-year warrants to purchase 386 shares of common stock at a price of $25.00 per share with a fair value of $2,960 at the date of issuance, and 1,930 shares of common stock with a value of $3,160; these amounts were recorded as discounts on the Diamond Note 4. Interest in the amount of $3,245 was accrued on the Diamond Note 4 during the year ended December 31, 2022. Discounts in the amount of $17,885 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $51,765 and $3,245, respectively, were due on the Diamond Note 4 at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $2,141 and $6,446 was accrued on the Diamond Note 4. On September 29, 2023, an equity investment incentive in the amount of $39,946 representing 65% of the total amount due under the Diamond Note 4, along with original principal of $47,059, premium of $4,706, and accrued interest of $9,691 (a total of $101,402) was converted to 101 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $200,624, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At September 30, 2023, there were no amounts due under the Diamond Note 4. Diamond Note 5 On May 26, 2022, the Company issued a 10% Promissory Note in the principal amount of $58,823 in a related party transaction to Lawrence Diamond, who was Chief Executive Officer and a member of our Board of Directors (the “Diamond Note 5”). The Diamond Note 5 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Diamond Note 5 was $50,000; the amount payable at maturity will be $58,823 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Diamond Note 5, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Diamond Note 5 entered default status on December 1, 2022, and the interest rate increased to 18%. The Diamond Note 5 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Diamond reasonably believes contains a term that is more favorable than those in the Diamond Note 5, the Company shall notify Mr. Diamond of such term, and such term, at the option of Mr. Diamond, shall become a part of the Diamond Note 5. In addition, Mr. Diamond received five-year warrants to purchase 483 shares of common stock at a price of $25.00 per share with a fair value of $2,500 at the date of issuance, and 483 shares of common stock with a value of $4,050; these amounts were recorded as discounts to the Diamond Note 5. Interest in the amount of $3,929 was accrued on the Diamond Note 5 during the year ended December 31, 2022. Discounts in the amount of $21,256 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $64,705 and $3,929, respectively, were due on the Diamond Note 5 at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $2,677 and $8,055, respectively, was accrued on the Diamond Note 5. On September 29, 2023, an equity investment incentive in the amount of $49,849 representing 65% of the total amount due under the Diamond Note 5, along with original principal of $58,824, premium of $5,882, and accrued interest of $11,984 (a total of $126,539) was converted to 127 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $200,624, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At September 30, 2023, there were no amounts due under the Diamond Note 5. Lindstrom Note 1 On May 26, 2022, the Company issued a 10% Promissory Note in the principal amount of $41,176 in a related party transaction to Jenny Lindstrom, who was the Company’s Chief Legal Officer (the “Lindstrom Note 1”). The Lindstrom Note 1 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Lindstrom Note 1 was $35,000; the amount payable at maturity will be $41,176 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Lindstrom Note 1, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Lindstrom Note 1 entered default status on December 1, 2022, and the interest rate increased to 18%. The Lindstrom Note 1 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Ms. Lindstrom reasonably believes contains a term that is more favorable than those in the Lindstrom Note 1, the Company shall notify Ms. Lindstrom of such term, and such term, at the option of Ms. Lindstrom, shall become a part of the Lindstrom Note 1. In addition, Ms. Lindstrom received five-year warrants to purchase 338 shares of common stock at a price of $25.00 per share with a fair value of $1,750 at the date of issuance, and 338 shares of common stock with a value of $2,835; these amounts were recorded as discounts to the Lindstrom Note 1. Interest in the amount of $2,750 was accrued on the Lindstrom Note 1 during the year ended December 31, 2022. Discounts in the amount of $14,879 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $45,294 and $2,750, respectively, were due on the Lindstrom Note 1 at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $1,894 and $5,659, respectively, was accrued on the Lindstrom Note; principal and accrued interest in the amount of $45,294 and $8,409, respectively, were due on this note at September 30, 2023. This note was in default at September 30, 2023. Dobbertin Note On May 26, 2022, the Company issued a 10% Promissory Note in the principal amount of $17,647 in a related party transaction to Alexander Dobbertin (the “Dobbertin Note”). Mr. Dobbertin is the spouse of Jenny Lindstrom, who was the Company’s Chief Legal Officer. The Dobbertin Note bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Dobbertin Note was $15,000; the amount payable at maturity will be $17,647 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Dobbertin Note, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Dobbertin Note entered default status on December 1, 2022, and the interest rate increased to 18%. The Dobbertin Note contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Dobbertin reasonably believes contains a term that is more favorable than those in the Dobbertin Note, the Company shall notify Mr. Dobbertin of such term, and such term, at the option of Mr. Dobbertin, shall become a part of the Dobbertin Note. In addition, Mr. Dobbertin received five-year warrants to purchase 145 shares of common stock at a price of $25.00 per share with a fair value of $750 at the date of issuance, and 145 shares of common stock with a value of $1,215; these amounts were recorded as discounts to the Dobbertin Note. Interest in the amount of $1,179 was accrued on the Dobbertin Note during the year ended December 31, 2022. Discounts in the amount of $6,377 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $19,412 and $1,179, respectively, were due on the Dobbertin Note at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $811 and $2,425, respectively, was accrued on the Dobbertin Note; principal and accrued interest in the amount of $19,412 and $3,604, respectively, were due on this note at September 30, 2023. This note was in default at September 30, 2023. Howe Note 2 On June 9, 2022, the Company issued a 10% Promissory Note in the principal amount of $300,000 in a related party transaction to the Michael C. Howe Living Trust (the “Howe Note 2”). Michael C. Howe was the Chief Executive Officer of the Good Clinic LLC, one of our subsidiaries. The Howe Note 2 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Howe Note 2 was $255,000; the amount payable at maturity will be $300,000 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Howe Note 2, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Howe Note 2 entered default status on December 1, 2022, and the interest rate increased to 18%. The Howe Note 2 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Howe reasonably believes contains a term that is more favorable than those in the Howe Note 2, the Company shall notify Mr. Howe of such term, and such term, at the option of Mr. Howe, shall become a part of the Howe Note 2. In addition, Mr. Howe received five-year warrants to purchase 2,460 shares of common stock at a price of $25.00 per share with a fair value of $10,965 at the date of issuance, and 2,460 shares of common stock with a value of $22,440; these amounts were recorded as discounts to the Howe Note 2. Interest in the amount of $18,888 was accrued on the Howe Note 2 during the year ended December 31, 2022. Discounts in the amount of $108,405 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $330,000 and $18,888, respectively, were due on the Howe Note 2 at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $13,800 and $41,212, respectively, was accrued on the Howe Note 2; principal and accrued interest in the amount of $330,000 and $60,100, respectively, were due on this note at September 30, 2023. This note was in default at September 30, 2023. Howe Note 3 On July 21, 2022, the Company issued a 10% Promissory Note in the principal amount of $300,000 in a related party transaction to the Michael C. Howe Living Trust (the “Howe Note 3”). Michael C. Howe was the Chief Executive Officer of the Good Clinic LLC, one of our subsidiaries. The Howe Note 3 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Howe Note 3 was $255,000; the amount payable at maturity will be $300,000 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Howe Note 3, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Howe Note 3 entered default status on December 1, 2022, and the interest rate increased to 18%. The Howe Note 3 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Howe reasonably believes contains a term that is more favorable than those in the Howe Note 3, the Company shall notify Mr. Howe of such term, and such term, at the option of Mr. Howe, shall become a part of the Howe Note 3. In addition, Mr. Howe received five-year warrants to purchase 2,460 shares of common stock at a price of $25.00 per share with a fair value of $9,945 at the date of issuance, and 2,460 shares of common stock with a value of $12,495; these amounts were recorded as discounts to the Howe Note 3. Interest in the amount of $15,436 was accrued on the Howe Note 3 during the year ended December 31, 2022. Discounts in the amount of $97,440 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $330,000 and $15,436, respectively, were due on the Howe Note 3 at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $13,800 and $41,164, respectively, was accrued on the Howe Note 3; principal and accrued interest in the amount of $330,000 and $56,600, respectively, were due on this note at September 30, 2023. This note was in default at September 30, 2023. Iturregui Note 1 On July 21, 2022, the Company issued a 10% Promissory Note in the principal amount of $29,412 in a related party transaction to Juan Carlos Iturregui, who was a member of the Company’s Board of Directors (the “Iturregui Note 1”). The Iturregui Note 1 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) January 21, 2023, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Iturregui Note 1 was $25,000; the amount payable at maturity will be $29,412 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Iturregui Note 1, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Iturregui Note 1 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Iturregui reasonably believes contains a term that is more favorable than those in the Iturregui Note 1, the Company shall notify Mr. Iturregui of such term, and such term, at the option of Mr. Iturregui, shall become a part of the Iturregui Note 1. In addition, Mr. Iturregui received five-year warrants to purchase 242 shares of common stock at a price of $25.00 per share with a fair value of $975 at the date of issuance, and 242 shares of common stock with a value of $1,225; these amounts were recorded as discounts to the Iturregui Note 1. Interest in the amount of $1,313 was accrued on the Iturregui Note 1 during the year ended December 31, 2022. Discounts in the amount of $8,464 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $1,089 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $32,353 and $1,313, respectively, were due on the Iturregui Note 1 at December 31, 2022. During the three and nine months ended September 2023, interest in the amount of $1,338 and $3,881, respectively, was accrued on the Iturregui Note 1. On September 29, 2023, an equity investment incentive in the amount of $24,406 representing 65% of the total amount due under the Iturregui Note 1, along with original principal of $29,412, premium of $2,941, and accrued interest of $5,194 (a total of $61,953) was converted to 62 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $24,406, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At September 30, 2023, there were no amounts due under the Iturregui Note 1. Howe Note 4 On August 18, 2022, the Company issued a 10% Promissory Note in the principal amount of $200,000 in a related party transaction to the Michael C. Howe Living Trust (the “Howe Note 4”). Michael C. Howe was the Chief Executive Officer of the Good Clinic LLC, one of our subsidiaries. The Howe Note 4 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Howe Note 4 was $170,000; the amount payable at maturity will be $200,000 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Howe Note 4, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Howe Note 4 entered default status on December 1, 2022, and the interest rate increased to 18%. The Howe Note 4 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Howe reasonably believes contains a term that is more favorable than those in the Howe Note 4, the Company shall notify Mr. Howe of such term, and such term, at the option of Mr. Howe, shall become a part of the Howe Note 4. In addition, Mr. Howe received 1,640 shares of common stock with a value of $10,775; this amount was recorded as a discount to the Howe Note 4. Interest in the amount of $8,756 was accrued on the Howe Note 4 during the year ended December 31, 2022. Discounts in the amount of $60,775 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $220,000 and $8,756, respectively, were due on the Howe Note 4 at December 31, 2022. During the three and nine months ended September 30, 2023, interest in the amount of $9,200 and $27,977, respectively, was accrued on the Howe Note 4; principal and accrued interest in the amount of $220,000 and $36,733, respectively, were due on this note at September 30, 2023. This note was in default at September 30, 2023. November 29, 2022 Notes On November 29, 2022, the Company issued seven identical promissory notes (the “November 29 Notes”) in related party transactions to the following individuals: (1) Thomas Brodmerkel, who was the Company’s CFO and Board Member; (2) Lawrence Diamond, who was the Company’s Chief Executive Officer and Bo

Derivative Liabilities

Derivative Liabilities	9 Months Ended
	Sep. 30, 2023
Disclosure Text Block [Abstract]
Derivatives and Fair Value [Text Block]	Note 12: Derivative Liabilities Certain of the Company’s convertible notes and warrants contain features that create derivative liabilities. The pricing model the Company uses for determining fair value of its derivatives is the Lattice Model. Valuations derived from this model are subject to ongoing internal and external verification and review. The model uses market-sourced inputs such as interest rates and stock price volatilities. Selection of these inputs involves management’s judgment and may impact net income. The derivative components of these notes are valued at issuance, at conversion, at restructuring, and at each period end. Derivative liability activity for the for the periods ended September 30, 2023, December 31, 2022 and 2021 is summarized in the table below: December 31, 2021 $ - True-up features issued 192,375 Settled upon conversion or exercise (310,641 ) Loss on revaluation 687,178 December 31, 2022 $ 568,912 Settled upon conversion or exercise (501,740 ) Loss on revaluation 85,765 September 30, 2023 $ 152,937 The Company uses a Monte Carlo model to value certain features of its notes payable that create derivative liabilities. The following table summarizes the assumptions for the valuations: December 31, 2022 Volatility 95.1% to 123.2 % Stock Price $ 1.06 to 3.50 Risk-free interest rates 4.35% to 4.37 % Term (years) 0.73 to 0.86 September 30, 2023 Volatility 159.6% to 540.40 % Stock Price $ 0.025 to 1.44 Risk-free interest rates 4.35 to 5.24 % Term (years) 0.11 to 0.61 Certain of our notes payable contain a commitment fee obligation with a true-up feature. The following assumptions were used for the valuation of the derivative liability associated with this obligation: ● The stock price would fluctuate with the Company projected volatility. ● The projected volatility curve from an annualized analysis for each valuation date was based on the historical volatility of the Company and the term remaining for the True-Up obligation. ● The Company expected the note would be repaid 90% of the time by the maturity date, at which point the Company would redeem the 1,000,000 redeemable commitment fee shares for $1. ● In the event the Company did not repay the note in time, the shareholders would sell their shares subject to volume restrictions. ● Discount rates were based on risk free rates in effect based on the remaining term. 50,000 simulations were run for each Monte Carlo simulation.

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit)	9 Months Ended
	Sep. 30, 2023
Stockholders' Equity Note [Abstract]
Equity [Text Block]	Note 13: Stockholders Equity (Deficit) Common Stock The Company has authorized 500,000,000 shares of common stock, par value $0.01; 5,544,519 shares were issued and outstanding on September 30, 2023. Common Stock Transactions During the Nine Months Ended September 30, 2023 On January 23, 2023, the Company issued 150,000 shares of common stock at the market price of $3.45 per share to a service provider. The aggregate value of $517,500 was charged to operations during the nine months ended September 30, 2023. On February 21, 2023, the Company issued 150,000 shares of common stock at the market price of $2.53 per share to a service provider. The aggregate value of $379,500 was charged to operations during the nine months ended September 30, 2023. During the nine months ended September 30, 2023, GS Capital converted principal and accrued interest in a convertible note payable into shares of common stock as follows: On February 14, 2023, principal of $15,000 and accrued interest of $1,632 were converted at a price of $1.74 per share into 9,846 shares of common stock; on February 28, 2023, principal of $17,777 and accrued interest of $2,057 were converted at a price of $1.50 per share into 13,555 shares of common stock; on March 9, 2023, principal of $20,000 and accrued interest of $2,399 were converted at a price of $1.50 per share into 15,265 shares of common stock; and on March 28, 2023, principal of $20,000 and accrued interest of $2,581 were converted at a price of $1.25 per share into 18,472 shares of common stock. These conversions were made pursuant to the terms of the convertible note agreement and no gain or loss was recognized on these transactions. On March 31, 2023, the Company issued a total of 8,063 shares of common stock for accrued dividends on its Series X Preferred Stock. Of this amount, a total of 1,066 shares were issued to officers and directors, 4,160 were issued to a related party shareholder, and 2,837 were issued to non-related parties. On April 4, 2023, the Company issued 2,952 shares of common stock to a consultant at a price of $1.29 per share as a commission on funds previously raised. The Company recorded a gain in the amount of $33,092 on this transaction. On April 4, 2023, the Company issued 94,738 shares of common stock to GS Capital at an average price of pursuant to a make-whole agreement entered into in connection with the GS Capital Warrants. See note 10. A gain in the amount of $21,506 was recorded on the settlement of this derivative liability. See note 12. On May 5, 2023, the Company issued 2,552 shares of common stock to a vendor at a price of $0.85 per share, and on May 9, 2023, the Company issued 19,622 shares of common stock at a price of $0.85 per share to the Michael C. Howe Living Trust (the “Howe Trust”), an entity controlled by a related party. These shares were issued in satisfaction of a vendor dispute. The shares issued to the Howe Trust were reimbursement for shares previously issued to the vendor by the Howe Trust with regard to this dispute. There was no gain or loss recorded on these transactions. On June 29, 2023, the Company issued a total of 20,212 shares of common stock for accrued dividends on its Series X Preferred Stock. Of this amount, a total of 2,673 shares were issued to officers and directors, 10,426 were issued to a related party shareholder, and 7,113 were issued to non-related parties. Effective June 30, 2023, the Company issued 2,926 shares of common stock at a price of $12.50 to a previous board member for the conversion of accounts payable in the amount of $36,575. These shares had been carried on the Company balance sheet as Common Stock Subscribed. On August 21, 2023, the Company issued 131,362 shares of common stock at a price of $0.80 per share for accounts payable in the amount of $105,089. A gain in the amount of $59,112 was recorded on this transaction. On August 21, 2023, the Company issued 43,750 shares of common stock at a price of $0.80 per share for accounts payable in the amount of $35,000. A gain in the amount of $19,687 was recorded on this transaction. On August 21, 2023, the Company issued 49,226 shares of common stock at a price of $0.80 per share for accounts payable in the amount of $39,380. A gain in the amount of $22,151 was recorded on this transaction. Effective September 29, 2023, the Company’s now former Chief Operating Officer and now former board member converted a note in the amount of $18,750, accrued interest of $2,101, accrued salary of $64,434, and board of director fees of $60,000 (a total of $145,285) at a price of $0.80 per share into 181,606 shares of the Company’s common stock. A gain in the amount of $138,531 was recorded on this transaction. Common Stock Transactions During the Nine Months Ended September 30, 2022 On January 12, 2022, the Company entered into a settlement agreement with an ex-employee. Pursuant to the terms of this agreement, the Company agreed to pay the amount of $19,032 for accrued salary, and the employee returned to the Company for cancellation 8,000 shares of common stock previously issued as compensation. These shares were valued at par value of $0.01 or a total value of $4,000; the Company recorded a gain on cancellation of these shares in the amount of $15,032. The Company entered into a debt-for-equity exchange agreement with Gardner Builders Holdings, LLC (“Gardner”) on January 7, 2022 (the “Debt for Equity Agreement”). Pursuant to the Debt for Equity Agreement, the Company issued shares of restricted common stock to Gardner in exchange for the Company Debt Obligations, as defined below. The Agreement settled for certain accounts payable amounts owed by the Company to the Creditor (the “Accounts Payable Amount”) as well as upcoming amounts that will become due between the date of the Agreement and April 1, 2022. The Agreement also settled accrued interest and penalties on the amounts due through January 5, 2022, as well as future interest payments on amounts to be accrued in the first quarter of 2022 (collectively, the “Additional Costs”, and combined with the Accounts Payable Amount, the “Company Debt Obligations”). The Accounts Payable Amount was $500,000, the Additional Costs were $294,912 and the conversion price was $12.50. As a result, 63,593 Restricted Shares were authorized to be issued. The Company’s Board of Directors approved the Agreement on January 5, 2022. On March 22, 2022 and March 31, 2022, the Company issued an aggregate 30,834 shares of common stock as waiver fees to holders of the Series C and Series D Preferred Stock for their waivers of certain covenants as set forth and defined in the Series C and Series C Certificates of Designations. The Company valued these shares at their contractual price of $12.50 per share and recorded the amount of $385,431 as waiver fees during the three months ended March 31, 2022. The Company recorded an aggregate gain upon issuance of these shares in the amount of $198,273 based on the market price of the Company’s common stock on the date of issuance. On March 31, 2022, the Company issued 34,400 Commitment Fee Shares to AJB Capital Investors, LLC; see note 9. The Company utilized an outside valuation consultant to value the commitment fee shares, the True-Up Provision, and warrants. A Monte Carlo model was used to value the warrants and call features, and a probability weighted expected return model was used to value the True-Up Provision. The contractual price of the common stock $12.50 per share; valuation purposes, the common stock was valued at the market price on the date of the transaction of $6.14 per share. The derivative liability was valued at $106,608 on the date of the transaction. The discount on the notes due to the Commitment Fee Shares and warrants was valued at $349,914. The Company recorded the amount of $226,106 to additional paid-in capital pursuant to this transaction. On March 31, 2022, the Company issued 7,647 shares of common stock at a price of $12.50 per share which were previously subscribed for the conversion of accounts payable in the amount of $95,558. On April 27, 2022, the Company issued 14,400 shares of stock to Cavalry Fund 1 LP at a price of $6.35 per share for a total value of $91,440 as compensation for the waiver of certain covenants as set forth in the Series C Certificate of Designation. The Company recorded a gain in the amount of $88,560 on this transaction. On April 27, 2022, the Company issued 1,929 shares of common stock with a contract price of $12.50 per share or $24,118 and a grant date market value of $8.00 or $15,434 to Larry Diamond, its Chief Executive as commitment shares as set forth and defined in Diamond Note 3. The Company recorded these shares at their relative fair value of the components of Diamond Note 3, or $16,200, and recorded a loss in the amount of $765 on this transaction. The Company also issued five-year warrants to purchase 1,929 shares of common stock at a price of $12.50 to Mr. Diamond pursuant to Diamond Note 3. On May 1, 2022, the Company issued 15,000 shares of common stock to a service provider at a price of $6.88 per share. On May 10, 2022, the Company entered into a securities purchase agreement with Kishon Investments, LLC with respect to the sale and issuance of: (i) an initial commitment fee in the amount of $159,259 in the form of 12,741 shares of the Company’s common stock, (ii) promissory note in the principal amount of $277,777 due on November 10, 2022, and (iii) warrants to purchase up to 5,556 shares of the common stock. The note and warrants were issued on May 10, 2022 and were held in escrow pending effectiveness of the Purchase Agreement. Pursuant to the terms of the purchase agreement, the initial shares were issued at a value of $159,259, the note was issued in the principal amount of $277,777 for a purchase price of $250,000, resulting in the original issue discount of $27,777; and the warrants were issued, with an initial exercise price of $12.50 per share, subject to adjustment. On May 18, 2022, the Company issued 386 shares of common stock to Larry Diamond, its Chief Executive Officer at a contractual price of $12.50 per share and a market price at issuance date of $7.585 per share as commitment shares as set forth and defined in Diamond Note 4. The Company recorded these shares at their relative fair value of the components of Diamond Note 4, or $3,160 and recorded a loss in the amount of $249 on this transaction. The Company also issued five-year warrants to purchase 386 shares of common stock at a price of $12.50 to Mr. Diamond pursuant to Diamond Note 4. On May 23, 2022, the Company issued 386 shares of common stock to Jessica Finnegan at a contractual price of $12.50 per share and a market price at issuance date of $8.97 per share as commitment shares as set forth and defined in Finnegan Note 1. The Company recorded these shares at their relative fair value of the components of Finnegan Note 1, or $3,240, and recorded a gain in the amount of $222 on this transaction. The Company also issued five-year warrants to purchase 386 shares of common stock at a price of $12.50 to Ms. Finnegan pursuant to Finnegan Note 1. On May 26, 2022, the Company issued 1,688 shares of common stock to the May 26 Lenders at a contractual price of $12.50 per share and a market price at issuance date of $7.585 per share as commitment shares as set forth and defined in the May 26, 2022 Notes. The Company recorded these shares at their relative fair value of the components of the May 26 Note, or $14,175, and recorded a loss in the amount of $1,369 on these transactions. The Company also issued five-year warrants to purchase 1,688 shares of common stock at a price of $25.00 to the May 26 Lenders pursuant to the May 26, 2022. On June 7, 2022, the Company issued 8,103 shares of common stock at a price of $12.50 per share to investors for accumulated dividends on Series X Preferred Stock. See Note 13. On June 9, 2022, the Company issued 7,284 shares of common stock to the June 9 Lenders at a contractual price of $12.50 per share and a market price at issuance date of $7,425 per share as commitment shares as set forth and defined in the June 9 Notes. The Company recorded these shares at the relative fair value of the components of June 9 Notes, or $66,400, and recorded an aggregate loss in the amount of $9,356 on these transactions. The Company also issued five-year warrants to purchase 7,284 shares of common stock at a price of $25.00 to the May 26 Lenders pursuant to the June 9 notes. On June 22, 2022, the Company issued 4,824 shares of common stock at fair value of $10.45 per share to Dragon Dynamic at a fair value of $10.45 per share as a commitment fee. On June 22, 2022, the Company issued 12,741 shares of common stock at fair value of $10.45 per share to GS Capital at a fair value of $10.45 per share as a commitment fee. On June 22, 2022, the Company issued 8,600 shares of common stock at fair value of $10.45 per share to Anson East and an additional 25,800 shares of common stock at a fair value of $10.45 per share to Anson Investments as a commitment fee. On July 7, 2022, the Company issued 2,412 shares of common stock to William Mackay at a contractual price of $12.50 per share and a market price at issuance date of $7.45 per share as commitment shares as set forth and defined in the Mackay Note. The Company recorded these shares at their relative fair value of the components of Mackay Note, or $12,500, and recorded a gain in the amount of $5,456 on this transaction. The Company also issued five-year warrants to purchase 2,412 shares of common stock at a price of $25.00 to Mr. Mackay pursuant to the Mackay Note. See Note 10. On July 7, 2022, the Company issued 193 shares of common stock to Charlies Schrier at a contractual price of $12.50 per share and a market price at issuance date of $7.45 per share as commitment shares as set forth and defined in the Schrier Note. The Company recorded these shares at their relative fair value of the components of Schrier Note, or $1,000, and recorded a gain in the amount of $436 on this transaction. The Company also issued five-year warrants to purchase 193 shares of common stock at a price of $12.50 to Mr. Schrier pursuant to the Schrier Note. See Note 10. On July 21, 2022, the Company issued 241 shares of common stock to Juan Carlos Iturregui, a related party, at a contractual price of $12.50 per share and a market price at issuance date of $7.23 per share as commitment shares as set forth and defined in the Iturregui Note. The Company recorded these shares at their relative fair value of the components of Schrier Note, or $1,225, and recorded a gain in the amount of $518 on this transaction. The Company also issued five-year warrants to purchase 241 shares of common stock at a price of $12.50 to Mr. Iturregui pursuant to the Iturregui Note. See Note 11. On July 21, 2022, the Company issued 2,460 shares of common stock to the Michael C. Howe Living Trust, a related party, at a contractual price of $12.50 per share and a market price at issuance date of $7.23 per share as commitment shares as set forth and defined in the Howe Note 3. The Company recorded these shares at their relative fair value of the components of Howe Note 3, or $12,495, and recorded a gain in the amount of $5,729 on this transaction. The Company also issued five-year warrants to purchase 2,460 shares of common stock at a price of $12.50 to the Michael C. Howe Living Trust pursuant to the Howe Note 3. See Note 11. On July 26, 2022, the Company issued 482 shares of common stock to Eric S. Nommsen at a contractual price of $12.50 per share and a market price at issuance date of $6.84 per share as commitment shares as set forth and defined in the Nommsen Note. The Company recorded these shares at their relative fair value of the components of Nommsen Note, or $2,350, and recorded a gain in the amount of $949 on this transaction. The Company also issued five-year warrants to purchase 482 shares of common stock at a price of $12.50 to Mr. Nommsen pursuant to the Nommsen Note. See Note 10. On July 27, 2022, the Company issued 482 shares of common stock to James H. Caplan at a contractual price of $12.50 per share and a market price at issuance date of $6.94 per share as commitment shares as set forth and defined in the Caplan Note. The Company recorded these shares at their relative fair value of the components of the Caplan Note, or $2,350, and recorded a gain in the amount of $995 on this transaction. The Company also issued five-year warrants to purchase 482 shares of common stock at a price of $12.50 to Mr. Caplan pursuant to the Caplan Note. See Note 10. On August 4, 2022, the Company issued a total of 241 shares of common stock to Jessica, Kevin C., Brody, Isabella, and Jack Finnegan at a contractual price of $12.50 per share and a market price at issuance date of $6.42 per share as commitment shares as set forth and defined in the Finnegan Note 3. The Company recorded these shares at their relative fair value of the components of the Finnegan Note 3, or $1,000, and recorded a gain in the amount of $448 on this transaction. The Company also issued five-year warrants to purchase a total of 241 shares of common stock at a price of $12.50 to the holders of the Finnegan Note 3. See Note 10. On August 4, 2022, the Company issued 984 shares of common stock to Jack Enright at a contractual price of $12.50 per share and a market price at issuance date of $6.42 per share as commitment shares as set forth and defined in the Caplan Note. The Company recorded these shares at their fair value of $6,317. See Note 10. On August 4, 2022, the Company issued 12,064 shares of common stock to a service provider as payment for investor relations services. The transaction was effective August 1, 2022 and has a six month term. The shares were valued at the closing price of the Company’s common stock on August 4, 2022, of $6.42 per share or $77,448. On August 18, 2022, the Company issued 1,640 shares of common stock to the Michael C. Howe Living Trust, a related party, at a contractual price of $12.50 per share and a market price at issuance date of $6.57 per share as commitment shares as set forth and defined in the Howe Note 4. The Company recorded these shares at their fair value of $10,775. See Note 11. On September 2, 2022, the Company issued 582 shares of common stock to John Mitchell at a contractual price of $12.50 per share and a market price at issuance date of $5.37 per share as commitment shares as set forth and defined in the Mitchell Note. The Company recorded these shares at their fair value of $3,124. See Note 10. On September 2, 2022, the Company issued 492 shares of common stock to Frank Lightmas at a contractual price of $12.50 per share and a market price at issuance date of $5.37 per share as commitment shares as set forth and defined in the Lightmas Note. The Company recorded these shares at their fair value of $2,640. See Note 10. On September 2, 2022, the Company issued 246 shares of common stock to Lisa Lewis at a contractual price of $12.50 per share and a market price at issuance date of $5.37 per share as commitment shares as set forth and defined in the Lewis Note. The Company recorded these shares at their fair value of $1,320. See Note 10. On September 2, 2022, the Company issued 246 shares of common stock to Sharon Goff at a contractual price of $12.50 per share and a market price at issuance date of $5.37 per share as commitment shares as set forth and defined in the Goff Note. The Company recorded these shares at their fair value of $1,320. See Note 10. On September 9, 2022, the Company issued 820 shares of common stock to Cliff Hagan at a contractual price of $12.50 per share and a market price at issuance date of $5.75 per share as commitment shares as set forth and defined in the Hagan Note. The Company recorded these shares at their fair value of $4,715. See Note 10. On September 14, 2022, the Company issued 1,640 shares of common stock to Darling Capital at a contractual price of $12.50 per share and a market price at issuance date of $6.60 per share as commitment shares as set forth and defined in the Darling Capital Note. The Company recorded these shares at their fair value of $10,824. See Note 10. On September 15, 2022, the Company issued 410 shares of common stock to Mack Leath at a contractual price of $12.50 per share and a market price at issuance date of $7.00 per share as commitment shares as set forth and defined in the Leath Note. The Company recorded these shares at their fair value of $2,868. See Note 10. Preferred Stock We have authorized to issue 100,000,000 shares of Preferred Stock with such rights designations and preferences as determined by our Board of Directors. We have designated 500,000 shares as series A Preferred, 3,000,000 shares as Series C Preferred, 10,000,000 shares as Series D Preferred, 10,000 shares as Series E Preferred, 140,000 as Series F Preferred, and 27,324 shares as Series X Preferred. Series A Preferred Stock Transactions During the Nine Months Ended September 30, 2023 None. Series A Preferred Stock Transactions During the Nine Months Ended September 30, 2022 None. Series C Preferred Stock Series C Preferred Stock Transactions During the Nine Months Ended September 30, 2023 The Company accrued dividends in the amount of $17,603 on the Series C Preferred Stock. On April 11, 2023, a total of 1,047,619 shares of Series C Preferred Stock with a stated value of $1,100,000, accrued dividends in the amount $171,109, and equity investment incentives in the amount of $1,016,888 were exchanged for 2,289 shares of Series F Preferred Stock. Series C Preferred Stock Transactions During the Nine Months Ended September 30, 2022 The Company accrued dividends on the Series C Preferred Stock in the amount of $49,700. The Company also adjusted the number of shares of Series C Preferred Stock outstanding by an increase in the amount of 98,064 shares in connection with previous conversions of Series C Preferred Stock to common stock; the amount of $981 was charged to additional paid-in capital pursuant to this adjustment. Series D Preferred Stock Series D Preferred Stock Transactions During the Nine Months Ended September 30, 2023 The Company accrued dividends in the amount of $76,307 on the Series D Preferred Stock. On April 11, 2023, a total of 2,350,000 shares of Series D Preferred Stock with a stated value of $2,467,500, accrued dividends in the amount $215,659, and equity investment incentives in the amount of $1,371,846 were exchanged for 4,055 shares of Series F Preferred Stock. There was no gain or loss recorded in connection with these transactions. Series D Preferred Stock Transactions During the Nine Months Ended September 30, 2022 The Company accrued dividends in the amount of $96,847 on the Series D Preferred Stock. Series F Preferred Stock On March 23, 2023, the Company filed a Certificate of Designations, Preferences and Rights of Series F 12% PIK $0.01 par value Convertible Perpetual Preferred Stock with the Delaware Secretary of State. The number of shares of Series F Preferred Stock designated is 140,000 and each share of Series F Preferred Stock has a liquidation preference of $1,000. The Series F Preferred Stock will rank senior to the Corporation’s Common Stock and on parity with all Preferred Stock of the Corporation with terms specifically providing that such Preferred Stock rank on parity with the Series F Preferred Stock with respect to rights to the distribution of assets upon any liquidation, dissolution or winding up of the Corporation; and (iii) junior to all Preferred Stock of the Corporation with terms specifically providing that such Preferred Stock rank senior to the Series F Preferred Stock with respect to rights to the distribution of assets upon any liquidation, dissolution or winding up of the Company. Holders of shares of the Series F Preferred Stock are entitled to receive payment-in-kind dividends payable only in additional shares of Series F Preferred Stock (“PIK Dividends”) at rate of 12% per annum. The Series F Preferred Stock will be convertible into common stock of the Company upon the listing of the Company’s stock on any of the following trading markets: the NYSE, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, or the Nasdaq Global Select Market. The conversion price will be calculated as 65% of the volume-weighted average price of the Company’s common stock on the conversion date. The number of shares issuable upon conversion will be calculated as the liquidation preference of the Series F Preferred stock plus any accrued but unpaid dividends divided by the conversion price. Series F Preferred Stock Transactions During the Nine Months Ended September 30, 2023 On April 11, 2023, the Company issued a total of 8,116 shares of Series F Preferred Stock at its liquidation value of $1,000 per share to nine investors upon the conversion of notes payable. The total amount converted was $8,111,334, consisting of principal $3,602,059, default penalties of $888,889, fees of $60,000, accrued interest of $365,012, and equity investment incentives of $3,195,374. Other than the equity investment incentive, there were no gains or losses recorded in connection with these transactions. See note 10. On April 11, 2023, the Company issued a total of 2,289 shares of Series F Preferred Stock at its liquidation value of $1,000 per share to two investors upon the conversion of Series C Preferred Stock. The total amount converted was $2,287,997, consisting of the Series C Preferred Stock stated value of $1,100,000, accrued dividends of $171,109, and equity investment incentives of $1,016,888. Other than the equity investment incentive, there were no gains or losses recorded in connection with these transactions. On April 11, 2023, the Company issued a total of 4,055 shares of Series F Preferred Stock to two investors at its liquidation value of $1,000 per share upon the conversion of Series D Preferred Stock. The total amount converted was $4,055,005 consisting of the Series D Preferred Stock stated value of $2,467,500, accrued dividends of $215,659, and equity investment incentives of $1,371,846. Other than the equity investment incentive, there were no gains or losses recorded in connection with these transactions. On April 11, 2023, the Company sold a total of 1,746 shares of Series F Preferred Stock to three investors at its liquidation value of $1,000 per share for cash. The total value of Series F Preferred Stock of issued was $1,745,000 consisting of cash proceeds of $900,000 and an equity investment incentive of $845,000, less costs of $161,500. Other than the equity investment incentive, there were no gains or losses recorded in connection with these transactions. On June 29, 2023, the Company issued a total of 147 shares of Series F Preferred Stock at its liquidation value of $1,000 per share to two service providers for accounts payable in the amount of $146,214. There was no gain or loss recorded on these transactions. On September 29, 2023, the Company issued a total of 2,138 shares of Series F Preferred Stock to three related parties at its liquidation value of $1,000 per share upon the conversion of notes payable in the amount of $601,839, premium on notes payable of $78,087, accrued interest of $124,777, accrued salary of $376,625, accrued board fees of $112,500, and equity investment incentives of $843,228. Other than the equity investment incentives, there were no gains or losses recorded in connection with these transactions. On September 29, 2023, the Company issued a total of 911 shares of Series F Preferred Stock to two investors at its liquidation value of $1,000 per share upon the conversion of notes payable in the aggregate amount of $414,118, premium on notes payable in the aggregate amount of $41,412, accrued interest in the aggregate amount of $84,187, and fees of $10,000, and equity investment incentive of $360,385. Other than the equity investment incentive, there were no gains or losses recorded in connection with these transactions. The Company accrued dividends in the amount of $940,769 on the Series F Preferred Stock. Series F Preferred Stock Transactions During the Nine Months Ended September 30, 2022 None. Series X Preferred Stock The Company has 24,227 shares of its 10% Series X Cumulative Redeemable Perpetual Preferred Stock (the “Series X Preferred Stock”) outstanding as of September 30, 2023 and December 31, 2022. The Series X Preferred Stock has a par value of $0.01 per share, no stated maturity, a liquidation preference of $25.00 per share, and will not be subject to any sinking fund or mandatory redemption and will remain outstanding indefinitely unless the Company decides to redeem or otherwise repurchase the Series X Preferred Stock; the Series X Preferred Stock is not redeemable prior to November 4, 2020. The Series X Preferred Stock will rank senior to all classes of the Company’s common and preferred stock and accrues dividends at the rate of 10% on $25.00 per share. The Company reserves the right to pay the dividends in shares of the Company’s common stock at a price equal to the average closing price over the five days prior to the date of the dividend declaration. Beginning in July 2023 the Company elected to use a price per share of $.80, a 20% discount to the average price of its common stock of $1.00, before the trading of its common stock was moved to the OTC Expert Market system. Each one share of the Series X Preferred Stock is entitled to 400 votes on all matters submitted to a vote of our shareholders. Series X Preferred Stock Transactions During the Nine Months Ended September 30, 2023 During the nine months ended September 30, 2023, the Company accrued dividends on its Series X Preferred Stock in the total amount of $45,423. Of this amount, a total of $5,905 was payable to officers and directors, $23,620 was payable to a related party shareholder, and $15,898 was payable to non-related parties. During the nine months ended September 30, 2023, the Company issued a total of 28,275 shares of common stock for accrued dividends on its Series X Preferred Stock. Of this amount, a total of 3,739 shares were issued to officers and directors, 14,586 were issued to a related party shareholder, and 9,950 were issued to non-related parties. Series X Preferred Stock Transactions During the Nine Months Ended September 30, 2022 On June 7, 2022, the Company issued 8,103 shares of common stock at an average price of $10.75 per share as payment for dividends payable on the Series X Preferred Stock in the amount of $87,053. During the nine months ended September 30, 2022, the Company accrued dividends in the amount of $45,423 on the Series X Preferred Stock. Stock Options The following table summarizes the options outstanding at September 30, 2023 and the related prices for the options to purchase shares of the Company’s common stock: Weighted Weighted Weighted average average average exercise exercise Range of Number of remaining price of Number of price of exercise options contractual outstanding options exercisable prices outstanding life (years) options exercisable options $ 1.50 - 16.00 100,934 7.41 $ 10.05 15,767 $ 15.48 100,934 7.41 $ 10.05 15,767 $ 15.48 Transactions involving stock options are summarized as follows: Shares Weighted- Average Exercise Price ($) Outstanding at December 31, 2022 310,692 $ 10.01 Granted - - Expired (209,758 ) 10.00 Outstanding at September 30, 2023 100,934 $ 10.05 Options vested and exercisable 15,767 $ 15.48 At September 30, 2023, the total stock-based compensation cost related to unvested awards not yet recognized was $0.8 million. Warrants The following table summarizes the warrants outstanding on September 30, 2023, and the related prices for the warrants to purchase shares of the Company’s common stock: Shares Weighted- Average Exercise Price ($) Outstanding on December 31, 2022 672,334 $ 30.68 Granted 874 $ 2.50 Exercised - $ - Outstanding on September 30, 2023 673,208 $ 30.64

Fair Value Financial Instrument

Fair Value Financial Instruments	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	Note 14: Fair Value Measurements The following summarizes the Company’s derivative financial liabilities that are recorded at fair value on a recurring basis at September 30, 2023 and December 31, 2022. September 30, 2023 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ 152,937 $ 152,937 December 31, 2022 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ 568,912 $ 568,912

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 15: Commitments and Contingencies Legal From time to time, we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. On June 23, 2022, The Good Clinic LLC was notified that a former employee had filed a lawsuit for wrongful termination. The Good Clinic believes the lawsuit is without merit. Mitesco (Company) was not named in the suit. The Company expects to resolve it for nominal consideration. On October 25, 2022, the Company was notified that a vendor filed a lawsuit related to a contract dispute naming both The Good Clinic and The CEO of the Good Clinic. This suit was settled on May 5, 2023, and dismissed with prejudice on May 12, 2023. The settlement included the issuance of the Company’s restricted common stock. As a part of the settlement the Company issued 2,552 shares of its restricted common stock to the plaintiff and it issued to the CEO of The Good Clinic 19,622 of its restricted common stock, plus $3,000 in cash for reimbursement of expenses related to settling the suit with the vendor. The Company has a number of legal situations involved with the winding down of its clinic business activities. These include claims regarding certain construction contracts and cancellation of leases. The following is a summary as of this filing: ● The Wayzata, MN clinic leases was terminated for a commitment to pay $25,000. This amount has not been paid as of June 30, 2023. ● The two Denver, Colorado clinic leases, known as Quincy and Radiant, possession has been relinquished to the landlords. The lease obligations remain in negotiations as does the handling of the mechanics liens placed on the property. The Company has verbally accepted a stipulated settlement to the Quincy lease obligation which has not been entered into the record or signed by either party. This settlement calls for (i) a stipulated judgment of $231,353, which includes all back rent and front rent through November 2023; (i) Interest of $16,700;(iii) Late fees of $22,434; (iv) attorney fees of $24,888; (v) Costs of $2,300. Claims for rent beyond November, and any defenses thereto, are preserved. ● The Eagan clinic, aka Vikings clinic, the Good Clinic gave up possession in January of 2023. The mechanics lien has been placed on the property and was settled by the landlord in a confidential settlement. The Landlord terminated the lease as of March 3, 2023. Mitesco is now in settlement negotiations with the landlord for the handling of lease obligations. The Landlord filed suit against the Company on July 21, 2023 for unpaid rent, expenses related to unpaid lease obligations and the settled construction lien. The Company has received discovery requests and a renewed request to agree to a stipulated judgement. The discovery is onerous and not feasible for the Company to comply with given the current staff and limited resources. Negotiations are underway. See note 16. ● The St. Paul clinic possession was relinquished in March 2023. The handling of lease obligations remains in negotiation as does the handling of the mechanics liens placed on the properties. Our existing legal counsel has agreed to represent Mitesco, Inc. and The Good Clinic in these matters. In Ramsey County, Continental 560 Fund LLC (Case No. 62-CV-23-2910) initiated a lawsuit. The Company’s attorney will prepare a Notice of Appearance and draft Answer in the Continental 560 Fund matter. The deadline under the Minnesota Rules of Civil Procedure for filing an answer has passed. Accordingly, the plaintiff could seek a default judgment at any time See note 16. ● The St. Louis Park clinic possession was relinquished in April 2023. The handling of lease obligations remains in negotiations as does the handling of the mechanics liens placed on the properties. The plaintiff’s counsel reached out to our attorney to reinitiate negotiations. We proposed to our attorney a settlement approach using a zero coupon note with common stock used as collateral. On November 1, 2023, we were notified that the landlord had rejected our settlement proposal and wishes to proceed with the lawsuit. At that time, plaintiff Excelsior & Grand Apartments, LLC submitted interrogatories and request for the production of documents. See note 16. ● The Maple Grove clinic eviction occurred in April 2023. The handling of lease obligations remains in negotiations as does the handling of the mechanics liens placed on the properties. On August 22, 2023 the landlord filed a lawsuit related to alleged unmet lease obligations and related to a construction lien on the property by the general contractor related to alleged non-payment of construction expenses. We have been told the facility has been re-leased but have not received notice of such or cancelation of the lease. ● The Northeast Minneapolis clinic, aka Nordhaus clinic, possession was relinquished in May 2023. There is no lien on the property. The handling of lease obligations remains in negotiations with the landlord.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 16: Subsequent Events Issuance of Common Stock On October 10, 2023, the Company issued 23,438 shares of common stock to a service provider at a price of $0.80 per share for accounts payable in the amount of $18,750. On February 9, 2024, the Company issued 41,057 shares of common stock for dividends payable on its Series X Preferred Stock. Court Order Stipulating Judgments Gardner Builders On November 14, 2023, the District Court, City and County of Denver, Colorado, in Case Number 2022CV33173 consolidated with Case Number 2022cv33653, stipulated an entry of judgment against the Company’s subsidiary The Good Clinic, LLC, and in favor of Gardner Builders Minneapolis, LLC, in the amount of $348,764 and interest at the rate of 12% per annum until the amount is paid in full. Egan Clinic A Summary Judgment was granted December 4, 2023 in the amount of $488,491. Plaintiff has submitted a separate request for attorneys’ fees, and we are awaiting entry of final judgment. St. Paul Clinic A Stipulation for Judgment was filed December 21, 2023 in the amount of $421,678. The stipulated judgment includes $178,542 in unpaid back rent, $172,124 in resolution of mechanics’ liens, and $64,600 in attorneys’ fees. We are awaiting a final entry of judgment by the Court. St. Louis Park Clinic Excelsior & Grand provided a proposed Settlement Agreement and Confession of Judgment in the amount of $421,678. We have countered with a redline of the proposed Settlement Agreement in the amount of $256,727 which includes amounts for unpaid rent, resolution of mechanics’ liens, and attorneys’ fees. Plaintiffs’ counsel has provided our counterproposal to Excelsior & Grand. Debt Exchange Agreement On December 8, 2023, the Company sold the remaining assets of The Good Clinic, LLC to Leading Primary Care LLC, a company organized by Michael C. Howe, the former CEO of The Good Clinic, LLC for total consideration of approximately $2.5 million. Consideration consisted of cancelling existing notes payable and accrued interest owed to Mr. Howe in the amount of approximately $2.5 million. The Company expects to recognize a gain on this transaction in the amount of approximately $2.5 million. Significant liabilities remain in The Good Clinic, LLC. On December 8, 2023, Mr. Howe also exchanged (i) 500,000 shares of Series D Preferred Stock with a stated value of approximately $0.5 million and accrued dividends of approximately $67,000, and (ii) accrued salary owed to Mr. Howe in the amount of approximately $38,000 plus a conversion incentive of 65% or approximately $25,000 for 655 shares of the Company’s Series F Preferred Stock with a liquidation value of approximately $0.6 million. Other than the conversion of incentive of the approximately $25,000, there was no gain or loss recorded on this transaction. On December 8, 2023, Mr. Howe also exchanged accrued salary in the amount of $39,300 plus a conversion premium in the amount of 65% or approximately $25,545 for 65 shares of the Company’s Series F Preferred Stock with a liquidation value of approximately $65,000. Other than the conversion of incentive of the approximately $25,554, there was no gain or loss recorded on this transaction. Resignation of Directors On November 7, 2023, Mr. Juan Carlos Iturregui resigned from his position as a director effective November 5, 2023. The decision by Mr. Iturregui to resign was not the result of any disagreement with the Company on any matter relating to the operations, internal controls, policies or practices of the Company but related to his transition to public service on a full-time basis. On December 12, 2023, Mr. Allen Plunk resigned from his position as a director. The decision by Mr. Plunk to resign was not the result of any disagreement with the Company on any matter relating to the operations, internal controls, policies, or practices of the Company but related to personal matters. On December 15, 2023, Mr. Larry Diamond resigned from all positions including the Board of Directors, CEO of Mitesco and all positions related to The Good Clinic, LLC and its sole member Mitesco N.A. LLC. The decision by Mr. Diamond to resign was not the result of any disagreement with the Company on any matter relating to the operations, internal controls, policies, or practices of the Company but related to personal matters. On December 15, 2023, Mr. Tom Brodmerkel resigned from his position as Chief Financial Officer and a director. The decision by Mr. Brodmerkel to resign was not the result of any disagreement with the Company on any matter relating to the operations, internal controls, policies, or practices of the Company but related to personal matters. On December 19, 2023, Ms. Sheila Schwartz resigned from her position as Chief Operating Officer and a director, citing a limited time availability to support the needs of the Company. Appointment of Directors During December 2023, the following appointments were made to the Board of Directors: Mr. Mack Leath Mr. Leath will serve as CEO, CFO and Chairman of the Board of Directors. Mr. Leath is a senior executive with 30 + years’ experience in business management, including a number of rapid growth and start-up situations. He has been a sales and marketing professional in Petro-chemical distribution, software and construction related products as well as healthcare. His roles include financial management and capital markets. He has previously served on the Board of the Company from September 2016 until May 2017 where he assisted in restructuring and evaluating various business situations. Mr. Leath provided bridge financing to the Company in September 2022 which remains unpaid. Dr. Jordan Balencic Mr. Balencic will serve as a board member. Mr. Balencic’s history includes positions in both the healthcare arena, and as an entrepreneur. His healthcare experience is as follows: From October 2016 until the present, he has served as the Service Chief, Medical Director, and a staff physician for Home Based Primary Care (HBPC) November for the U.S. Department of Veterans Affairs, Veterans Health Administration, Lebanon, PA (Lebanon VA Medical Center). Mr. John Mitchell Mr. Mitchell will serve as Secretary and Treasurer. Mr. Mitchell has been an independent business owner and advisor since 2001 until the present with an emphasis on the lighting and electrical products area in the yachting industry, as well as certain home improvement business activities. From 1997 until 2001 he was employed by Microsoft Corporation as a recruiter. From 1989 until 1997 Mr. Mitchell served in the U.S. Marine Corps, most recently as Sergeant E-5. Mr. Mitchell provided bridge financing to the Company in September 2022, which remains unpaid.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation
Use of Estimates, Policy [Policy Text Block]	Use of Estimates -
New Accounting Pronouncements, Policy [Policy Text Block]	New Accounting Standards From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies that the Company adopts as of the specified effective date. Unless otherwise discussed, the Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on its financial position or results of operations upon adoption.

Discontinued Operations (Tables

Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations [Table Text Block]	The following information presents the major classes of line item of assets and liabilities included as part of discontinued operations in the consolidated balance sheets: September 30, December 31, 2023 2022 Current assets - discontinued operations: Cash $ 1,665 $ 29,432 Accounts receivable - 30,943 Prepaid expenses and deposits - 62,090 Total current assets - discontinued operations $ 1,665 $ 122,465 Noncurrent assets - discontinued operations: Property and equipment $ - $ 1,832,974 Right-of-use assets - 460,254 Total noncurrent assets - discontinued operations $ - $ 2,293,228 Current liabilities - discontinued operations: Accounts payable $ 5,555,218 $ 5,114,559 Accrued payroll and related liabilities 225,515 292,808 Other current liabilities 25,000 - Accrued interest 176,362 176,362 Operating lease liabilities 3,973,069 349,109 Total current liabilities - discontinued operations $ 9,955,164 $ 5,932,838 Long term liabilities - discontinued operations: Operating lease liabilities $ - $ 3,936,858 Total long term liabilities - discontinued operations $ - $ 3,936,858 Three Months Ended September 30, September 30, 2023 2022 Revenue $ - $ 198,049 Cost of goods sold - 2,262 Gross margin - 195,787 Selling, general, and administrative expenses (188,248 ) (1,653,075 ) Other (income) expense: Gain on sale of assets 91,746 - Gain on settlement of accounts payable 81,263 - Loss from discontinued operations, net of tax $ (15,239 ) $ (1,457,288 ) Nine Months Ended September 30, September 30, 2023 2022 Revenue $ - $ 487,510 Cost of goods sold - 13,510 Gross margin - 474,000 Selling, general, and administrative expenses (1,085,269 ) (5,536,920 ) Other (income) expense: Impairment of assets (2,211,462 ) - Gain on sale of assets 102,967 - Gain on settlement of accounts payable 81,263 - Gain on settlement of operating lease 287,897 - Loss from discontinued operations, net of tax $ (2,824,604 ) $ (5,062,920 ) Nine months Ended September 30, September 30, 2023 2022 Depreciation expense $ 78,230 $ 587,222 Cash used for construction in progress $ - $ (1,030,397 ) Cash used for the purchase of fixed assets $ - $ (29,771 ) Impairment of RTU assets $ 544,063 $ - Impairment of property and equipment $ 1,799,399 -

Net Loss Per Share Applicable_2

Net Loss Per Share Applicable to Common Shareholders (Tables)	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table sets forth the computation of loss per share for the three and nine months ended September 30, 2023 and 2022, respectively: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Numerator: Net loss applicable to common shareholders – continuing operations $ (2,068,872 ) $ (2,707,575 ) $ (12,965,966 ) $ (6,712,506 ) Net loss applicable to common shareholders – discontinued operations $ (15,239 ) $ (1,457,288 ) $ (2,824,604 ) $ (5,062,920 ) Net loss per share: Basic and diluted – continuing operations $ (0.39 ) $ (0.59 ) $ (2.57 ) $ (1.52 ) Basic and diluted – discontinued operations $ (0.00 ) $ (0.32 ) $ (0.56 ) $ (1.15 ) Denominator: Weighted average common shares outstanding 5,329,816 4,569,115 5,048,070 4,408,891
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	As of September 30, 2023 and 2022, the following shares were issuable and excluded from the calculation of diluted loss: For the Nine Months Ended September 30, 2023 2022 Common stock options 100,934 327,099 Common stock purchase warrants 673,208 672,325 Convertible Preferred Stock 63,000 847,652 Accrued interest on Preferred Stock 33,105 30,451 Potentially dilutive securities 870,247 1,377,527

Accounts Payable and Accrued _2

Accounts Payable and Accrued Liabilities (Tables)	9 Months Ended
	Sep. 30, 2023
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	Accounts payable and accrued liabilities consisted of the following at September 30, 2023 and December 31, 2022: September 30, December 31, 2023 2022 Trade accounts payable $ 1,466,337 $ 1,647,233 Accrued payroll and payroll taxes 437,263 298,108 Other - 507 Total accounts payable and accrued liabilities $ 1,903,600 $ 1,945,848

Right to Use Assets and Lease_2

Right to Use Assets and Lease Liabilities - Operating Leases (Tables)	9 Months Ended
	Sep. 30, 2023
Disclosure Text Block [Abstract]
Lease, Cost [Table Text Block]	Right to use assets – operating leases are summarized below: September 30, 2023 December 31, 2022 Right to use assets, net $ - $ 83,810 September 30, 2023 December 31, 2022 Lease liability $ 93,758 $ 93,758 Less: current portion (93,758 ) (93,758 ) Lease liability, non-current $ - $ -
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]	Maturity analysis under these lease agreements are as follows: For the twelve months ended September 30, 2024 $ 99,477 For the twelve months ended September 30, 2025 - For the twelve months ended September 30, 2026 - For the twelve months ended September 30, 2027 - For the twelve months ended September 30, 2028 - Thereafter - Total $ 99,477 Less: Present value discount (5,719 ) Lease liability $ 93,758

Notes Payable (Tables)

Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2023
Notes Payable (Tables) [Line Items]
Schedule of Debt [Table Text Block]	These amounts are reflected in the table below: September 30, 2023 December 31, 2022 Notes Payable $ 1,143,235 $ 5,144,741 Less: Discount - (32,040 ) Notes payable - net of discount $ 1,143,235 $ 5,112,701 Current Portion, net of discount $ 1,143,235 $ 5,112,701 Long-term portion, net of discount $ - $ -
Related Party [Member]
Notes Payable (Tables) [Line Items]
Schedule of Debt [Table Text Block]	These amounts are reflected in the table below: September 30, 2023 December 31, 2022 Notes Payable $ 2,100,956 $ 2,799,632 Less: Discount $ - $ (22,670 ) Notes payable – net of discounts $ 2,100,956 $ 2,776,962 Current Portion, net of discount $ 2,100,956 $ 2,776,962 Long-term portion, net of discount $ - $ -

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	9 Months Ended
	Sep. 30, 2023
Disclosure Text Block [Abstract]
Schedule of Derivative Instruments [Table Text Block]	Derivative liability activity for the for the periods ended September 30, 2023, December 31, 2022 and 2021 is summarized in the table below: December 31, 2021 $ - True-up features issued 192,375 Settled upon conversion or exercise (310,641 ) Loss on revaluation 687,178 December 31, 2022 $ 568,912 Settled upon conversion or exercise (501,740 ) Loss on revaluation 85,765 September 30, 2023 $ 152,937
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]	The Company uses a Monte Carlo model to value certain features of its notes payable that create derivative liabilities. The following table summarizes the assumptions for the valuations: December 31, 2022 Volatility 95.1% to 123.2 % Stock Price $ 1.06 to 3.50 Risk-free interest rates 4.35% to 4.37 % Term (years) 0.73 to 0.86 September 30, 2023 Volatility 159.6% to 540.40 % Stock Price $ 0.025 to 1.44 Risk-free interest rates 4.35 to 5.24 % Term (years) 0.11 to 0.61

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit) (Tables)	9 Months Ended
	Sep. 30, 2023
Stockholders' Equity Note [Abstract]
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]	The following table summarizes the options outstanding at September 30, 2023 and the related prices for the options to purchase shares of the Company’s common stock: Weighted Weighted Weighted average average average exercise exercise Range of Number of remaining price of Number of price of exercise options contractual outstanding options exercisable prices outstanding life (years) options exercisable options $ 1.50 - 16.00 100,934 7.41 $ 10.05 15,767 $ 15.48 100,934 7.41 $ 10.05 15,767 $ 15.48
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Transactions involving stock options are summarized as follows: Shares Weighted- Average Exercise Price ($) Outstanding at December 31, 2022 310,692 $ 10.01 Granted - - Expired (209,758 ) 10.00 Outstanding at September 30, 2023 100,934 $ 10.05 Options vested and exercisable 15,767 $ 15.48
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	The following table summarizes the warrants outstanding on September 30, 2023, and the related prices for the warrants to purchase shares of the Company’s common stock: Shares Weighted- Average Exercise Price ($) Outstanding on December 31, 2022 672,334 $ 30.68 Granted 874 $ 2.50 Exercised - $ - Outstanding on September 30, 2023 673,208 $ 30.64

Fair Value Financial Instrume_2

Fair Value Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	The following summarizes the Company’s derivative financial liabilities that are recorded at fair value on a recurring basis at September 30, 2023 and December 31, 2022. September 30, 2023 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ 152,937 $ 152,937 December 31, 2022 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ 568,912 $ 568,912

Description of Business (Detail

Description of Business (Details) - USD ($)			9 Months Ended
	Dec. 08, 2023	Dec. 12, 2022	Sep. 30, 2023	Sep. 30, 2022
Accounting Policies [Abstract]
Proceeds from Sale of Productive Assets	$ 2,500,000		$ 102,967	$ 0
Stockholders' Equity, Reverse Stock Split		every fifty (50) shares of our issued and outstanding common stock was automatically combined into one (1) issued and outstanding share of common stock

Financial Condition, Going Co_2

Financial Condition, Going Concern and Management Plans (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and Cash Equivalents, at Carrying Value	$ 24,642	$ 6,191
Liabilities, Current	$ 17,508,089	$ 17,802,473

Discontinued Operations (Detail

Discontinued Operations (Details) - USD ($)		9 Months Ended
	Dec. 08, 2023	Sep. 30, 2023	Sep. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]
Proceeds from Sale of Productive Assets	$ 2,500,000	$ 102,967	$ 0

Discontinued Operations (Deta_2

Discontinued Operations (Details) - Disposal Groups, Including Discontinued Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Disposal Groups Including Discontinued Operations Abstract
Cash	$ 1,665	$ 4,623	$ 1,665	$ 4,623	$ 29,432
Accounts receivable	0		0		30,943
Prepaid expenses and deposits	0		0		62,090
Total current assets - discontinued operations	1,665		1,665		122,465
Property and equipment	0		0		1,832,974
Right-of-use assets	0		0		460,254
Total noncurrent assets - discontinued operations	0		0		2,293,228
Accounts payable	5,555,218		5,555,218		5,114,559
Accrued payroll and related liabilities	225,515		225,515		292,808
Other current liabilities	25,000		25,000		0
Accrued interest	176,362		176,362		176,362
Operating lease liabilities	3,973,069		3,973,069		349,109
Total current liabilities - discontinued operations	9,955,164		9,955,164		5,932,838
Operating lease liabilities	0		0		3,936,858
Total long term liabilities - discontinued operations	0		0		$ 3,936,858
Revenue	0	198,049	0	487,510
Cost of goods sold	0	2,262	0	13,510
Gross margin	0	195,787	0	474,000
Selling, general, and administrative expenses	(188,248)	(1,653,075)	(1,085,269)	(5,536,920)
Impairment of assets			(2,211,462)	0
Gain on sale of assets	91,746	0	102,967	0
Gain on settlement of accounts payable	81,263	0	81,263	0
Gain on settlement of operating lease			287,897	0
Loss from discontinued operations, net of tax	$ (15,239)	$ (1,457,288)	(2,824,604)	(5,062,920)
Depreciation expense			78,230	587,222
Cash used for construction in progress			0	(1,030,397)
Cash used for the purchase of fixed assets			0	(29,771)
Impairment of RTU assets			544,063	0
Impairment of property and equipment			$ 1,799,399	$ 0

Net Loss Per Share Applicable_3

Net Loss Per Share Applicable to Common Shareholders (Details) - Schedule of Earnings Per Share, Basic and Diluted - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Earnings Per Share [Abstract]
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic	$ (2,068,872)	$ (2,707,575)	$ (12,965,966)	$ (6,712,506)
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted	(2,068,872)	(2,707,575)	(12,965,966)	(6,712,506)
Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic	(15,239)	(1,457,288)	(2,824,604)	(5,062,920)
Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted	$ (15,239)	$ (1,457,288)	$ (2,824,604)	$ (5,062,920)
Income (Loss) from Continuing Operations, Per Basic Share	$ (0.39)	$ (0.59)	$ (2.57)	$ (1.52)
Income (Loss) from Continuing Operations, Per Diluted Share	(0.39)	(0.59)	(2.57)	(1.52)
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share	0	(0.32)	(0.56)	(1.15)
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share	$ 0	$ (0.32)	$ (0.56)	$ (1.15)
Weighted Average Number of Shares Outstanding, Basic	5,329,816	4,569,115	5,048,070	4,408,891
Weighted Average Number of Shares Outstanding, Diluted	5,329,816	4,569,115	5,048,070	4,408,891

Net Loss Per Share Applicable_4

Net Loss Per Share Applicable to Common Shareholders (Details) - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share - shares	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	870,247	1,377,527
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	100,934	327,099
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	673,208	672,325
Preferred Stock [Member] | Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	63,000	847,652
Accrued Interest [Member] | Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	33,105	30,451

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 29, 2023

Apr. 11, 2023

Aug. 18, 2022

Aug. 04, 2022

Jul. 21, 2022

Jun. 09, 2022

May 26, 2022

May 23, 2022

May 18, 2022

Apr. 27, 2022

Mar. 22, 2022

Mar. 18, 2022

Feb. 24, 2022

Feb. 14, 2022

Dec. 30, 2021

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Jul. 01, 2023

Feb. 21, 2023

Jan. 23, 2023

Related Party Transactions (Details) [Line Items]

Dividends, Preferred Stock

$ 531,738

$ 81,112

$ 1,080,102

$ 241,196

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

181,606

Gain on Conversion of Debt to Common Stock

139,837

0

$ 139,837

0

Class of Warrant or Rights, Granted (in Shares)

874

Debt Instrument, Unamortized Discount

0

$ 0

$ 32,040

Shares Issued, Price Per Share (in Dollars per share)

$ 0.8

$ 6.42

$ 7.23

$ 2.53

$ 3.45

Investment Incentive [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 1,371,846

Howe Note1 [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Maturity Date, Description

The principal amount of the Howe Note 1 is $1,000,000, carries a 10% interest rate per annum, payable in monthly installments, and had a maturity date, as extended, that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE

Debt Instrument, Face Amount

$ 1,000,000

Debt Instrument, Interest Rate, Stated Percentage

10%

Proceeds from Issuance of Debt

$ 850,000

Original Issue Discount

$ 150,000

Stock Issued During Period, Shares, Other (in Shares)

96,471

Debt Instrument, Debt Default, Amount

1,000,000

1,000,000

Amortization of Debt Discount (Premium)

150,000

Debt Instrument, Unamortized Discount

0

0

Howe Note1 [Member] | Measurement Input, Default Rate [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

18%

Howe Note1 [Member] | Warrants at $0.50 [Member]

Related Party Transactions (Details) [Line Items]

Class of Warrant or Rights, Granted (in Shares)

2,100,000

Warrants and Rights Outstanding, Term

5 years

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 0.5

Warrants and Rights Outstanding

$ 261,568

Diamond Note 1 [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 383,750

Debt Instrument, Maturity Date, Description

the Diamond Note 2 is $235,294, carries a 10% interest rate per annum, payable in monthly installments, and has a maturity date, as amended, that is the earlier of (i) November 30, 2022, (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE

Debt Instrument, Face Amount

$ 175,000

$ 235,294

Debt Instrument, Interest Rate, Stated Percentage

10%

10%

Proceeds from Issuance of Debt

$ 148,750

Debt Instrument, Debt Default, Amount

235,294

235,294

192,500

Amortization of Debt Discount (Premium)

35,294

46,664

Debt Instrument, Unamortized Discount

0

0

0

Diamond Note 1 [Member] | Measurement Input, Default Rate [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

18%

18%

Diamond Note 1 [Member] | Convertible Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

175,000

Diamond Note 1 [Member] | Premium on Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

17,500

Diamond Note 1 [Member] | Accrued Interest [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

40,076

Diamond Note 1 [Member] | Investment Incentive [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

151,174

Diamond Note 2 [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

41,626

Debt Instrument, Maturity Date, Description

the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE.

Debt Instrument, Face Amount

$ 235,294

Debt Instrument, Interest Rate, Stated Percentage

10%

Proceeds from Issuance of Debt

$ 200,000

Class of Warrant or Rights, Granted (in Shares)

200,000

Warrants and Rights Outstanding, Term

5 years

Warrants and Rights Outstanding

$ 2,213

0

Debt Instrument, Debt Default, Amount

23,529

23,529

23,529

Amortization of Debt Discount (Premium)

61,036

Diamond Note 2 [Member] | Measurement Input, Default Rate [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

18%

Diamond Note 2 [Member] | Premium on Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

23,529

Diamond Note 2 [Member] | Accrued Interest [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

1,699

Diamond Note 2 [Member] | Investment Incentive [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

16,398

Diamond Note 2 [Member] | Warrants at $25.00 [Member]

Related Party Transactions (Details) [Line Items]

Class of Warrant or Rights, Granted (in Shares)

1,930

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 25

Diamond Note 3 [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

509,277

Debt Instrument, Face Amount

$ 235,294

Proceeds from Issuance of Debt

$ 200,000

Class of Warrant or Rights, Granted (in Shares)

1,929

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 12.5

Warrants and Rights Outstanding

$ 8,800

Stock Issued During Period, Shares, Other (in Shares)

1,930

Debt Instrument, Debt Default, Amount

47,059

47,059

258,823

Amortization of Debt Discount (Premium)

14,778

83,823

Debt Instrument, Unamortized Discount

6,478

6,478

0

Stock Issued During Period, Value, Other

$ 16,200

Shares Issued, Price Per Share (in Dollars per share)

$ 8

Diamond Note 3 [Member] | Measurement Input, Default Rate [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

18%

Diamond Note 3 [Member] | Convertible Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

235,294

Diamond Note 3 [Member] | Premium on Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

23,529

Diamond Note 3 [Member] | Accrued Interest [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

49,830

Diamond Note 3 [Member] | Investment Incentive [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

200,624

Diamond Note 4 [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

101,402

Debt Instrument, Maturity Date, Description

the earlier of (i) November 30, 2022 or (ii) five days after the date on which we successfully list our shares of common stock on any of the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, or the Nasdaq Capital Market

Debt Instrument, Face Amount

$ 47,059

Debt Instrument, Interest Rate, Stated Percentage

10%

Proceeds from Issuance of Debt

$ 40,000

Class of Warrant or Rights, Granted (in Shares)

19,294

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 12.5

Warrants and Rights Outstanding

$ 2,960

Stock Issued During Period, Shares, Other (in Shares)

1,930

Debt Instrument, Debt Default, Amount

51,765

Amortization of Debt Discount (Premium)

17,885

Debt Instrument, Unamortized Discount

0

Stock Issued During Period, Value, Other

$ 3,160

Shares Issued, Price Per Share (in Dollars per share)

$ 7.585

Diamond Note 4 [Member] | Measurement Input, Default Rate [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

18%

Diamond Note 4 [Member] | Convertible Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

47,059

Diamond Note 4 [Member] | Premium on Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

4,706

Diamond Note 4 [Member] | Accrued Interest [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

9,691

Diamond Note 4 [Member] | Investment Incentive [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

39,946

Diamond Note 4 [Member] | Warrants at $25.00 [Member]

Related Party Transactions (Details) [Line Items]

Class of Warrant or Rights, Granted (in Shares)

386

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 25

Finnegan Note 1 [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Face Amount

$ 47,059

$ 47,059

Proceeds from Issuance of Debt

40,000

Original Issue Discount

$ 7,059

Class of Warrant or Rights, Granted (in Shares)

19,295

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 12.5

Warrants and Rights Outstanding

$ 2,000

Stock Issued During Period, Shares, Other (in Shares)

1,930

Debt Instrument, Debt Default, Amount

51,765

51,765

51,765

Amortization of Debt Discount (Premium)

12,478

17,005

Debt Instrument, Unamortized Discount

$ 17,005

4,518

4,518

0

Stock Issued During Period, Value, Other

$ 3,240

Shares Issued, Price Per Share (in Dollars per share)

$ 8.97

Debt Instrument, Unamortized Discount (Premium), Net

$ 4,706

Finnegan Note 1 [Member] | Measurement Input, Default Rate [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

18%

Finnegan Note 1 [Member] | Warrants at $25.00 [Member]

Related Party Transactions (Details) [Line Items]

Class of Warrant or Rights, Granted (in Shares)

386

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 25

May26 Notes [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Maturity Date, Description

the earlier of (i) November 30, 2022, or (ii) the date on which we successfully lists our shares of common stock on Nasdaq or NYSE

Debt Instrument, Face Amount

$ 205,883

Debt Instrument, Interest Rate, Stated Percentage

10%

Proceeds from Issuance of Debt

$ 175,000

Class of Warrant or Rights, Granted (in Shares)

84,412

Warrants and Rights Outstanding, Term

5 years

Debt Instrument, Debt Default, Amount

205,883

205,883

Amortization of Debt Discount (Premium)

51,724

Debt Instrument, Unamortized Discount

22,672

22,672

Shares Issued, Price Per Share (in Dollars per share)

$ 7.585

May26 Notes [Member] | Measurement Input, Default Rate [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

18%

May26 Notes [Member] | Warrants at $0.50 [Member]

Related Party Transactions (Details) [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 0.5

May26 Notes [Member] | Warrants at $25.00 [Member]

Related Party Transactions (Details) [Line Items]

Class of Warrant or Rights, Granted (in Shares)

1,688

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 25

Howe Note 2 [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Maturity Date, Description

The Howe Note 2 has a maturity date, as extended, that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which we successfully list our shares of common stock on Nasdaq or NYSE.

Debt Instrument, Face Amount

$ 300,000

Debt Instrument, Interest Rate, Stated Percentage

10%

Proceeds from Issuance of Debt

$ 255,000

Class of Warrant or Rights, Granted (in Shares)

123,000

Warrants and Rights Outstanding

$ 10,965

Stock Issued During Period, Shares, Other (in Shares)

2,460

Debt Instrument, Debt Default, Amount

330,000

300,000

330,000

300,000

330,000

Amortization of Debt Discount (Premium)

71,012

108,405

Debt Instrument, Unamortized Discount

37,393

37,393

0

Stock Issued During Period, Value, Other

$ 22,440

Howe Note 2 [Member] | Measurement Input, Default Rate [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

18%

Howe Note 2 [Member] | Warrants at $0.50 [Member]

Related Party Transactions (Details) [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 0.5

Howe Note 2 [Member] | Warrants at $25.00 [Member]

Related Party Transactions (Details) [Line Items]

Class of Warrant or Rights, Granted (in Shares)

2,460

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 25

Howe Note 3 [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Maturity Date, Description

the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE

Debt Instrument, Face Amount

$ 300,000

Debt Instrument, Interest Rate, Stated Percentage

10%

Proceeds from Issuance of Debt

$ 255,000

Class of Warrant or Rights, Granted (in Shares)

2,460

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 12.5

Warrants and Rights Outstanding

$ 9,945

Stock Issued During Period, Shares, Other (in Shares)

2,460

Debt Instrument, Debt Default, Amount

330,000

330,000

330,000

Amortization of Debt Discount (Premium)

97,440

97,440

Debt Instrument, Unamortized Discount

$ 0

$ 0

Share Price (in Dollars per share)

$ 12.5

Stock Issued During Period, Value, Other

$ 12,495

0

Shares Issued, Price Per Share (in Dollars per share)

$ 7.23

Howe Note 3 [Member] | Measurement Input, Default Rate [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

18%

Howe Note 3 [Member] | Warrants at $25.00 [Member]

Related Party Transactions (Details) [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 25

Iturregui Note [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

61,953

Debt Instrument, Maturity Date, Description

the earlier of (i) January 21, 2023, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE

Debt Instrument, Face Amount

$ 29,412

Debt Instrument, Interest Rate, Stated Percentage

10%

10%

10%

Proceeds from Issuance of Debt

$ 25,000

Class of Warrant or Rights, Granted (in Shares)

241

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 12.5

Warrants and Rights Outstanding

$ 975

Stock Issued During Period, Shares, Other (in Shares)

242

Debt Instrument, Debt Default, Amount

32,353

Amortization of Debt Discount (Premium)

$ 3,686

8,464

Debt Instrument, Unamortized Discount

$ 5,867

5,867

Share Price (in Dollars per share)

$ 12.5

Stock Issued During Period, Value, Other

$ 1,225

Iturregui Note [Member] | Measurement Input, Default Rate [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

18%

Iturregui Note [Member] | Convertible Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

29,412

Iturregui Note [Member] | Premium on Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

2,941

Iturregui Note [Member] | Accrued Interest [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

5,194

Iturregui Note [Member] | Investment Incentive [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 24,406

Iturregui Note [Member] | Warrants at $25.00 [Member]

Related Party Transactions (Details) [Line Items]

Class of Warrant or Rights, Granted (in Shares)

242

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 25

Finnegan Note 3 [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Face Amount

$ 29,412

Debt Instrument, Interest Rate, Stated Percentage

10%

Proceeds from Issuance of Debt

$ 25,000

Class of Warrant or Rights, Granted (in Shares)

241

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 12.5

Warrants and Rights Outstanding

$ 850

Stock Issued During Period, Shares, Other (in Shares)

242

Debt Instrument, Debt Default, Amount

32,353

32,353

32,353

Amortization of Debt Discount (Premium)

2,898

7,575

Debt Instrument, Unamortized Discount

6,405

6,405

1,728

Share Price (in Dollars per share)

$ 12.5

Stock Issued During Period, Value, Other

$ 1,100

Shares Issued, Price Per Share (in Dollars per share)

$ 6.42

Finnegan Note 3 [Member] | Measurement Input, Default Rate [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

18%

Finnegan Note 3 [Member] | Warrants at $25.00 [Member]

Related Party Transactions (Details) [Line Items]

Class of Warrant or Rights, Granted (in Shares)

242

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 25

Howe Note 4 [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Maturity Date, Description

the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE

Debt Instrument, Face Amount

$ 200,000

Debt Instrument, Interest Rate, Stated Percentage

10%

Proceeds from Issuance of Debt

$ 170,000

Stock Issued During Period, Shares, Other (in Shares)

1,640

Debt Instrument, Debt Default, Amount

$ 220,000

220,000

220,000

Amortization of Debt Discount (Premium)

25,128

$ 60,775

Debt Instrument, Unamortized Discount

$ 35,647

35,647

Share Price (in Dollars per share)

$ 12.5

Stock Issued During Period, Value, Other

$ 10,775

Shares Issued, Price Per Share (in Dollars per share)

$ 6.57

Howe Note 4 [Member] | Measurement Input, Default Rate [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

18%

Series X Preferred Stock [Member]

Related Party Transactions (Details) [Line Items]

Dividends, Preferred Stock

$ 45,423

$ 45,423

Preferred Stock Dividends, Shares (in Shares)

28,275

Share Price (in Dollars per share)

$ 0.80

Series F Preferred Stock [Member]

Related Party Transactions (Details) [Line Items]

Dividends, Preferred Stock

$ 940,769

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

911

4,055

Series F Preferred Stock [Member] | Convertible Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 414,118

Series F Preferred Stock [Member] | Premium on Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

41,412

Series F Preferred Stock [Member] | Accrued Interest [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

84,187

Series F Preferred Stock [Member] | Investment Incentive [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 360,385

Series F Preferred Stock [Member] | Diamond Note 1 [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

384

Series F Preferred Stock [Member] | Diamond Note 2 [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

42

Series F Preferred Stock [Member] | Diamond Note 3 [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

509

Series F Preferred Stock [Member] | Diamond Note 4 [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

101

Series F Preferred Stock [Member] | Iturregui Note [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

62

Commitment Shares [Member] | Diamond Note 4 [Member]

Related Party Transactions (Details) [Line Items]

Stock Issued During Period, Shares, Other (in Shares)

19,294

Commitment Shares [Member] | Finnegan Note 1 [Member]

Related Party Transactions (Details) [Line Items]

Stock Issued During Period, Shares, Other (in Shares)

19,295

Commitment Shares [Member] | May26 Notes [Member]

Related Party Transactions (Details) [Line Items]

Stock Issued During Period, Shares, Other (in Shares)

84,412

Commitment Shares [Member] | Howe Note 2 [Member]

Related Party Transactions (Details) [Line Items]

Warrants and Rights Outstanding

$ 21,500

Stock Issued During Period, Shares, Other (in Shares)

123,000

Stock Issued During Period, Value, Other

$ 44,000

Commitment Shares [Member] | Howe Note 3 [Member]

Related Party Transactions (Details) [Line Items]

Stock Issued During Period, Shares, Other (in Shares)

2,460

Commitment Shares [Member] | Finnegan Note 3 [Member]

Related Party Transactions (Details) [Line Items]

Stock Issued During Period, Shares, Other (in Shares)

241

Commitment Shares [Member] | Howe Note 4 [Member]

Related Party Transactions (Details) [Line Items]

Stock Issued During Period, Shares, Other (in Shares)

1,640

Officer [Member] | Series X Preferred Stock [Member]

Related Party Transactions (Details) [Line Items]

Dividends, Preferred Stock

$ 5,905

Preferred Stock Dividends, Shares (in Shares)

3,739

Majority Shareholder [Member] | Series X Preferred Stock [Member]

Related Party Transactions (Details) [Line Items]

Dividends, Preferred Stock

$ 23,620

Preferred Stock Dividends, Shares (in Shares)

14,586

Non-Related Parties [Member] | Series X Preferred Stock [Member]

Related Party Transactions (Details) [Line Items]

Dividends, Preferred Stock

$ 15,898

Preferred Stock Dividends, Shares (in Shares)

9,950

Chief Executive Officer [Member]

Related Party Transactions (Details) [Line Items]

Class of Warrant or Rights, Granted (in Shares)

92,942

Stock Issued During Period, Shares, Other (in Shares)

0.25

168,221

Share Price (in Dollars per share)

$ 12.5

$ 0.25

Stock Issued During Period, Value, Other

$ 15,434

$ 21,364

Shares Issued, Price Per Share (in Dollars per share)

$ 0.16

$ 0.127

Chief Executive Officer [Member] | Measurement Input, Share Price [Member]

Related Party Transactions (Details) [Line Items]

Stock Issued During Period, Value, Other

$ 23,316

$ 42,055

Shares Issued, Price Per Share (in Dollars per share)

$ 24,118

Chief Executive Officer [Member] | Convertible Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 534,927

Chief Executive Officer [Member] | Premium on Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

75,146

Chief Executive Officer [Member] | Accrued Interest [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

115,381

Chief Executive Officer [Member] | Accrued Salary [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

250,106

Chief Executive Officer [Member] | Investment Incentive [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 634,114

Chief Executive Officer [Member] | Warrants at $0.50 [Member]

Related Party Transactions (Details) [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 0.5

Chief Executive Officer [Member] | Diamond Note 1 [Member]

Related Party Transactions (Details) [Line Items]

Stock Issued During Period, Shares, Other (in Shares)

96,471

Chief Executive Officer [Member] | Series F Preferred Stock [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

2,138

1,610

Chief Executive Officer [Member] | Series F Preferred Stock [Member] | Convertible Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 601,839

Chief Executive Officer [Member] | Series F Preferred Stock [Member] | Premium on Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 78,087

Director [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 209,971

Director [Member] | Convertible Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

48,162

Director [Member] | Premium on Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

2,941

Director [Member] | Accrued Interest [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

7,295

Director [Member] | Investment Incentive [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

84,073

Director [Member] | Accrued Board Fees [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 67,500

Director [Member] | Series F Preferred Stock [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

210

Chief Financial Officer [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 317,411

Stock Issued During Period, Shares, Other (in Shares)

4,000

Chief Financial Officer [Member] | Convertible Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

18,750

Chief Financial Officer [Member] | Accrued Interest [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

2,101

Chief Financial Officer [Member] | Accrued Salary [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

126,519

Chief Financial Officer [Member] | Investment Incentive [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

125,041

Chief Financial Officer [Member] | Accrued Board Fees [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 45,000

Chief Financial Officer [Member] | Series F Preferred Stock [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

318

Chief Operating Officer [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

181,606

Debt Conversion, Original Debt, Amount

$ 145,285

Chief Operating Officer [Member] | Convertible Notes Payable [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

18,750

Chief Operating Officer [Member] | Accrued Interest [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

2,101

Chief Operating Officer [Member] | Accrued Salary [Member]

Related Party Transactions (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 64,434

Accounts Payable and Accrued _3

Accounts Payable and Accrued Liabilities (Details) - Schedule of Accounts Payable and Accrued Liabilities - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Schedule Of Accounts Payable And Accrued Liabilities Abstract
Trade accounts payable	$ 1,466,337	$ 1,647,233
Accrued payroll and payroll taxes	437,263	298,108
Other	0	507
Total accounts payable and accrued liabilities	$ 1,903,600	$ 1,945,848

Right to Use Assets and Lease_3

Right to Use Assets and Lease Liabilities - Operating Leases (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Disclosure Text Block [Abstract]
Impairment, Lessor Asset under Operating Lease	$ 500,000	$ 3,200,000
Operating Lease, Right-of-Use Asset	0	83,810
Operating Lease, Liability	$ 93,758	$ 93,758

Right to Use Assets and Lease_4

Right to Use Assets and Lease Liabilities - Operating Leases (Details) - Lease, Cost - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Lease, Cost [Abstract]
Right to use assets, net	$ 0	$ 83,810
Lease liability	93,758	93,758
Less: current portion	(93,758)	(93,758)
Lease liability, non-current	$ 0	$ 0

Right to Use Assets and Lease_5

Right to Use Assets and Lease Liabilities - Operating Leases (Details) - Lessee, Operating Lease, Liability, Maturity - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Lessee Operating Lease Liability Maturity Abstract
For the twelve months ended September 30, 2024	$ 99,477
For the twelve months ended September 30, 2025	0
For the twelve months ended September 30, 2026	0
For the twelve months ended September 30, 2027	0
For the twelve months ended September 30, 2028	0
Thereafter	0
Total	99,477
Less: Present value discount	(5,719)
Lease liability	$ 93,758	$ 93,758

SBA Loan Payable (Details)

SBA Loan Payable (Details) - USD ($)			3 Months Ended	9 Months Ended		12 Months Ended
	Jul. 12, 2023	Jan. 12, 2022	Sep. 30, 2023	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	May 04, 2020
SBA Loan Payable (Details) [Line Items]
Debt Instrument, Periodic Payment	$ 2,595
Loans Payable to Bank	$ 467,117
Gains (Losses) on Restructuring of Debt		$ 15,032		$ 100,950	$ 0
Notes Payable			$ 1,143,235	1,143,235		$ 5,112,701
PPP Loan [Member]
SBA Loan Payable (Details) [Line Items]
Debt Instrument, Face Amount							$ 460,400
Debt Instrument, Interest Rate, Effective Percentage							1%
Debt Instrument, Increase, Accrued Interest						$ 4,632
Gains (Losses) on Restructuring of Debt			40,622
Notes Payable			433,343	433,343
Debt Instrument, Debt Default, Amount			1	1
Repayments of Debt			4,836	4,836
PPP Loan [Member] | Accrued Interest [Member]
SBA Loan Payable (Details) [Line Items]
Repayments of Debt			$ 1,081	$ 3,351

Notes Payable (Details)

Notes Payable (Details) - USD ($)																																		3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 29, 2023	Apr. 11, 2023	Mar. 28, 2023	Mar. 09, 2023	Feb. 28, 2023	Feb. 14, 2023	Dec. 02, 2022	Nov. 29, 2022	Nov. 18, 2022	Oct. 24, 2022	Oct. 10, 2022	Oct. 07, 2022	Oct. 05, 2022	Sep. 15, 2022	Sep. 14, 2022	Sep. 02, 2022	Aug. 18, 2022	Aug. 04, 2022	Jul. 27, 2022	Jul. 26, 2022	Jul. 21, 2022	Jul. 07, 2022	Jun. 09, 2022	May 26, 2022	May 23, 2022	May 18, 2022	May 10, 2022	Apr. 27, 2022	Apr. 18, 2022	Apr. 06, 2022	Mar. 18, 2022	Feb. 24, 2022	Dec. 30, 2021	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Mar. 31, 2022	Feb. 14, 2022
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																																				874
Debt Instrument, Unamortized Discount																																		$ 0		$ 0		$ 32,040
Debt Related Commitment Fees and Debt Issuance Costs																																		$ 1,214,970	$ 0	$ 7,644,077	$ 0
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	181,606
Class of Warrant or Right, Outstanding (in Shares)																																		673,208		673,208		672,334
Common Stock, Shares, Issued (in Shares)																																		5,544,519		5,544,519		4,630,372
Common Stock, Value, Issued																																		$ 55,448		$ 55,448		$ 46,305
Gain (Loss) on Extinguishment of Debt																																		0	0	25,000	0
Interest Expense, Debt																																		69,525	50,321	413,137	86,438
M Diamond Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Increase, Accrued Interest																																		2,706
Investment Incentive [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		$ 1,371,846
AJB Capital Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other									$ 9,007
Stock Issued During Period, Shares, Other (in Shares)									91,328
Debt Instrument, Face Amount																															$ 750,000
Class of Warrant or Rights, Granted (in Shares)																															15,000
Derivative Liability																															$ 106,608								$ 106,608
Proceeds from Issuance of Debt																															675,000
Debt Instrument, Unamortized Discount																															$ 349,914							0
Debt Instrument, Maturity Date																															Mar. 17, 2023
Debt Instrument, Interest Rate, Stated Percentage																															12%
Interest Expense, Long-Term Debt																																						62,000
Amortization of Debt Discount (Premium)																																						424,914
Debt Instrument, Debt Default, Amount																																						750,000
Interest Payable																																						22,833
Debt Instrument, Fee Amount																																		15,000		15,000
Debt Instrument, Increase, Accrued Interest																																		6,270		62,897
Debt Related Commitment Fees and Debt Issuance Costs		800,800
Debt Conversion, Original Debt, Amount		2,032,800
AJB Capital Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																															18%
AJB Capital Note [Member] | Minimum [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																															10%
AJB Capital Note [Member] | Principal [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		750,000
AJB Capital Note [Member] | Default Penalty [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		375,000
AJB Capital Note [Member] | Fees [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		15,000
AJB Capital Note [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		92,000
Anson Investments Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																														$ 322,500
Stock Issued During Period, Shares, Other (in Shares)																														25,800
Debt Instrument, Face Amount																														$ 562,500
Derivative Liability																														27,040
Debt Instrument, Unamortized Discount																														$ 416,375								0
Debt Instrument, Interest Rate, Stated Percentage																														12%
Interest Expense, Long-Term Debt																																						68,844
Amortization of Debt Discount (Premium)																																						472,625
Debt Instrument, Debt Default, Amount																																						562,500
Interest Payable																																						41,500
Debt Instrument, Fee Amount																																		15,000		15,000
Debt Instrument, Increase, Accrued Interest																																		4,724		27,157
Debt Related Commitment Fees and Debt Issuance Costs		602,815
Debt Conversion, Original Debt, Amount		1,530,222
Class of Warrant or Right, Outstanding (in Shares)																														11,250
Payments to Acquire Debt Securities, Available-for-Sale																														$ 506,250
Debt Conversion, Converted Instrument, Expiration or Due Date																														Oct. 06, 2022
Anson Investments Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																														18%
Anson Investments Note [Member] | Minimum [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																														10%
Anson Investments Note [Member] | Principal [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		562,500
Anson Investments Note [Member] | Default Penalty [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		281,250
Anson Investments Note [Member] | Fees [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		15,000
Anson Investments Note [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		68,657
Anson East Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																														$ 107,500
Stock Issued During Period, Shares, Other (in Shares)																														8,600
Debt Instrument, Face Amount																														$ 187,500
Derivative Liability																														9,014
Debt Instrument, Unamortized Discount																														$ 147,290								0
Debt Instrument, Interest Rate, Stated Percentage																														12%
Interest Expense, Long-Term Debt																																						22,948
Amortization of Debt Discount (Premium)																																						166,040
Debt Instrument, Debt Default, Amount																																						187,500
Interest Payable																																						13,833
Debt Instrument, Fee Amount																																		15,000		15,000
Debt Instrument, Increase, Accrued Interest																																		9,552		23,385
Debt Related Commitment Fees and Debt Issuance Costs		207,763
Debt Conversion, Original Debt, Amount		527,398
Class of Warrant or Right, Outstanding (in Shares)																														3,750
Payments to Acquire Debt Securities, Available-for-Sale																														$ 168,750
Debt Conversion, Converted Instrument, Expiration or Due Date																														Oct. 06, 2022
Anson East Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																														18%
Anson East Note [Member] | Minimum [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																														10%
Anson East Note [Member] | Principal [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		187,500
Anson East Note [Member] | Default Penalty [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		93,750
Anson East Note [Member] | Fees [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		15,000
Anson East Note [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		23,385
GS Capital Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																													$ 159,259
Stock Issued During Period, Shares, Other (in Shares)																													12,741
Debt Instrument, Face Amount																													$ 277,777
Derivative Liability																													21,920
Debt Instrument, Unamortized Discount																													$ 162,158
Debt Instrument, Interest Rate, Stated Percentage																													12%
Interest Expense, Long-Term Debt																																						32,155
Amortization of Debt Discount (Premium)																																						212,435
Debt Instrument, Debt Default, Amount																																						277,777
Interest Payable																																						19,578
Debt Instrument, Fee Amount																																		15,000		15,000
Debt Instrument, Increase, Accrued Interest																																		$ 2,374		13,965
Debt Related Commitment Fees and Debt Issuance Costs		249,439
Debt Conversion, Original Debt, Amount																																				$ 72,777
Debt Conversion, Converted Instrument, Shares Issued (in Shares)			18,472	15,265	13,555	9,846
Class of Warrant or Right, Outstanding (in Shares)																													5,556
Payments to Acquire Debt Securities, Available-for-Sale																													$ 250,000
Debt Conversion, Converted Instrument, Expiration or Due Date																													Nov. 10, 2022
Debt Instrument, Unamortized Discount, Current																													$ 27,777
Debt Instrument, Discount Outstanding																																						0
Debt Instrument, Convertible, Conversion Price (in Dollars per share)			$ 1.25	$ 1.5	$ 1.5	$ 1.74																												$ 1.46		$ 1.46
GS Capital Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																													18%
GS Capital Note [Member] | Minimum [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																													10%
GS Capital Note [Member] | Principal [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		205,000	$ 20,000	$ 20,000	$ 17,777	$ 15,000
GS Capital Note [Member] | Default Penalty [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		138,889
GS Capital Note [Member] | Fees [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		15,000																																		$ 57,140
GS Capital Note [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount			$ 2,581	$ 2,399	$ 2,057	$ 1,632																														8,679
Kishon Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																											$ 159,259
Stock Issued During Period, Shares, Other (in Shares)																											12,741
Debt Instrument, Face Amount																											$ 277,777
Class of Warrant or Rights, Granted (in Shares)																											5,556
Derivative Liability																											$ 27,793
Proceeds from Issuance of Debt																											250,000
Debt Instrument, Unamortized Discount																											$ 138,492											0
Debt Instrument, Maturity Date																											Nov. 10, 2022
Debt Instrument, Interest Rate, Stated Percentage																											12%
Interest Expense, Long-Term Debt																																						28,624
Amortization of Debt Discount (Premium)																																						181,269
Debt Instrument, Debt Default, Amount																																		$ 431,666		431,666		277,777
Interest Payable																																		69,324		69,324		17,822
Debt Instrument, Fee Amount																																		15,000		15,000
Debt Instrument, Increase, Accrued Interest																																		19,641		51,502
Kishon Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																											18%
Kishon Note [Member] | Minimum [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																											10%
Finnegan Note 1 [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																									$ 3,240
Stock Issued During Period, Shares, Other (in Shares)																									1,930
Debt Instrument, Face Amount																									$ 47,059			$ 47,059
Class of Warrant or Rights, Granted (in Shares)																									19,295
Proceeds from Issuance of Debt																									$ 40,000
Debt Instrument, Unamortized Discount																									$ 17,005										4,518		4,518	0
Debt Instrument, Maturity Date																									Nov. 20, 2022
Interest Expense, Long-Term Debt																																						3,285
Amortization of Debt Discount (Premium)																																					12,478	17,005
Debt Instrument, Debt Default, Amount																																		51,765		51,765		51,765
Interest Payable																																		9,754		9,754		3,285
Debt Instrument, Increase, Accrued Interest																																		2,164		6,469
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																									$ 12.5
Warrants and Rights Outstanding																									$ 2,000
Finnegan Note 1 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																									18%
Finnegan Note 1 [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																									386
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																									$ 25
M Diamond Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																								$ 4,050
Stock Issued During Period, Shares, Other (in Shares)																								483
Debt Instrument, Face Amount																								$ 58,823
Proceeds from Issuance of Debt																								$ 50,000
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																								Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																								10%
Interest Expense, Long-Term Debt																																						3,929
Amortization of Debt Discount (Premium)																																						21,256
Debt Instrument, Debt Default, Amount																																		64,705		64,705		64,705
Interest Payable																																		12,013		12,013		3,929
Debt Instrument, Increase, Accrued Interest																																				8,084
Warrants and Rights Outstanding																								$ 2,500
M Diamond Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																								18%
M Diamond Note [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																								483
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																								$ 25
Finnegan Note 2 [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																								$ 2,025
Stock Issued During Period, Shares, Other (in Shares)																								242
Debt Instrument, Face Amount																								$ 29,412
Proceeds from Issuance of Debt																								$ 25,000
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																								Nov. 30, 2022
Interest Expense, Long-Term Debt																																						1,965
Amortization of Debt Discount (Premium)																																						10,625
Debt Instrument, Debt Default, Amount																																		32,353		32,353		32,353
Interest Payable																																		6,007		6,007		1,965
Debt Instrument, Increase, Accrued Interest																																		1,353		4,042
Warrants and Rights Outstanding																								$ 1,250
Finnegan Note 2 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																								18%
Finnegan Note 2 [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																								242
Share Price (in Dollars per share)																								$ 25
Dragon Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																							$ 44,000
Stock Issued During Period, Shares, Other (in Shares)																							4,824
Debt Instrument, Face Amount																							$ 588,235
Proceeds from Issuance of Debt																							$ 500,000
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																							Dec. 09, 2022
Debt Instrument, Interest Rate, Stated Percentage																							10%
Interest Expense, Long-Term Debt																																						35,874
Amortization of Debt Discount (Premium)																																						260,059
Debt Instrument, Debt Default, Amount																																						647,059
Interest Payable																																						35,874
Debt Instrument, Increase, Accrued Interest																																		3,235		29,706
Debt Related Commitment Fees and Debt Issuance Costs		463,539
Debt Conversion, Original Debt, Amount		1,176,676
Warrants and Rights Outstanding																							$ 21,500
Debt Issuance Costs, Gross																							$ 47,500
Dragon Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																							18%
Dragon Note [Member] | Principal [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		647,059
Dragon Note [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		66,078
Dragon Note [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																							4,824
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																							$ 25
Mackay Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																						$ 44,118
Stock Issued During Period, Shares, Other (in Shares)																						2,412
Debt Instrument, Face Amount																						$ 294,118
Class of Warrant or Rights, Granted (in Shares)																						2,412
Proceeds from Issuance of Debt																						$ 250,000
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																						Aug. 10, 2022
Debt Instrument, Interest Rate, Stated Percentage																						10%
Interest Expense, Long-Term Debt																																						20,193
Amortization of Debt Discount (Premium)																																						96,280
Debt Instrument, Debt Default, Amount																																						323,530
Interest Payable																																						20,193
Debt Instrument, Increase, Accrued Interest																																		13,382		43,614
Debt Related Commitment Fees and Debt Issuance Costs	$ 258,269
Debt Conversion, Original Debt, Amount	655,606
Warrants and Rights Outstanding																						$ 10,250
Mackay Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																						18%
Mackay Note [Member] | Fees [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	10,000
Mackay Note [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	63,807
Mackay Note [Member] | Investment Incentive [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	258,269
Mackay Note [Member] | Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	294,118
Mackay Note [Member] | Premium on Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	29,412
Mackay Note [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																						2,412
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																						$ 25
Schrier Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																						$ 1,000
Stock Issued During Period, Shares, Other (in Shares)																						193
Debt Instrument, Face Amount																						$ 23,259
Class of Warrant or Rights, Granted (in Shares)																						193
Proceeds from Issuance of Debt																						$ 20,000
Debt Instrument, Unamortized Discount																																						335
Debt Instrument, Maturity Date																						Jan. 08, 2023
Debt Instrument, Interest Rate, Stated Percentage																						10%
Interest Expense, Long-Term Debt																																						1,141
Amortization of Debt Discount (Premium)																																						7,367
Debt Instrument, Debt Default, Amount																																		25,882		25,882		25,882
Interest Payable																																		4,315		4,315		1,141
Debt Instrument, Increase, Accrued Interest																																		1,071		3,174
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																						$ 12.5
Warrants and Rights Outstanding																						$ 820
Schrier Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																						18%
Schrier Note [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																						$ 25
Nommsen Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																				$ 2,350
Stock Issued During Period, Shares, Other (in Shares)																				483
Debt Instrument, Face Amount																				$ 58,823
Class of Warrant or Rights, Granted (in Shares)																				482
Proceeds from Issuance of Debt																				$ 50,000
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																				Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																				10%
Interest Expense, Long-Term Debt																																						2,946
Amortization of Debt Discount (Premium)																																						18,905
Debt Instrument, Debt Default, Amount																																		64,705		64,705		64,705
Interest Payable																																		11,016		11,016		2,946
Debt Instrument, Increase, Accrued Interest																																		2,706		8,070
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																				$ 12.5
Warrants and Rights Outstanding																				$ 1,850
Nommsen Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																				18%
Nommsen Note [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																				483
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																				$ 25
Caplan Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																			$ 2,350
Stock Issued During Period, Shares, Other (in Shares)																			483
Debt Instrument, Face Amount																			$ 58,823
Class of Warrant or Rights, Granted (in Shares)																			482
Proceeds from Issuance of Debt																			$ 50,000
Debt Instrument, Maturity Date																			Jan. 21, 2023
Debt Instrument, Interest Rate, Stated Percentage																			10%
Interest Expense, Long-Term Debt																																						2,531
Amortization of Debt Discount (Premium)																																						16,675
Debt Instrument, Debt Default, Amount																																		64,705		64,705		64,705
Interest Payable																																		10,320		10,320		2,531
Debt Instrument, Increase, Accrued Interest																																		2,706		7,789
Debt Instrument, Discount Outstanding																																						2,230
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																			$ 12.5
Warrants and Rights Outstanding																			$ 1,850
Caplan Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																			18%
Caplan Note [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																			483
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																			$ 25
Finnegan Note 3 [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																		$ 1,100
Stock Issued During Period, Shares, Other (in Shares)																		242
Debt Instrument, Face Amount																		$ 29,412
Class of Warrant or Rights, Granted (in Shares)																		241
Proceeds from Issuance of Debt																		$ 25,000
Debt Instrument, Unamortized Discount																																			6,405		6,405	1,728
Debt Instrument, Maturity Date																		Feb. 03, 2023
Debt Instrument, Interest Rate, Stated Percentage																		10%
Interest Expense, Long-Term Debt																																						1,200
Amortization of Debt Discount (Premium)																																					2,898	7,575
Debt Instrument, Debt Default, Amount																																		32,353		32,353		32,353
Interest Payable																																		5,016		5,016		1,200
Debt Instrument, Increase, Accrued Interest																																		1,353		3,816
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																		$ 12.5
Warrants and Rights Outstanding																		$ 850
Share Price (in Dollars per share)																		$ 12.5
Finnegan Note 3 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																		18%
Finnegan Note 3 [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																		242
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																		$ 25
Enright Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																		$ 6,317
Stock Issued During Period, Shares, Other (in Shares)																		984
Debt Instrument, Face Amount																		$ 120,000
Proceeds from Issuance of Debt																		$ 102,000
Debt Instrument, Unamortized Discount																																						6,746
Debt Instrument, Maturity Date																		Feb. 03, 2023
Debt Instrument, Interest Rate, Stated Percentage																		10%
Interest Expense, Long-Term Debt																																						4,899
Amortization of Debt Discount (Premium)																																						29,571
Debt Instrument, Debt Default, Amount																																						132,000
Interest Payable																																						4,899
Debt Instrument, Increase, Accrued Interest																																		5,460		15,481
Debt Related Commitment Fees and Debt Issuance Costs	102,116
Debt Conversion, Original Debt, Amount	$ 254,496
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	255
Enright Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																		18%
Enright Note [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 20,380
Enright Note [Member] | Investment Incentive [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	102,116
Enright Note [Member] | Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	120,000
Enright Note [Member] | Premium on Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	12,000
Mitchell Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Face Amount																$ 71,000
Proceeds from Issuance of Debt																$ 60,350
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																10%
Interest Expense, Long-Term Debt																																						2,817
Amortization of Debt Discount (Premium)																																						20,874
Debt Instrument, Debt Default, Amount																																		78,100		78,100		78,100
Interest Payable																																		12,547		12,547		2,817
Debt Instrument, Increase, Accrued Interest																																		3,266		9,730
Common Stock, Shares, Issued (in Shares)																582
Common Stock, Value, Issued																$ 3,124
Mitchell Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																18%
Lightmas Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																$ 2,640
Stock Issued During Period, Shares, Other (in Shares)																492
Debt Instrument, Face Amount																$ 60,000
Proceeds from Issuance of Debt																$ 51,000
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																10%
Interest Expense, Long-Term Debt																																						2,380
Amortization of Debt Discount (Premium)																																						17,640
Debt Instrument, Debt Default, Amount																																		66,000		66,000		66,000
Interest Payable																																		10,603		10,603		2,380
Debt Instrument, Increase, Accrued Interest																																		2,760		8,223
Lightmas Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																18%
Lewis Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																$ 1,320
Stock Issued During Period, Shares, Other (in Shares)																246
Debt Instrument, Face Amount																$ 30,000
Proceeds from Issuance of Debt																$ 25,500
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																10%
Interest Expense, Long-Term Debt																																						1,190
Amortization of Debt Discount (Premium)																																						8,820
Debt Instrument, Debt Default, Amount																																		33,000		33,000		33,000
Interest Payable																																		5,302		5,302		1,190
Debt Instrument, Increase, Accrued Interest																																		1,380		4,112
Lewis Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																18%
Goff Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																$ 1,320
Stock Issued During Period, Shares, Other (in Shares)																246
Debt Instrument, Face Amount																$ 30,000
Proceeds from Issuance of Debt																$ 25,500
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																10%
Interest Expense, Long-Term Debt																																						1,190
Amortization of Debt Discount (Premium)																																						8,820
Debt Instrument, Debt Default, Amount																																		33,000		33,000		33,000
Interest Payable																																		5,302		5,302		1,190
Debt Instrument, Increase, Accrued Interest																																		1,380		4,112
Goff Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																18%
Hagan Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																$ 4,715
Stock Issued During Period, Shares, Other (in Shares)																820
Debt Instrument, Face Amount																$ 100,000
Proceeds from Issuance of Debt																$ 85,000
Debt Instrument, Maturity Date																Dec. 10, 2022
Debt Instrument, Interest Rate, Stated Percentage																10%
Interest Expense, Long-Term Debt																																						3,556
Amortization of Debt Discount (Premium)																																						29,715
Debt Instrument, Debt Default, Amount																																		110,000		110,000		110,000
Interest Payable																																		17,526		17,526		3,556
Debt Instrument, Increase, Accrued Interest																																		4,600		13,700
Debt Instrument, Discount Outstanding																																						0
Hagan Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																18%
Darling Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other															$ 10,824
Stock Issued During Period, Shares, Other (in Shares)															1,640
Debt Instrument, Face Amount															$ 200,000
Proceeds from Issuance of Debt															$ 170,000
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date															Dec. 15, 2022
Debt Instrument, Interest Rate, Stated Percentage															10%
Interest Expense, Long-Term Debt																																						6,619
Amortization of Debt Discount (Premium)																																						60,824
Debt Instrument, Debt Default, Amount																																						220,000
Interest Payable																																						6,619
Debt Instrument, Increase, Accrued Interest																																		0		10,192
Debt Related Commitment Fees and Debt Issuance Costs		153,927
Debt Conversion, Original Debt, Amount		390,738
Darling Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage															18%
Darling Note [Member] | Principal [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		220,000
Darling Note [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		16,811
Leath Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other														$ 2,868
Stock Issued During Period, Shares, Other (in Shares)														410
Debt Instrument, Face Amount														$ 50,000
Proceeds from Issuance of Debt														$ 42,500
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date														Dec. 15, 2022
Debt Instrument, Interest Rate, Stated Percentage														10%
Interest Expense, Long-Term Debt																																						1,641
Amortization of Debt Discount (Premium)																																						15,368
Debt Instrument, Debt Default, Amount																																		55,000		55,000		55,000
Interest Payable																																		8,489		8,489		1,641
Debt Instrument, Increase, Accrued Interest																																		2,300		6,848
Debt Securities, Held-to-Maturity, Fair Value														$ 55,000
Leath Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage														18%
Cavalry Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Face Amount													$ 500,000
Class of Warrant or Rights, Granted (in Shares)													750
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Interest Rate, Stated Percentage													10%
Amortization of Debt Discount (Premium)																																						10,500
Debt Instrument, Debt Default, Amount																																						500,000
Interest Payable																																						11,918
Debt Instrument, Increase, Accrued Interest																																		0		25,415
Debt Related Commitment Fees and Debt Issuance Costs		349,266
Debt Conversion, Original Debt, Amount		886,599
Debt Issuance Costs, Gross													$ 7,500
Cavalry Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage													18%
Cavalry Note [Member] | Principal [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		500,000
Cavalry Note [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		37,333
Mercer Note 1 [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Face Amount												$ 300,000
Class of Warrant or Rights, Granted (in Shares)												750
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date												Dec. 31, 2022
Debt Instrument, Interest Rate, Stated Percentage												10%
Interest Expense, Long-Term Debt																																						6,986
Amortization of Debt Discount (Premium)																																						10,500
Debt Instrument, Debt Default, Amount																																						300,000
Interest Payable																																						6,986
Debt Instrument, Increase, Accrued Interest																																		0		15,247
Debt Related Commitment Fees and Debt Issuance Costs		209,452
Debt Conversion, Original Debt, Amount		531,685
Mercer Note 1 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage												18%
Mercer Note 1 [Member] | Principal [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		300,000
Mercer Note 1 [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		22,233
Pinz Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Face Amount											$ 30,000
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date											Dec. 31, 2022
Debt Instrument, Interest Rate, Stated Percentage											10%
Interest Expense, Long-Term Debt																																						6,986
Amortization of Debt Discount (Premium)																																						2,100
Debt Instrument, Debt Default, Amount																																						30,000
Debt Instrument, Increase, Accrued Interest																																		1,650		15,247		$ 674
Debt Related Commitment Fees and Debt Issuance Costs		20,929
Debt Conversion, Original Debt, Amount		53,127
Pinz Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage											18%
Pinz Note [Member] | Principal [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		30,000
Pinz Note [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		2,198
Pinz Exchange Agreement [Member]
Notes Payable (Details) [Line Items]
Preferred Stock, Convertible, Shares Issuable (in Shares)																																						100,000
Mercer Note 2 [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Face Amount										$ 100,000
Class of Warrant or Rights, Granted (in Shares)							750
Debt Instrument, Unamortized Discount																																						$ 0
Debt Instrument, Maturity Date										Dec. 31, 2022
Interest Expense, Long-Term Debt																																						1,863
Amortization of Debt Discount (Premium)																																						1,900
Debt Instrument, Debt Default, Amount																																						100,000
Debt Instrument, Increase, Accrued Interest																																		0		5,076		1,863
Debt Related Commitment Fees and Debt Issuance Costs		69,510
Debt Conversion, Original Debt, Amount		176,449
Mercer Note 2 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage										18%
Mercer Note 2 [Member] | Principal [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		100,000
Mercer Note 2 [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		6,939
Mercer Note 3 [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Face Amount							$ 125,000
Class of Warrant or Rights, Granted (in Shares)							750
Debt Instrument, Unamortized Discount																																						20,972
Debt Instrument, Maturity Date							May 21, 2023
Debt Instrument, Interest Rate, Stated Percentage							10%
Amortization of Debt Discount (Premium)																																		12,500		20,972		4,028
Debt Instrument, Debt Default, Amount		172,448																																				125,000
Debt Instrument, Increase, Accrued Interest																																		0		3,521		993
Debt Related Commitment Fees and Debt Issuance Costs		67,934
Debt Instrument, Decrease, Forgiveness		25,000
Gain (Loss) on Extinguishment of Debt		25,000
Mercer Note 3 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage							18%
Mercer Note 3 [Member] | Principal [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		100,000
Mercer Note 3 [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		$ 4,514
Notes Payable, Other Payables [Member]
Notes Payable (Details) [Line Items]
Interest Payable, Current																																		187,264		187,264		362,094
Howe Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Face Amount																																	$ 1,000,000
Proceeds from Issuance of Debt																																	$ 850,000
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																																	Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																																	10%
Interest Expense, Long-Term Debt																																						106,795
Amortization of Debt Discount (Premium)																																						511,568
Debt Instrument, Debt Default, Amount																																		1,100,000		1,100,000		1,100,000
Interest Payable																																		245,056		245,056		106,795
Debt Instrument, Increase, Accrued Interest																																		46,000		138,261
Warrants and Rights Outstanding																																	$ 261,568
Howe Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																																	18%
Diamond Note 1 [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Face Amount																																$ 175,000								$ 235,294
Proceeds from Issuance of Debt																																$ 148,750
Debt Instrument, Unamortized Discount																																			0		0	0
Debt Instrument, Maturity Date																																Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																																10%								10%
Interest Expense, Long-Term Debt																																						16,052
Amortization of Debt Discount (Premium)																																					35,294	46,664
Debt Instrument, Debt Default, Amount																																			235,294		235,294	192,500
Interest Payable																																						16,052
Debt Instrument, Increase, Accrued Interest																																		7,963		24,024
Debt Related Commitment Fees and Debt Issuance Costs	151,174
Debt Conversion, Original Debt, Amount	383,750
Common Stock, Value, Issued																																$ 2,914
Diamond Note 1 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																																18%								18%
Diamond Note 1 [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	40,076
Diamond Note 1 [Member] | Investment Incentive [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	151,174
Diamond Note 1 [Member] | Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	175,000
Diamond Note 1 [Member] | Premium on Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	17,500
Diamond Note 2 [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Face Amount																															$ 235,294
Class of Warrant or Rights, Granted (in Shares)																															200,000
Proceeds from Issuance of Debt																															$ 200,000
Debt Instrument, Maturity Date																															Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																															10%
Interest Expense, Long-Term Debt																																						1,676
Amortization of Debt Discount (Premium)																																						61,036
Debt Instrument, Debt Default, Amount																																			23,529		23,529	23,529
Interest Payable																																						1,676
Debt Instrument, Increase, Accrued Interest																																				0
Debt Related Commitment Fees and Debt Issuance Costs	16,398
Debt Conversion, Original Debt, Amount	41,626
Warrants and Rights Outstanding																															$ 2,213							0
Debt Instrument, Repaid, Principal																																						235,294
Diamond Note 2 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																															18%
Diamond Note 2 [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	1,699
Diamond Note 2 [Member] | Investment Incentive [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	16,398
Diamond Note 2 [Member] | Premium on Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	23,529
Diamond Note 2 [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																															1,930
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																															$ 25
Diamond Note 3 [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																												$ 16,200
Stock Issued During Period, Shares, Other (in Shares)																												1,930
Debt Instrument, Face Amount																												$ 235,294
Class of Warrant or Rights, Granted (in Shares)																												1,929
Proceeds from Issuance of Debt																												$ 200,000
Debt Instrument, Unamortized Discount																																			6,478		6,478	0
Debt Instrument, Maturity Date																												Nov. 30, 2022
Interest Expense, Long-Term Debt																																						17,586
Amortization of Debt Discount (Premium)																																					14,778	83,823
Debt Instrument, Debt Default, Amount																																			47,059		47,059	258,823
Interest Payable																																						17,586
Debt Instrument, Increase, Accrued Interest																																		10,706		32,244
Debt Related Commitment Fees and Debt Issuance Costs	200,624
Debt Conversion, Original Debt, Amount	509,277
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																												$ 12.5
Warrants and Rights Outstanding																												$ 8,800
Diamond Note 3 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																												18%
Diamond Note 3 [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	49,830
Diamond Note 3 [Member] | Investment Incentive [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	200,624
Diamond Note 3 [Member] | Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	235,294
Diamond Note 3 [Member] | Premium on Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	23,529
Diamond Note 4 [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																										$ 3,160
Stock Issued During Period, Shares, Other (in Shares)																										1,930
Debt Instrument, Face Amount																										$ 47,059
Class of Warrant or Rights, Granted (in Shares)																										19,294
Proceeds from Issuance of Debt																										$ 40,000
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																										Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																										10%
Interest Expense, Long-Term Debt																																						3,245
Amortization of Debt Discount (Premium)																																						17,885
Debt Instrument, Debt Default, Amount																																						51,765
Interest Payable																																						3,245
Debt Instrument, Increase, Accrued Interest																																		2,141		6,446
Debt Related Commitment Fees and Debt Issuance Costs	200,624
Debt Conversion, Original Debt, Amount	101,402
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																										$ 12.5
Warrants and Rights Outstanding																										$ 2,960
Diamond Note 4 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																										18%
Diamond Note 4 [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	9,691
Diamond Note 4 [Member] | Investment Incentive [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	39,946
Diamond Note 4 [Member] | Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	47,059
Diamond Note 4 [Member] | Premium on Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	4,706
Diamond Note 4 [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																										386
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																										$ 25
Diamond Note 5 [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																								$ 4,050
Stock Issued During Period, Shares, Other (in Shares)																								483
Debt Instrument, Face Amount																								$ 58,823
Class of Warrant or Rights, Granted (in Shares)																								483
Proceeds from Issuance of Debt																								$ 50,000
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																								Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																								10%
Interest Expense, Long-Term Debt																																						3,929
Amortization of Debt Discount (Premium)																																						21,256
Debt Instrument, Debt Default, Amount																																						64,705
Interest Payable																																						3,929
Debt Instrument, Increase, Accrued Interest																																		2,677		8,055
Debt Related Commitment Fees and Debt Issuance Costs	200,624
Debt Conversion, Original Debt, Amount	126,539
Warrants and Rights Outstanding																								$ 2,500
Diamond Note 5 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																								18%
Diamond Note 5 [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	11,984
Diamond Note 5 [Member] | Investment Incentive [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	49,849
Diamond Note 5 [Member] | Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	58,824
Diamond Note 5 [Member] | Premium on Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	5,882
Diamond Note 5 [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																								$ 25
Lindstrom Note 1 [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																								$ 2,835
Stock Issued During Period, Shares, Other (in Shares)																								338
Debt Instrument, Face Amount																								$ 41,176
Class of Warrant or Rights, Granted (in Shares)																								338
Proceeds from Issuance of Debt																								$ 35,000
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																								Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																								10%
Interest Expense, Long-Term Debt																																						2,750
Amortization of Debt Discount (Premium)																																						14,879
Debt Instrument, Debt Default, Amount																																		45,294		45,294		45,294
Interest Payable																																		8,409		8,409		2,750
Debt Instrument, Increase, Accrued Interest																																		1,894		5,659
Warrants and Rights Outstanding																								$ 1,750
Lindstrom Note 1 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																								18%
Lindstrom Note 1 [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																								$ 25
Dobbertin Note 1 [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																								$ 1,215
Stock Issued During Period, Shares, Other (in Shares)																								145
Debt Instrument, Face Amount																								$ 17,647
Class of Warrant or Rights, Granted (in Shares)																								145
Proceeds from Issuance of Debt																								$ 15,000
Debt Instrument, Unamortized Discount																																						0
Debt Instrument, Maturity Date																								Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																								10%
Interest Expense, Long-Term Debt																																						1,179
Amortization of Debt Discount (Premium)																																						6,377
Debt Instrument, Debt Default, Amount																																		19,412		19,412		19,412
Interest Payable																																		3,604		3,604		1,179
Debt Instrument, Increase, Accrued Interest																																		811		2,425
Warrants and Rights Outstanding																								$ 750
Dobbertin Note 1 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																								18%
Dobbertin Note 1 [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																								$ 25
Howe Note 2 [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																							$ 22,440
Stock Issued During Period, Shares, Other (in Shares)																							2,460
Debt Instrument, Face Amount																							$ 300,000
Class of Warrant or Rights, Granted (in Shares)																							123,000
Proceeds from Issuance of Debt																							$ 255,000
Debt Instrument, Unamortized Discount																																			37,393		37,393	0
Debt Instrument, Maturity Date																							Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																							10%
Interest Expense, Long-Term Debt																																						18,888
Amortization of Debt Discount (Premium)																																					71,012	108,405
Debt Instrument, Debt Default, Amount																																		330,000	300,000	330,000	300,000	330,000
Interest Payable																																		60,100		60,100		18,888
Debt Instrument, Increase, Accrued Interest																																		13,800		41,212
Warrants and Rights Outstanding																							$ 10,965
Howe Note 2 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																							18%
Howe Note 2 [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																							2,460
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																							$ 25
Howe Note 3 [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																					$ 12,495																	0
Stock Issued During Period, Shares, Other (in Shares)																					2,460
Debt Instrument, Face Amount																					$ 300,000
Class of Warrant or Rights, Granted (in Shares)																					2,460
Proceeds from Issuance of Debt																					$ 255,000
Debt Instrument, Unamortized Discount																																			0		0
Debt Instrument, Maturity Date																					Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																					10%
Interest Expense, Long-Term Debt																																						15,436
Amortization of Debt Discount (Premium)																																					97,440	97,440
Debt Instrument, Debt Default, Amount																																		330,000		330,000		330,000
Interest Payable																																		56,600		56,600		15,436
Debt Instrument, Increase, Accrued Interest																																		13,800		41,164
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																					$ 12.5
Warrants and Rights Outstanding																					$ 9,945
Share Price (in Dollars per share)																					$ 12.5
Howe Note 3 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																					18%
Howe Note 3 [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																					$ 25
Iturregui Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																					$ 1,225
Stock Issued During Period, Shares, Other (in Shares)																					242
Debt Instrument, Face Amount																					$ 29,412
Class of Warrant or Rights, Granted (in Shares)																					241
Proceeds from Issuance of Debt																					$ 25,000
Debt Instrument, Unamortized Discount																																			$ 5,867		$ 5,867
Debt Instrument, Maturity Date																					Jan. 21, 2023
Debt Instrument, Interest Rate, Stated Percentage																					10%														10%		10%
Interest Expense, Long-Term Debt																																						1,313
Amortization of Debt Discount (Premium)																																					$ 3,686	8,464
Debt Instrument, Debt Default, Amount																																						32,353
Interest Payable																																						1,313
Debt Instrument, Increase, Accrued Interest																																		1,338		3,881
Debt Related Commitment Fees and Debt Issuance Costs	24,406
Debt Conversion, Original Debt, Amount	61,953
Debt Instrument, Discount Outstanding																																						1,089
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																					$ 12.5
Warrants and Rights Outstanding																					$ 975
Share Price (in Dollars per share)																					$ 12.5
Iturregui Note [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																					18%
Iturregui Note [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	5,194
Iturregui Note [Member] | Investment Incentive [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	24,406
Iturregui Note [Member] | Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	29,412
Iturregui Note [Member] | Premium on Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	2,941
Iturregui Note [Member] | Warrants at $25.00 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																					242
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																					$ 25
Howe Note 4 [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																	$ 10,775
Stock Issued During Period, Shares, Other (in Shares)																	1,640
Debt Instrument, Face Amount																	$ 200,000
Proceeds from Issuance of Debt																	$ 170,000
Debt Instrument, Unamortized Discount																																			$ 35,647		35,647
Debt Instrument, Maturity Date																	Nov. 30, 2022
Debt Instrument, Interest Rate, Stated Percentage																	10%
Interest Expense, Long-Term Debt																																						8,756
Amortization of Debt Discount (Premium)																																					25,128	60,775
Debt Instrument, Debt Default, Amount																																		220,000		220,000		220,000
Interest Payable																																		36,733		36,733		8,756
Debt Instrument, Increase, Accrued Interest																																		9,200		27,977
Debt Instrument, Discount Outstanding																																						0
Share Price (in Dollars per share)																	$ 12.5
Howe Note 4 [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																	18%
November 29, 2022 Notes [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)								750
Debt Instrument, Unamortized Discount																																						3,083
Debt Instrument, Maturity Date								May 28, 2023
Amortization of Debt Discount (Premium)																																						667
Debt Instrument, Debt Default, Amount																																						18,750
Interest Payable																																		6,303		6,303		$ 164
Debt Instrument, Increase, Accrued Interest																																		854		1,937
Debt Related Commitment Fees and Debt Issuance Costs	$ 13,553
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	26,064
Debt Instrument, Convertible, Conversion Price (in Dollars per share)	$ 0.8
Convertible Notes Payable																																		56,250		56,250
November 29, 2022 Notes [Member] | Measurement Input, Default Rate [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage								18%
November 29, 2022 Notes [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 2,101
November 29, 2022 Notes [Member] | Investment Incentive [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	13,553
November 29, 2022 Notes [Member] | Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 18,750
Series F Preferred Stock [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	911	4,055
Series F Preferred Stock [Member] | Fees [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 10,000
Series F Preferred Stock [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	84,187
Series F Preferred Stock [Member] | Investment Incentive [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	360,385
Series F Preferred Stock [Member] | Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	414,118
Series F Preferred Stock [Member] | Premium on Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 41,412
Series F Preferred Stock [Member] | AJB Capital Note [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		2,033
Series F Preferred Stock [Member] | Anson Investments Note [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		1,531
Series F Preferred Stock [Member] | Anson East Note [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		528
Series F Preferred Stock [Member] | GS Capital Note [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		$ 633,192
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		634
Series F Preferred Stock [Member] | GS Capital Note [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount		$ 24,864
Series F Preferred Stock [Member] | Dragon Note [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		1,177
Series F Preferred Stock [Member] | Mackay Note [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	656
Series F Preferred Stock [Member] | Darling Note [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		391
Series F Preferred Stock [Member] | Cavalry Note [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		887
Series F Preferred Stock [Member] | Mercer Note 1 [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		531
Series F Preferred Stock [Member] | Pinz Note [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		54
Series F Preferred Stock [Member] | Mercer Note 2 [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		177
Series F Preferred Stock [Member] | Mercer Note 3 [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		173
Series F Preferred Stock [Member] | Diamond Note 1 [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	384
Series F Preferred Stock [Member] | Diamond Note 2 [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	42
Series F Preferred Stock [Member] | Diamond Note 3 [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	509
Series F Preferred Stock [Member] | Diamond Note 4 [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	101
Series F Preferred Stock [Member] | Diamond Note 5 [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	127
Series F Preferred Stock [Member] | Iturregui Note [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	62
Series F Preferred Stock [Member] | November 29, 2022 Notes [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 34,404
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	34
Series F Preferred Stock [Member] | November 29, 2022 Notes [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 2,101
Series F Preferred Stock [Member] | November 29, 2022 Notes [Member] | Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	18,750
Series C Preferred Stock [Member]
Notes Payable (Details) [Line Items]
Debt Related Commitment Fees and Debt Issuance Costs		$ 1,016,888
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		2,289
Series C Preferred Stock [Member] | Cavalry Note [Member]
Notes Payable (Details) [Line Items]
Preferred Stock, Convertible, Shares Issuable (in Shares)													1,000,000
Series C Preferred Stock [Member] | Cavalry Exchange Agreement [Member]
Notes Payable (Details) [Line Items]
Preferred Stock, Convertible, Shares Issuable (in Shares)																																						1,000,000
Series C Preferred Stock [Member] | Mercer Note 1 [Member]
Notes Payable (Details) [Line Items]
Preferred Stock, Convertible, Shares Issuable (in Shares)												47,619
Series C Preferred Stock [Member] | Mercer Exchange Agreement [Member]
Notes Payable (Details) [Line Items]
Preferred Stock, Convertible, Shares Issuable (in Shares)																																						47,619
Series D Preferred Stock [Member] | Cavalry Note [Member]
Notes Payable (Details) [Line Items]
Preferred Stock, Convertible, Shares Issuable (in Shares)													750,000
Series D Preferred Stock [Member] | Cavalry Exchange Agreement [Member]
Notes Payable (Details) [Line Items]
Preferred Stock, Convertible, Shares Issuable (in Shares)																																						750,000
Series D Preferred Stock [Member] | Mercer Note 1 [Member]
Notes Payable (Details) [Line Items]
Preferred Stock, Convertible, Shares Issuable (in Shares)												750,000
Series D Preferred Stock [Member] | Mercer Exchange Agreement [Member]
Notes Payable (Details) [Line Items]
Preferred Stock, Convertible, Shares Issuable (in Shares)																																						750,000
Series D Preferred Stock [Member] | Pinz Note [Member]
Notes Payable (Details) [Line Items]
Preferred Stock, Convertible, Shares Issuable (in Shares)											100,000
Warrants at $25.00 [Member] | Howe Note [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																																	42,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																																	$ 25
Warrants at $25.00 [Member] | Diamond Note 1 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																																7,350
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																																$ 25
Warrants at $25.00 [Member] | Diamond Note 3 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																												1,930
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																												$ 25
Warrants at $37.50 [Member] | Howe Note [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																																	42,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																																	$ 37.5
Warrants at $37.50 [Member] | Diamond Note 1 [Member]
Notes Payable (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																																7,350
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																																$ 37.5
Commitments [Member] | AJB Capital Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Value, Other																															$ 430,000
Stock Issued During Period, Shares, Other (in Shares)																															34,400
Commitments [Member] | Iturregui Note [Member]
Notes Payable (Details) [Line Items]
Stock Issued During Period, Shares, Other (in Shares)																					242
Original Issue Discount [Member] | AJB Capital Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Unamortized Discount																															$ 75,000
Original Issue Discount [Member] | Anson Investments Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Unamortized Discount																														$ 56,250
Original Issue Discount [Member] | Anson East Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Unamortized Discount																														$ 18,750
Original Issue Discount [Member] | Kishon Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Unamortized Discount																											$ 27,777
Default Penalty [Member] | AJB Capital Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Fee Amount																																		375,000		375,000
Default Penalty [Member] | Anson Investments Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Fee Amount																																		281,250		281,250
Default Penalty [Member] | Anson East Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Fee Amount																																		93,750		93,750
Default Penalty [Member] | GS Capital Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Fee Amount																																		138,889		138,889
Default Penalty [Member] | Kishon Note [Member]
Notes Payable (Details) [Line Items]
Debt Instrument, Fee Amount																																		138,889		138,889
Related Party [Member]
Notes Payable (Details) [Line Items]
Proceeds from Issuance of Debt																																				0	2,918,100
Debt Instrument, Unamortized Discount																																		0		0		$ 22,670
Amortization of Debt Discount (Premium)																																				22,670	0
Interest Payable																																		416,805		416,805		198,753
Debt Instrument, Unamortized Discount, Current																																		0		0		22,670
Interest Expense, Debt																																		116,308	$ 27,174	358,894	$ 120,866
Interest Payable, Current																																		$ 416,815		$ 416,815		$ 198,753
Related Party [Member] | Series F Preferred Stock [Member] | Accrued Interest [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	124,777
Related Party [Member] | Series F Preferred Stock [Member] | Investment Incentive [Member]
Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 843,228

Notes Payable (Details) - Sche

Notes Payable (Details) - Schedule of Debt - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Schedule Of Debt Abstract
Notes Payable	$ 1,143,235	$ 5,144,741
Less: Discount	0	(32,040)
Notes payable - net of discount	1,143,235	5,112,701
Current Portion, net of discount	1,143,235	5,112,701
Long-term portion, net of discount	$ 0	$ 0

Notes Payable - Related Parties

Notes Payable - Related Parties (Details) - Schedule of Debt, Related Parties - Related Party [Member] - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Notes Payable - Related Parties (Details) - Schedule of Debt, Related Parties [Line Items]
Notes Payable	$ 2,100,956	$ 2,799,632
Less: Discount	0	(22,670)
Notes payable – net of discounts	2,100,956	2,776,962
Current Portion, net of discount	2,100,956	2,776,962
Long-term portion, net of discount	$ 0	$ 0

Derivative Liabilities (Details

Derivative Liabilities (Details) - Schedule of Derivative Liability Acitivity - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Schedule Of Derivative Liability Acitivity Abstract
Balance	$ 568,912	$ 0
True-up features issued		192,375
Settled upon conversion or exercise	(501,740)	(310,641)
Loss on revaluation	85,765	687,178
Balance	$ 152,937	$ 568,912

Derivative Liabilities (Detai_2

Derivative Liabilities (Details) - Schedule of Valuation Assumptions - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Derivative Liabilities (Details) - Schedule of Valuation Assumptions [Line Items]
Volatility	540.40%
Stock Price (in Dollars per share)	$ 1.44
Risk-free interest rates	5.24%
Term (years)	7 months 9 days
Minimum [Member]
Derivative Liabilities (Details) - Schedule of Valuation Assumptions [Line Items]
Volatility		95.10%
Stock Price (in Dollars per share)		$ 1.06
Risk-free interest rates		4.35%
Term (years)		8 months 23 days
Maximum [Member]
Derivative Liabilities (Details) - Schedule of Valuation Assumptions [Line Items]
Volatility	159.60%	123.20%
Stock Price (in Dollars per share)	$ 0.025	$ 3.5
Risk-free interest rates	4.35%	4.37%
Term (years)	1 month 9 days	10 months 9 days

Stockholders_ Equity (Deficit_2

Stockholders’ Equity (Deficit) (Details) - USD ($)																																												3 Months Ended		9 Months Ended
	Sep. 29, 2023	Aug. 21, 2023	Jul. 01, 2023	Jun. 30, 2023	Jun. 29, 2023	May 09, 2023	May 05, 2023	Apr. 11, 2023	Apr. 04, 2023	Mar. 31, 2023	Mar. 28, 2023	Mar. 09, 2023	Feb. 28, 2023	Feb. 21, 2023	Feb. 14, 2023	Jan. 23, 2023	Nov. 18, 2022	Sep. 15, 2022	Sep. 14, 2022	Sep. 09, 2022	Sep. 02, 2022	Aug. 18, 2022	Aug. 04, 2022	Jul. 27, 2022	Jul. 26, 2022	Jul. 21, 2022	Jul. 07, 2022	Jun. 22, 2022	Jun. 09, 2022	Jun. 07, 2022	May 26, 2022	May 23, 2022	May 18, 2022	May 10, 2022	Apr. 27, 2022	Apr. 18, 2022	Apr. 06, 2022	Mar. 31, 2022	Mar. 31, 2022	Mar. 22, 2022	Mar. 18, 2022	Jan. 12, 2022	Jan. 05, 2022	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Mar. 23, 2023	Dec. 31, 2022
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common Stock, Shares Authorized (in Shares)																																												500,000,000		500,000,000			500,000,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)																																										$ 0.01		$ 0.01		$ 0.01			$ 0.01
Common Stock, Shares, Issued (in Shares)																																												5,544,519		5,544,519			4,630,372
Stock Issued During Period, Shares, Issued for Services (in Shares)														150,000		150,000							12,064
Shares Issued, Price Per Share (in Dollars per share)	$ 0.8													$ 2.53		$ 3.45							$ 6.42			$ 7.23
Share-Based Payment Arrangement, Expense														$ 379,500		$ 517,500
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	181,606
Stock Issued During Period, Value, New Issues																																														$ 1,583,500
Common Stock Dividends, Shares (in Shares)					20,212
Debt Conversion, Converted Instrument, Amount	$ 145,285
Gain on Conversion of Debt	138,531																																											$ 19,687	$ (10,000)	19,687	$ (88,235)
Accrued Salaries, Current																																										$ 19,032
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited (in Shares)																																										8,000
Shares Issued, Value, Share-Based Payment Arrangement, Forfeited																																										$ 4,000
Gains (Losses) on Restructuring of Debt																																										$ 15,032				100,950	0
Other Accrued Liabilities, Current																																												0		0			$ 507
Other Noncash Expense																																														1,027,778	0
Gain (Loss) on Waiver Fee Shares																																														0	198,273
Debt Instrument, Unamortized Discount																																												$ 0		$ 0			32,040
Class of Warrant or Rights, Granted (in Shares)																																														874
Stock Issued During Period, Value, Issued for Services																							$ 77,448																						77,448	$ 897,000	180,573
Preferred Stock, Shares Authorized (in Shares)																																												100,000,000		100,000,000
Dividends, Preferred Stock																																												$ 531,738	81,112	$ 1,080,102	241,196
Debt Related Commitment Fees and Debt Issuance Costs																																												1,214,970	0	7,644,077	0
Proceeds from Issuance of Preferred Stock and Preference Stock																																														738,500	0
Dividends, Preferred Stock, Stock																																														60,564	83,002
Stock Subscribed [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																																						$ 12.5	$ 12.5
Stock Issued During Period, Shares, Other (in Shares)																																							7,647
Waiver Fee [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, Other (in Shares)																																						30,834
Other Noncash Expense																																															385,431
Gain (Loss) on Waiver Fee Shares																																															198,273
Share-Based Payment Arrangement, Option [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount																																												$ 800,000		800,000
Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Amount	2,101
Accounts Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Amount																																														78,519	500,000
Convertible Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Amount	18,750																																													83,456	0
Accrued Salary [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Amount	64,434
Accrued Board Fees [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Amount	60,000
Accrued Dividends [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								$ 215,659
Investment Incentive [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								1,371,846
Two Investors [Member] | Series C Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Conversion of Stock, Amount Converted								1,100,000
Two Investors [Member] | Accrued Dividends [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Conversion of Stock, Amount Converted								171,109
Two Investors [Member] | Investment Incentive [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Conversion of Stock, Amount Converted								1,016,888
Two Investors [Member] | Series D Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Conversion of Stock, Amount Converted								2,467,500
GS Capital Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																												$ 10.45
Debt Conversion, Original Debt, Amount																																														$ 72,777
Debt Instrument, Convertible, Conversion Price (in Dollars per share)											$ 1.25	$ 1.5	$ 1.5		$ 1.74																													$ 1.46		$ 1.46
Debt Conversion, Converted Instrument, Shares Issued (in Shares)											18,472	15,265	13,555		9,846
Stock Issued During Period, Shares, New Issues (in Shares)																												12,741
Stock Issued During Period, Shares, Other (in Shares)																																				12,741
Derivative Liability																																				$ 21,920
Debt Instrument, Unamortized Discount																																				162,158
Debt Instrument, Fee Amount																																												$ 15,000		$ 15,000
Debt Instrument, Face Amount																																				$ 277,777
Debt Related Commitment Fees and Debt Issuance Costs								249,439
GS Capital Note [Member] | Principal [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								205,000			$ 20,000	$ 20,000	$ 17,777		$ 15,000
GS Capital Note [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount											$ 2,581	$ 2,399	$ 2,057		$ 1,632																															8,679
GS Capital Note [Member] | Default Penalty [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								138,889
GS Capital Note [Member] | Fees [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								15,000																																						57,140
Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																														$ 12.5
Stock Issued During Period, Shares, New Issues (in Shares)										8,063																				8,103
Accounts Payable 1 [Member] | Accounts Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)		$ 0.8
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		131,362
Debt Conversion, Converted Instrument, Amount		$ 105,089
Gain on Conversion of Debt		$ 59,112
Accounts Payable 2 [Member] | Accounts Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)		$ 0.8
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		43,750
Debt Conversion, Converted Instrument, Amount		$ 35,000
Gain on Conversion of Debt		$ 19,687
Accounts Payable 3 [Member] | Accounts Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)		$ 0.8
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		49,226
Debt Conversion, Converted Instrument, Amount		$ 39,380
Gain on Conversion of Debt		$ 22,151
AJB Capital Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								2,032,800
Stock Issued During Period, Shares, Other (in Shares)																	91,328
Derivative Liability																																						$ 106,608	$ 106,608		$ 106,608
Debt Instrument, Unamortized Discount																																									$ 349,914								0
Class of Warrant or Rights, Granted (in Shares)																																									15,000
Debt Instrument, Fee Amount																																												15,000		15,000
Debt Instrument, Face Amount																																									$ 750,000
Debt Instrument, Maturity Date																																									Mar. 17, 2023
Proceeds from Issuance of Debt																																									$ 675,000
Debt Related Commitment Fees and Debt Issuance Costs								800,800
AJB Capital Note [Member] | Principal [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								750,000
AJB Capital Note [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								92,000
AJB Capital Note [Member] | Default Penalty [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								375,000
AJB Capital Note [Member] | Fees [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								15,000
Accounts Payable [Member] | Stock Subscribed [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																							$ 95,558
Cavalry Fund 1 LP [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																																			$ 6.35
Stock Issued During Period, Shares, New Issues (in Shares)																																			14,400
Stock Issued During Period, Value, New Issues																																			$ 91,440
Gain (Loss) on Waiver Fee Shares																																			$ 88,560
Diamond Note 3 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																																			$ 8
Debt Conversion, Original Debt, Amount	509,277
Stock Issued During Period, Shares, New Issues (in Shares)																																			1,929
Stock Issued During Period, Value, New Issues																																			$ 16,200
Stock Issued During Period, Shares, Other (in Shares)																																			1,930
Gain (Loss) on Waiver Fee Shares																																			$ 765
Contract, Price per share (in Dollars per share)																																			$ 12.5
Debt Instrument, Unamortized Discount																																													6,478		6,478		0
Value of contract shares																																			$ 24,118
Commitment Shares Value																																			$ 15,434
Class of Warrant or Rights, Granted (in Shares)																																			1,929
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																																			$ 12.5
Debt Instrument, Face Amount																																			$ 235,294
Debt Instrument, Maturity Date																																			Nov. 30, 2022
Proceeds from Issuance of Debt																																			$ 200,000
Debt Related Commitment Fees and Debt Issuance Costs	200,624
Diamond Note 3 [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	49,830
Diamond Note 3 [Member] | Convertible Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	235,294
Diamond Note 3 [Member] | Investment Incentive [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	200,624
Diamond Note 3 [Member] | Premium on Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	23,529
Diamond Note 4 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																																	$ 7.585
Debt Conversion, Original Debt, Amount	101,402
Stock Issued During Period, Shares, New Issues (in Shares)																																	386
Stock Issued During Period, Value, New Issues																																	$ 3,160
Stock Issued During Period, Shares, Other (in Shares)																																	1,930
Gain (Loss) on Waiver Fee Shares																																	$ 249
Contract, Price per share (in Dollars per share)																																	$ 12.5
Debt Instrument, Unamortized Discount																																																	0
Class of Warrant or Rights, Granted (in Shares)																																	19,294
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																																	$ 12.5
Debt Instrument, Face Amount																																	$ 47,059
Debt Instrument, Maturity Date																																	Nov. 30, 2022
Proceeds from Issuance of Debt																																	$ 40,000
Debt Related Commitment Fees and Debt Issuance Costs	200,624
Diamond Note 4 [Member] | Warrants at $12.50 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																																	386
Diamond Note 4 [Member] | Warrants at $25.00 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																																	386
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																																	$ 25
Diamond Note 4 [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	9,691
Diamond Note 4 [Member] | Convertible Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	47,059
Diamond Note 4 [Member] | Investment Incentive [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	39,946
Diamond Note 4 [Member] | Premium on Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	4,706
Finnegan Note 1 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																																$ 8.97
Stock Issued During Period, Shares, New Issues (in Shares)																																386
Stock Issued During Period, Value, New Issues																																$ 3,240
Stock Issued During Period, Shares, Other (in Shares)																																1,930
Gain (Loss) on Waiver Fee Shares																																$ 222
Contract, Price per share (in Dollars per share)																																$ 12.5
Debt Instrument, Unamortized Discount																																$ 17,005													4,518		4,518		0
Class of Warrant or Rights, Granted (in Shares)																																19,295
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																																$ 12.5
Debt Instrument, Face Amount																																$ 47,059			$ 47,059
Debt Instrument, Maturity Date																																Nov. 20, 2022
Proceeds from Issuance of Debt																																$ 40,000
Finnegan Note 1 [Member] | Warrants at $12.50 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																																386
Finnegan Note 1 [Member] | Warrants at $25.00 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																																386
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																																$ 25
May26 Notes [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																															$ 7.585
Stock Issued During Period, Shares, New Issues (in Shares)																															1,688
Stock Issued During Period, Value, New Issues																															$ 14,175
Gain (Loss) on Waiver Fee Shares																															$ 1,369
Contract, Price per share (in Dollars per share)																															$ 12.5
Debt Instrument, Unamortized Discount																																													22,672		22,672
Class of Warrant or Rights, Granted (in Shares)																															84,412
Debt Instrument, Face Amount																															$ 205,883
Proceeds from Issuance of Debt																															$ 175,000
May26 Notes [Member] | Warrants at $25.00 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																															1,688
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																															$ 25
June9 Notes [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)																													7,284
Stock Issued During Period, Value, New Issues																													$ 66,400
Gain (Loss) on Waiver Fee Shares																													$ 9,356
Contract, Price per share (in Dollars per share)																													$ 12.5
Class of Warrant or Rights, Granted (in Shares)																													7,284
June9 Notes [Member] | Measurement Input, Share Price [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																													$ 7,425
June9 Notes [Member] | Warrants at $25.00 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																													$ 25
Dragon Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																												$ 10.45
Debt Conversion, Original Debt, Amount								1,176,676
Stock Issued During Period, Shares, New Issues (in Shares)																												4,824
Stock Issued During Period, Shares, Other (in Shares)																													4,824
Debt Instrument, Unamortized Discount																																																	0
Debt Instrument, Face Amount																													$ 588,235
Debt Instrument, Maturity Date																													Dec. 09, 2022
Proceeds from Issuance of Debt																													$ 500,000
Debt Related Commitment Fees and Debt Issuance Costs								463,539
Dragon Note [Member] | Warrants at $25.00 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																													4,824
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																													$ 25
Dragon Note [Member] | Principal [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								647,059
Dragon Note [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								66,078
Anson East Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																												$ 10.45
Debt Conversion, Original Debt, Amount								527,398
Stock Issued During Period, Shares, New Issues (in Shares)																												8,600
Stock Issued During Period, Shares, Other (in Shares)																																					8,600
Derivative Liability																																					$ 9,014
Debt Instrument, Unamortized Discount																																					147,290												0
Debt Instrument, Fee Amount																																												15,000		15,000
Debt Instrument, Face Amount																																					$ 187,500
Debt Related Commitment Fees and Debt Issuance Costs								207,763
Anson East Note [Member] | Principal [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								187,500
Anson East Note [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								23,385
Anson East Note [Member] | Default Penalty [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								93,750
Anson East Note [Member] | Fees [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								15,000
Anson Investments Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																												$ 10.45
Debt Conversion, Original Debt, Amount								1,530,222
Stock Issued During Period, Shares, New Issues (in Shares)																												25,800
Stock Issued During Period, Shares, Other (in Shares)																																					25,800
Derivative Liability																																					$ 27,040
Debt Instrument, Unamortized Discount																																					416,375												0
Debt Instrument, Fee Amount																																												$ 15,000		15,000
Debt Instrument, Face Amount																																					$ 562,500
Debt Related Commitment Fees and Debt Issuance Costs								602,815
Anson Investments Note [Member] | Principal [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								562,500
Anson Investments Note [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								68,657
Anson Investments Note [Member] | Default Penalty [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								281,250
Anson Investments Note [Member] | Fees [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								15,000
Mackay Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																											$ 7.45
Debt Conversion, Original Debt, Amount	655,606
Stock Issued During Period, Shares, New Issues (in Shares)																											2,412
Stock Issued During Period, Value, New Issues																											$ 12,500
Stock Issued During Period, Shares, Other (in Shares)																											2,412
Gain (Loss) on Waiver Fee Shares																											$ 5,456
Contract, Price per share (in Dollars per share)																											$ 12.5
Debt Instrument, Unamortized Discount																																																	0
Class of Warrant or Rights, Granted (in Shares)																											2,412
Debt Instrument, Face Amount																											$ 294,118
Debt Instrument, Maturity Date																											Aug. 10, 2022
Proceeds from Issuance of Debt																											$ 250,000
Debt Related Commitment Fees and Debt Issuance Costs	258,269
Mackay Note [Member] | Warrants at $25.00 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																											2,412
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																											$ 25
Mackay Note [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	63,807
Mackay Note [Member] | Convertible Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	294,118
Mackay Note [Member] | Investment Incentive [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	258,269
Mackay Note [Member] | Fees [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	10,000
Mackay Note [Member] | Premium on Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	29,412
Schrier Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																											$ 7.45
Stock Issued During Period, Shares, New Issues (in Shares)																											193
Stock Issued During Period, Value, New Issues																											$ 1,000
Stock Issued During Period, Shares, Other (in Shares)																											193
Gain (Loss) on Waiver Fee Shares																											$ 436
Contract, Price per share (in Dollars per share)																											$ 12.5
Debt Instrument, Unamortized Discount																																																	335
Class of Warrant or Rights, Granted (in Shares)																											193
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																											$ 12.5
Debt Instrument, Face Amount																											$ 23,259
Debt Instrument, Maturity Date																											Jan. 08, 2023
Proceeds from Issuance of Debt																											$ 20,000
Schrier Note [Member] | Warrants at $25.00 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																											$ 25
Iturregui Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	61,953
Stock Issued During Period, Shares, New Issues (in Shares)																										241
Stock Issued During Period, Value, New Issues																										$ 1,225
Stock Issued During Period, Shares, Other (in Shares)																										242
Gain (Loss) on Waiver Fee Shares																										$ 518
Contract, Price per share (in Dollars per share)																										$ 12.5
Debt Instrument, Unamortized Discount																																													5,867		5,867
Class of Warrant or Rights, Granted (in Shares)																										241
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																										$ 12.5
Debt Instrument, Face Amount																										$ 29,412
Debt Instrument, Maturity Date																										Jan. 21, 2023
Proceeds from Issuance of Debt																										$ 25,000
Debt Related Commitment Fees and Debt Issuance Costs	24,406
Share Price (in Dollars per share)																										$ 12.5
Iturregui Note [Member] | Warrants at $25.00 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																										242
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																										$ 25
Iturregui Note [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	5,194
Iturregui Note [Member] | Convertible Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	29,412
Iturregui Note [Member] | Investment Incentive [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	24,406
Iturregui Note [Member] | Premium on Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 2,941
Howe Note 3 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																										$ 7.23
Stock Issued During Period, Shares, New Issues (in Shares)																										2,460
Stock Issued During Period, Value, New Issues																										$ 12,495
Stock Issued During Period, Shares, Other (in Shares)																										2,460
Gain (Loss) on Waiver Fee Shares																										$ 5,729
Contract, Price per share (in Dollars per share)																										$ 12.5
Debt Instrument, Unamortized Discount																																													0		0
Class of Warrant or Rights, Granted (in Shares)																										2,460
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																										$ 12.5
Debt Instrument, Face Amount																										$ 300,000
Debt Instrument, Maturity Date																										Nov. 30, 2022
Proceeds from Issuance of Debt																										$ 255,000
Share Price (in Dollars per share)																										$ 12.5
Howe Note 3 [Member] | Warrants at $25.00 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																										$ 25
Nommsen Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																									$ 6.84
Stock Issued During Period, Shares, New Issues (in Shares)																									482
Stock Issued During Period, Value, New Issues																									$ 2,350
Stock Issued During Period, Shares, Other (in Shares)																									483
Gain (Loss) on Waiver Fee Shares																									$ 949
Contract, Price per share (in Dollars per share)																									$ 12.5
Debt Instrument, Unamortized Discount																																																	0
Class of Warrant or Rights, Granted (in Shares)																									482
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																									$ 12.5
Debt Instrument, Face Amount																									$ 58,823
Debt Instrument, Maturity Date																									Nov. 30, 2022
Proceeds from Issuance of Debt																									$ 50,000
Nommsen Note [Member] | Warrants at $25.00 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																									483
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																									$ 25
Caplan Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																							$ 6.42	$ 6.94
Stock Issued During Period, Shares, New Issues (in Shares)																							984	482
Stock Issued During Period, Value, New Issues																							$ 6,317	$ 2,350
Stock Issued During Period, Shares, Other (in Shares)																								483
Gain (Loss) on Waiver Fee Shares																								$ 995
Contract, Price per share (in Dollars per share)																							$ 12.5	$ 12.5
Class of Warrant or Rights, Granted (in Shares)																								482
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																								$ 12.5
Debt Instrument, Face Amount																								$ 58,823
Debt Instrument, Maturity Date																								Jan. 21, 2023
Proceeds from Issuance of Debt																								$ 50,000
Caplan Note [Member] | Warrants at $25.00 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																								483
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																								$ 25
Finnegan Note 3 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																							$ 6.42
Stock Issued During Period, Shares, New Issues (in Shares)																							241
Stock Issued During Period, Value, New Issues																							$ 1,000
Stock Issued During Period, Shares, Other (in Shares)																							242
Gain (Loss) on Waiver Fee Shares																							$ 448
Contract, Price per share (in Dollars per share)																							$ 12.5
Debt Instrument, Unamortized Discount																																													6,405		6,405		1,728
Class of Warrant or Rights, Granted (in Shares)																							241
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																							$ 12.5
Debt Instrument, Face Amount																							$ 29,412
Debt Instrument, Maturity Date																							Feb. 03, 2023
Proceeds from Issuance of Debt																							$ 25,000
Share Price (in Dollars per share)																							$ 12.5
Finnegan Note 3 [Member] | Warrants at $25.00 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)																							242
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																							$ 25
Howe Note 4 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																						$ 6.57
Stock Issued During Period, Shares, New Issues (in Shares)																						1,640
Stock Issued During Period, Value, New Issues																						$ 10,775
Stock Issued During Period, Shares, Other (in Shares)																						1,640
Contract, Price per share (in Dollars per share)																						$ 12.5
Debt Instrument, Unamortized Discount																																													35,647		35,647
Debt Instrument, Face Amount																						$ 200,000
Debt Instrument, Maturity Date																						Nov. 30, 2022
Proceeds from Issuance of Debt																						$ 170,000
Share Price (in Dollars per share)																						$ 12.5
Mitchell Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common Stock, Shares, Issued (in Shares)																					582
Shares Issued, Price Per Share (in Dollars per share)																					$ 5.37
Stock Issued During Period, Shares, New Issues (in Shares)																					582
Stock Issued During Period, Value, New Issues																					$ 3,124
Contract, Price per share (in Dollars per share)																					$ 12.5
Debt Instrument, Unamortized Discount																																																	0
Debt Instrument, Face Amount																					$ 71,000
Debt Instrument, Maturity Date																					Nov. 30, 2022
Proceeds from Issuance of Debt																					$ 60,350
Lightmas Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																					$ 5.37
Stock Issued During Period, Shares, New Issues (in Shares)																					492
Stock Issued During Period, Value, New Issues																					$ 2,640
Stock Issued During Period, Shares, Other (in Shares)																					492
Contract, Price per share (in Dollars per share)																					$ 12.5
Debt Instrument, Unamortized Discount																																																	0
Debt Instrument, Face Amount																					$ 60,000
Debt Instrument, Maturity Date																					Nov. 30, 2022
Proceeds from Issuance of Debt																					$ 51,000
Lewis Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																					$ 5.37
Stock Issued During Period, Shares, New Issues (in Shares)																					246
Stock Issued During Period, Value, New Issues																					$ 1,320
Stock Issued During Period, Shares, Other (in Shares)																					246
Contract, Price per share (in Dollars per share)																					$ 12.5
Debt Instrument, Unamortized Discount																																																	0
Debt Instrument, Face Amount																					$ 30,000
Debt Instrument, Maturity Date																					Nov. 30, 2022
Proceeds from Issuance of Debt																					$ 25,500
Goff Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																					$ 5.37
Stock Issued During Period, Shares, New Issues (in Shares)																					246
Stock Issued During Period, Value, New Issues																					$ 1,320
Stock Issued During Period, Shares, Other (in Shares)																					246
Contract, Price per share (in Dollars per share)																					$ 12.5
Debt Instrument, Unamortized Discount																																																	0
Debt Instrument, Face Amount																					$ 30,000
Debt Instrument, Maturity Date																					Nov. 30, 2022
Proceeds from Issuance of Debt																					$ 25,500
Hagan Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																				$ 5.75
Stock Issued During Period, Shares, New Issues (in Shares)																				820
Stock Issued During Period, Value, New Issues																				$ 4,715
Stock Issued During Period, Shares, Other (in Shares)																					820
Contract, Price per share (in Dollars per share)																				$ 12.5
Debt Instrument, Face Amount																					$ 100,000
Debt Instrument, Maturity Date																					Dec. 10, 2022
Proceeds from Issuance of Debt																					$ 85,000
Darling Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																			$ 6.6
Debt Conversion, Original Debt, Amount								390,738
Stock Issued During Period, Shares, New Issues (in Shares)																			1,640
Stock Issued During Period, Value, New Issues																			$ 10,824
Stock Issued During Period, Shares, Other (in Shares)																			1,640
Contract, Price per share (in Dollars per share)																			$ 12.5
Debt Instrument, Unamortized Discount																																																	0
Debt Instrument, Face Amount																			$ 200,000
Debt Instrument, Maturity Date																			Dec. 15, 2022
Proceeds from Issuance of Debt																			$ 170,000
Debt Related Commitment Fees and Debt Issuance Costs								153,927
Darling Note [Member] | Principal [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								220,000
Darling Note [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								$ 16,811
Leath Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																		$ 7
Stock Issued During Period, Shares, New Issues (in Shares)																		410
Stock Issued During Period, Value, New Issues																		$ 2,868
Stock Issued During Period, Shares, Other (in Shares)																		410
Contract, Price per share (in Dollars per share)																		$ 12.5
Debt Instrument, Unamortized Discount																																																	$ 0
Debt Instrument, Face Amount																		$ 50,000
Debt Instrument, Maturity Date																		Dec. 15, 2022
Proceeds from Issuance of Debt																		$ 42,500
Series A Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Adjustments to Additional Paid in Capital, Other																																														$ 10,967
Preferred Stock, Shares Authorized (in Shares)																																												500,000		500,000
Preferred Stock, Shares Issued (in Shares)																																												0		0			0
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)																																												$ 0.01		$ 0.01			$ 0.01
Preferred Stock, Shares Outstanding (in Shares)																																												0		0			0
Series A Preferred Stock [Member] | The Good Clinic [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred Stock, Dividend Rate, Percentage																																														10%
Series C Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)								2,289
Adjustments to Additional Paid in Capital, Other																																															981
Preferred Stock, Shares Authorized (in Shares)																																												3,000,000		3,000,000
Dividends, Preferred Stock																																														$ 17,603	49,700
Preferred Stock, Shares Issued (in Shares)								1,047,619																																				0		0			1,047,619
Conversion of Stock, Amount Converted								$ 1,100,000																																						$ 0	$ 981
Debt Related Commitment Fees and Debt Issuance Costs								1,016,888
Stock Issued During Period, Shares, Period Increase (Decrease) (in Shares)																																															98,064
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)																																												$ 0.01		$ 0.01			$ 0.01
Preferred Stock, Shares Outstanding (in Shares)																																												0		0			1,047,619
Series C Preferred Stock [Member] | Accrued Dividends [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Conversion of Stock, Amount Converted								171,109
Series C Preferred Stock [Member] | Two Investors [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Conversion of Stock, Amount Converted								2,287,997
Series D Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred Stock, Shares Authorized (in Shares)																																												10,000,000		10,000,000
Dividends, Preferred Stock																																														$ 76,307	$ 96,847
Preferred Stock, Shares Issued (in Shares)																																												750,000		750,000			3,100,000
Conversion of Stock, Amount Converted								$ 2,467,500
Conversion of Stock, Shares Converted (in Shares)								2,350,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)																																												$ 0.01		$ 0.01			$ 0.01
Preferred Stock, Shares Outstanding (in Shares)																																												750,000		750,000			3,100,000
Series D Preferred Stock [Member] | Two Investors [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Conversion of Stock, Amount Converted								$ 4,055,005
Series D Preferred Stock [Member] | Two Investors [Member] | Investment Incentive [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Conversion of Stock, Amount Converted								1,371,846
Series D Preferred Stock [Member] | Two Investors [Member] | Accrued Dividends [Member] | Accrued Dividends [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Conversion of Stock, Amount Converted								$ 215,659
Series E Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred Stock, Shares Authorized (in Shares)																																												10,000		10,000
Series F Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	911							4,055
Preferred Stock, Shares Authorized (in Shares)																																												140,000		140,000		140,000
Dividends, Preferred Stock																																														$ 940,769
Preferred Stock, Shares Issued (in Shares)																																												16,353		16,353			0
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)																																												$ 0.01		$ 0.01		$ 0.01	$ 0.01
Preferred Stock, Value, Outstanding																																																$ 1,000
Preferred Stock, Liquidation Preference Per Share (in Dollars per share)	$ 1,000
Preferred Stock, Shares Outstanding (in Shares)																																												16,353		16,353			0
Series F Preferred Stock [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 84,187
Series F Preferred Stock [Member] | Accounts Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount					$ 146,214
Debt Conversion, Converted Instrument, Shares Issued (in Shares)					147
Debt Conversion, Converted Instrument, Amount																																														$ 146,214	0
Series F Preferred Stock [Member] | Convertible Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	414,118
Debt Conversion, Converted Instrument, Amount																																														$ 11,158,379	0
Series F Preferred Stock [Member] | Investment Incentive [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	360,385
Series F Preferred Stock [Member] | Fees [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	10,000
Series F Preferred Stock [Member] | Premium on Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 41,412
Series F Preferred Stock [Member] | Nine Investors Member
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)								8,116
Debt Conversion, Converted Instrument, Amount								$ 8,111,334
Preferred Stock, Liquidation Preference Per Share (in Dollars per share)								$ 1,000
Series F Preferred Stock [Member] | Nine Investors Member | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								$ 365,012
Series F Preferred Stock [Member] | Nine Investors Member | Convertible Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								3,602,059
Series F Preferred Stock [Member] | Nine Investors Member | Investment Incentive [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								3,195,374
Series F Preferred Stock [Member] | Nine Investors Member | Default Penalty [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								888,889
Series F Preferred Stock [Member] | Nine Investors Member | Fees [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								$ 60,000
Series F Preferred Stock [Member] | Two Investors [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred Stock, Liquidation Preference Per Share (in Dollars per share)								$ 1,000
Series F Preferred Stock [Member] | Two Investors [Member] | Series C Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred Stock, Liquidation Preference Per Share (in Dollars per share)								$ 1,000
Conversion of Stock, Shares Issued (in Shares)								2,289
Series F Preferred Stock [Member] | Two Investors [Member] | Series D Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Conversion of Stock, Shares Issued (in Shares)								4,055
Series F Preferred Stock [Member] | Three Investors [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)								1,746
Preferred Stock, Liquidation Preference Per Share (in Dollars per share)								$ 1,000
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants								$ 1,745,000
Proceeds from Issuance of Preferred Stock and Preference Stock								900,000
Payments of Stock Issuance Costs								161,500
Series F Preferred Stock [Member] | Three Investors [Member] | Investment Incentive [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants								845,000
Series F Preferred Stock [Member] | Two Service Providers [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred Stock, Liquidation Preference Per Share (in Dollars per share)					$ 1,000
Series F Preferred Stock [Member] | GS Capital Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								$ 633,192
Debt Conversion, Converted Instrument, Shares Issued (in Shares)								634
Series F Preferred Stock [Member] | GS Capital Note [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount								$ 24,864
Series F Preferred Stock [Member] | AJB Capital Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)								2,033
Series F Preferred Stock [Member] | Diamond Note 3 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	509
Series F Preferred Stock [Member] | Diamond Note 4 [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	101
Series F Preferred Stock [Member] | Dragon Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)								1,177
Series F Preferred Stock [Member] | Anson East Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)								528
Series F Preferred Stock [Member] | Anson Investments Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)								1,531
Series F Preferred Stock [Member] | Mackay Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	656
Series F Preferred Stock [Member] | Iturregui Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	62
Series F Preferred Stock [Member] | Darling Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)								391
Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common Stock Dividends, Shares (in Shares)																														8,103																28,275
Preferred Stock, Shares Authorized (in Shares)																																												27,324		27,324
Dividends, Preferred Stock																																														$ 45,423	45,423
Preferred Stock, Shares Issued (in Shares)																																												24,227		24,227			24,227
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)																																												$ 0.01		$ 0.01			$ 0.01
Preferred Stock, Liquidation Preference Per Share (in Dollars per share)																																												$ 25		$ 25
Preferred Stock, Shares Outstanding (in Shares)																																												24,227		24,227			24,227
Preferred Stock, Dividend Payment Terms																																														The Company reserves the right to pay the dividends in shares of the Company’s common stock at a price equal to the average closing price over the five days prior to the date of the dividend declaration.
Share Price (in Dollars per share)			$ 0.80
Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Offering Date			20%
Preferred Stock, Voting Rights																																														Each one share of the Series X Preferred Stock is entitled to 400 votes on all matters submitted to a vote of our shareholders.
Preferred Stock, Dividends Per Share, Declared (in Dollars per share)																														$ 10.75
Dividends, Preferred Stock, Stock																														$ 87,053
Series X Preferred Stock [Member] | Officers And Directors [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Dividends, Preferred Stock																																														$ 5,905
Common Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Share Price (in Dollars per share)			$ 1
Principal [Member] | Officers And Directors [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common Stock Dividends, Shares (in Shares)																																														3,739
Consultant [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)									2,952
Common Stock, Dividends, Per Share, Declared (in Dollars per share)									$ 1.29
Stock Issued During Period, Value, New Issues									$ 33,092
GS Capital Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)									94,738
Stock Issued During Period, Value, New Issues									$ 21,506
Vendor [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)							2,552
Common Stock, Dividends, Per Share, Declared (in Dollars per share)							$ 0.85
Howe Trust [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)						19,622
Common Stock, Dividends, Per Share, Declared (in Dollars per share)						$ 0.85
Officer [Member] | Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)										1,066
Majority Shareholder [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common Stock Dividends, Shares (in Shares)					10,426
Majority Shareholder [Member] | Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)										4,160
Majority Shareholder [Member] | Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common Stock Dividends, Shares (in Shares)																																														14,586
Dividends, Preferred Stock																																														$ 23,620
Nonrelated Party [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common Stock Dividends, Shares (in Shares)					7,113
Proceeds from Issuance of Debt																																														0	1,812,500
Dividends, Preferred Stock																																												$ 530,502	52,723	$ 1,001,745	186,219
Nonrelated Party [Member] | Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)										2,837
Nonrelated Party [Member] | Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common Stock Dividends, Shares (in Shares)																																														9,950
Officers And Directors [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common Stock Dividends, Shares (in Shares)					2,673
Board [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)					2,926
Board [Member] | Accounts Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)					$ 12.5
Debt Conversion, Original Debt, Amount				$ 36,575
Gardner Agreement [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																																											$ 12.5
Debt Conversion, Converted Instrument, Amount																																											$ 500,000
Other Accrued Liabilities, Current																																											$ 294,912
Gardner Agreement [Member] | Restricted Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																																											63,593
AJB Capital Investors [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)																																							34,400
Contract, Price per share (in Dollars per share)																																							$ 12.5
Adjustments to Additional Paid in Capital, Other																																							$ 226,106
AJB Capital Investors [Member] | Valuation, Market Approach [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																																						$ 6.14	$ 6.14
AJB Capital Investors [Member] | AJB Capital Note [Member] | Warrant and Commitment Fees [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Instrument, Unamortized Discount																																						$ 349,914	$ 349,914
Service Provider [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																																			$ 6.88
Stock Issued During Period, Shares, New Issues (in Shares)																																			15,000
Kishon Investments SPA [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)																																		12,741
Debt Instrument, Unamortized Discount																																		$ 27,777
Class of Warrant or Rights, Granted (in Shares)																																		5,556
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																																		$ 12.5
Debt Instrument, Fee Amount																																		$ 159,259
Debt Instrument, Face Amount																																		$ 277,777
Debt Instrument, Maturity Date																																		Nov. 10, 2022
Proceeds from Issuance of Debt																																		$ 250,000
Chief Executive Officer [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																																			$ 0.16					$ 0.127
Stock Issued During Period, Shares, Other (in Shares)																																			0.25					168,221
Class of Warrant or Rights, Granted (in Shares)																																			92,942
Share Price (in Dollars per share)																																			$ 12.5					$ 0.25
Chief Executive Officer [Member] | Measurement Input, Share Price [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)																																			$ 24,118
Chief Executive Officer [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																														$ 115,381
Chief Executive Officer [Member] | Convertible Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																														534,927
Chief Executive Officer [Member] | Accrued Salary [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																														250,106
Chief Executive Officer [Member] | Investment Incentive [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																														634,114
Chief Executive Officer [Member] | Premium on Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																														$ 75,146
Chief Executive Officer [Member] | Series F Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	2,138																																													1,610
Chief Executive Officer [Member] | Series F Preferred Stock [Member] | Convertible Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 601,839
Chief Executive Officer [Member] | Series F Preferred Stock [Member] | Premium on Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	78,087
Related Party [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Instrument, Unamortized Discount																																												0		$ 0			$ 22,670
Proceeds from Issuance of Debt																																														0	2,918,100
Dividends, Preferred Stock																																												$ 1,236	$ 28,389	78,357	$ 54,977
Related Party [Member] | Series F Preferred Stock [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	124,777
Related Party [Member] | Series F Preferred Stock [Member] | Accrued Salary [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	376,625
Related Party [Member] | Series F Preferred Stock [Member] | Accrued Board Fees [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	112,500
Related Party [Member] | Series F Preferred Stock [Member] | Investment Incentive [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 843,228
Non-Related Parties [Member] | Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Dividends, Preferred Stock																																														$ 15,898

Stockholders_ Equity (Deficit_3

Stockholders’ Equity (Deficit) (Details) - Share-based Payment Arrangement, Option, Exercise Price Range - $ / shares	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Share Based Payment Arrangement Option Exercise Price Range Abstract
Range of exercise prices	$ 1.5
Range of exercise prices	$ 16
Number of options outstanding (in Shares)	100,934	310,692
Weighted average remaining contractual life (years)	7 years 4 months 28 days
Weighted average exercise price of outstanding options	$ 10.05	$ 10.01
Number of options exercisable (in Shares)	15,767
Weighted average exercise price of exercisable options	$ 15.48

Stockholders_ Equity (Deficit_4

Stockholders’ Equity (Deficit) (Details) - Share-based Payment Arrangement, Option, Activity	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Share Based Payment Arrangement Option Activity Abstract
Outstanding, Number of Shares | shares	310,692
Outstanding, Weighted-Average Exercise Price | $ / shares	$ 10.01
Options Vested and Exercisable, Number of Shares | shares	15,767
Options Vested and Exercisable, Weighted-Average Exercise Price | $ / shares	$ 15.48
Granted, Number of Shares | shares	0
Granted, Weighted-Average Exercise Price | $ / shares	$ 0
Cancelled/Expired, Number of Shares | shares	(209,758)
Cancelled/Expired, Weighted-Average Exercise Price | $ / shares	$ 10
Outstanding, Number of Shares | shares	100,934
Outstanding, Weighted-Average Exercise Price | $ / shares	$ 10.05

Stockholders_ Equity (Deficit_5

Stockholders’ Equity (Deficit) (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Schedule Of Stockholders Equity Note Warrants Or Rights Abstract
Outstanding, Number of Shares | shares	672,334
Outstanding, Weighted Average Exercise Price | $ / shares	$ 30.68
Granted, Number of Shares | shares	874
Granted, Weighted Average Exercise Price | $ / shares	$ 2.5
Exercised, Number of Shares | shares	0
Exercised, Weighted Average Exercise Price | $ / shares	$ 0
Outstanding, Number of Shares | shares	673,208
Outstanding, Weighted Average Exercise Price | $ / shares	$ 30.64

Fair Value Financial Instrume_3

Fair Value Financial Instruments (Details) - Schedule of Derivative Financial Liabilities at Fair Value - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Fair Value Financial Instruments (Details) - Schedule of Derivative Financial Liabilities at Fair Value [Line Items]
Derivative liabilities	$ 152,937	$ 568,912
Fair Value, Inputs, Level 1 [Member]
Fair Value Financial Instruments (Details) - Schedule of Derivative Financial Liabilities at Fair Value [Line Items]
Derivative liabilities	0	0
Fair Value, Inputs, Level 2 [Member]
Fair Value Financial Instruments (Details) - Schedule of Derivative Financial Liabilities at Fair Value [Line Items]
Derivative liabilities	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value Financial Instruments (Details) - Schedule of Derivative Financial Liabilities at Fair Value [Line Items]
Derivative liabilities	$ 152,937	$ 568,912

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)		9 Months Ended
	Oct. 25, 2022	Sep. 30, 2023	Jun. 30, 2023
Commitments and Contingencies (Details) [Line Items]
Lease Termination Commitment Due			$ 25,000
Loss Contingency, Settlement Agreement, Terms		This settlement calls for (i) a stipulated judgment of $231,353, which includes all back rent and front rent through November 2023; (i) Interest of $16,700;(iii) Late fees of $22,434; (iv) attorney fees of $24,888; (v) Costs of $2,300.
Paid to Plaintiff [Member]
Commitments and Contingencies (Details) [Line Items]
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares	2,552
Paid to CEO [Member]
Commitments and Contingencies (Details) [Line Items]
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares	19,622
Payments for Legal Settlements	$ 3,000

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)

Feb. 09, 2024

Dec. 22, 2023

Dec. 21, 2023

Dec. 08, 2023

Nov. 14, 2023

Oct. 10, 2023

Sep. 29, 2023

Jun. 29, 2023

Apr. 11, 2023

Feb. 21, 2023

Jan. 23, 2023

Aug. 04, 2022

Jul. 21, 2022

Subsequent Events (Details) [Line Items]

Shares Issued, Price Per Share (in Dollars per share)

$ 0.8

$ 2.53

$ 3.45

$ 6.42

$ 7.23

Common Stock Dividends, Shares (in Shares)

20,212

Litigation Settlement, Amount Awarded to Other Party

$ 488,491

Loss Contingency, Damages Sought, Value

$ 421,678

$ 421,678

Loss Contingency, Actions Taken by Defendant

We have countered with a redline of the proposed Settlement Agreement in the amount of $256,727

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

181,606

Debt Conversion, Converted Instrument, Amount

$ 145,285

Accrued Salary [Member]

Subsequent Events (Details) [Line Items]

Debt Conversion, Converted Instrument, Amount

$ 64,434

Series D Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Conversion of Stock, Shares Converted (in Shares)

2,350,000

Conversion of Stock, Amount Converted

$ 2,467,500

Series F Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

911

4,055

Subsequent Event [Member]

Subsequent Events (Details) [Line Items]

Stock Issued During Period, Shares, New Issues (in Shares)

23,438

Shares Issued, Price Per Share (in Dollars per share)

$ 0.8

Debt Conversion, Original Debt, Amount

$ 18,750

Common Stock Dividends, Shares (in Shares)

41,057

Noncash or Part Noncash Divestiture, Amount of Consideration Received

$ 2,500,000

Other Significant Noncash Transaction, Consideration Received

Consideration consisted of cancelling existing notes payable and accrued interest owed to Mr. Howe in the amount of approximately $2.5 million.

Conversion of Stock, Amount Converted

$ 500,000

Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants

600,000

Subsequent Event [Member] | Accrued Dividends [Member]

Subsequent Events (Details) [Line Items]

Conversion of Stock, Amount Converted

67,000

Subsequent Event [Member] | Accrued Salary [Member]

Subsequent Events (Details) [Line Items]

Debt Conversion, Original Debt, Amount

38,000

Debt Conversion, Incentive, Amount

25,000

Subsequent Event [Member] | Conversion Incentive [Member]

Subsequent Events (Details) [Line Items]

Debt Conversion, Original Debt, Amount

25,000

Subsequent Event [Member] | Gardner Builders Minneapolis [Member]

Subsequent Events (Details) [Line Items]

Litigation Settlement, Amount Awarded to Other Party

$ 348,764

Litigation Settlement, Interest Rate, Percent

12%

Subsequent Event [Member] | Howe [Member]

Subsequent Events (Details) [Line Items]

Debt Conversion, Incentive, Amount

25,554

Subsequent Event [Member] | Howe [Member] | Accrued Salary [Member]

Subsequent Events (Details) [Line Items]

Debt Conversion, Original Debt, Amount

39,300

Subsequent Event [Member] | Howe [Member] | Conversion Incentive [Member]

Subsequent Events (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 25,545

Subsequent Event [Member] | Series D Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Conversion of Stock, Shares Converted (in Shares)

500,000

Subsequent Event [Member] | Series F Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Stock Issued During Period, Shares, New Issues (in Shares)

655

Subsequent Event [Member] | Series F Preferred Stock [Member] | Howe [Member]

Subsequent Events (Details) [Line Items]

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

65

Debt Conversion, Converted Instrument, Amount

$ 65,000

Unpaid Back Rent [Member]

Subsequent Events (Details) [Line Items]

Loss Contingency, Damages Sought, Value

178,542

Mechanics Liens [Member]

Subsequent Events (Details) [Line Items]

Loss Contingency, Damages Sought, Value

172,124

Attorneys Fees [Member]

Subsequent Events (Details) [Line Items]

Loss Contingency, Damages Sought, Value

$ 64,600